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Abstract 
 Cell-derived microvesicles (MVs) are naturally released into the human 
circulation and an increase in the concentration of certain MV populations have 
been observed after exercise. However, the MV appearance dynamics, the 
exercise-related stimuli that induce their formation and physiological relevance 
are poorly understood. Hence, the overall objectives of this thesis were to: 1) 
characterise the circulating platelet (PMV) and endothelial-derived MVs (EMVs) 
responses during exercise and recovery, as well as their arteriovenous 
dynamics, 2) investigate the potential role of haemodynamic forces on MVs 
formation in vivo by vascular shear stress manipulations, and 3) explore the 
putative proliferative, chemotactic and angiogenic potential of exercise-derived 
MVs upon human vascular endothelial cells in vitro. Chapter 5 of this thesis 
describes the time-course of MV appearance in response to prolonged cycling, 
and demonstrates that intravascular [PMV] increases during and after exercise 
performed in the heavy intensity domain, whereas [EMV] remains unaltered. 
Moreover, [PMV] during exercise was related to estimates of vascular shear 
stress and plasma noradrenaline levels. Results from chapter 6 revealed that 
PMVs increased in the arterial circulation during passive heat stress, and in the 
arterial as well as venous circulation during short duration very heavy exercise 
engaging either a large or small muscle mass. The increases in [PMV] were not 
directly linked to local changes in vascular shear stress through heat stress and 
exercise, indicating a systemic PMV response. Finally, chapter 7 revealed that 
exercise-derived MVs supported endothelial proliferation and migration, while 
displaying pro-angiogenic potential in vitro. In conclusion, results of this thesis 
provide original information about MV dynamics, by demonstrating that PMV 
increase systemically in the circulation not only after but during exercise 
involving a small and large muscle mass. This MV response seems to be 
modulated by exercise intensity, and is only partially linked to levels of vascular 
shear stress. Moreover, circulating MVs produced during exercise present 
stimulatory angiogenic and mitogenic effects upon endothelial cells in vitro, 
suggesting a novel potential link between vascular adaptation and exercise 
training.  
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1. Chapter 1 - Introduction 
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1.1. Study background 
In recent years, great interest has been placed on understanding the 
relevance of cell-derived microvesicles (MVs) in health and disease. The 
interchangeable terms “microvesicle” and “microparticle” refer to biologically 
active subcellular packages shed by the plasma membrane of various cells 
(Jimenez et al., 2003; Shantsila et al., 2010), and were originally observed as 
by-products of platelets in the late 60’s (Wolf, 1967). Contemporary evidence 
indicates that several pathological conditions, including cardiovascular 
disorders, are linked with increased levels of circulating MVs (Shantsila et al., 
2010), and disturbed levels of these tiny vesicles may even impair endothelial 
function (Boulanger et al., 2001; Vanwijk et al., 2002). Certain MVs, however, 
have been reported to increase within the intravascular space after exercise, 
suggesting that variations in the concentration of these extracellular vesicles 
may be a necessary physiological response. 
 The rise in blood concentrations of MVs have been primarily explored 
during the recovery period, with several authors reporting an increase in certain 
populations of MVs at some point after the exercise bout (Sossdorf et al., 2010; 
Chaar et al., 2011; Sossdorf et al., 2011; Lansford et al., 2015). Identifying the 
underlying mechanisms leading to acute adjustments to exercise is an 
important step in understanding the physiological effects of exercise, but 
currently the influence of different variables, such as exercise intensity and 
volume, have been overlooked. Since studies primarily focused on changes in 
MV concentration during recovery, the MV responses during exercise are also 
unknown. Moreover, our understanding of acute exercise bouts on intravascular 
MVs is restricted to data obtained from the venous circulation draining non-
exercising limbs, and information about stimuli leading to their release remains 
sparse.  
Increased physical activity levels have been known for sometime to 
protect against cardiovascular diseases by improving the profile of blood lipids, 
inflammatory factors, and arterial pressure, but amelioration of these and 
additional traditional risk factors with exercise seems to explain only ~50-60% of 
its protective effect against cardiovascular diseases (Mora et al., 2007). Part of 
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the beneficial cardiovascular effects caused by chronic exercise (i.e. training) 
may be a consequence of enhanced endothelial function (Jensen-Urstad et al., 
1999; DeSouza et al., 2000; Tanaka et al., 2000; Walsh et al., 2003), which is 
thought to occur in response to repetitive increases in vascular shear stress 
(Credeur et al., 2010; Tinken et al., 2010; Birk et al., 2012), but other 
mechanisms may also act in synergy to bring about endothelial adaptations 
(Padilla et al., 2011a). In this context, in vitro work outside the area of exercise 
indicates that certain MVs found in the circulation can protect endothelial cells 
(Kim et al., 2004). Hence, it seems possible that exercise-derived circulating 
MVs may interact with endothelial cells and serve as a circulating messenger 
involved in the translation of exercise stress upon vascular adaptations. 
Therefore, to further the present knowledge and understanding on how 
intravascular MVs respond to exercise and interact with the surrounding milieu, 
this thesis aims to explore the dynamics MV appearance in the circulation 
during and after moderate and heavy exercise, investigate potential 
mechanisms linked to their formation in response to exercise in vivo, and look at 
potential effects of exercise-derived MVs upon endothelial cell activity in vitro. 
The next chapter presents a general overview of the literature related to MVs, 
exercise and the vascular endothelium, followed by the thesis aims and 
hypotheses and the general methods used in the experimental chapters. 
Finally, results derived from in vivo (chapter 5 and 6) and in vitro (chapter 7) 
experiments will be presented, followed by the overall discussion and 
conclusions. 
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2. Chapter 2 - Literature Review 
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2.1. Circulating microvesicles 
 The history of microvesicle research dates back to 1967 when Peter Wolf 
first identified subcellular coagulant elements derived from platelets, which he 
called “platelet dust” (Wolf, 1967). These platelet products, later named MVs, 
displayed significant coagulant activity, inducing clot formation even in platelet 
free plasma. At the beginning of the next decade platelet membrane 
vesiculation after incubation with thrombin was imaged by electron microscopy 
(Webber & Johnson, 1970), providing some of the first images of MVs (Hargett 
& Bauer, 2013). Over the following years MVs were quantified in various 
biological fluids by different techniques including enzyme-linked immunosorbent 
assay (ELISA), nanoparticle tracking analysis, flow cytometry, with the recent 
advent of image flow cytometers enabling scientists not only quantify the 
number of MV, but also visualise each of them individually. 
 Today it is recognised that altered blood MV levels are associated with 
unhealthy or pathological conditions, with augmented levels reported in obesity 
(Esposito et al., 2006; Dimassi et al., 2016), dyslipidaemia (Amabile et al., 
2014), metabolic syndrome (Amabile et al., 2014), and coronary artery disease 
(CAD) (Bernal-Mizrachi et al., 2003) to list a few conditions. In addition, some 
MV populations correlate positively with poor vascular outcomes, such as 
endothelial dysfunction (Esposito et al., 2006) and increased arterial stiffness 
(Wang et al., 2007a), indicating a role of extracellular vesicles in the 
pathophysiology of cardiovascular diseases. Furthermore, abnormally reduced 
MV concentrations have been observed to be detrimental. For example, a low 
blood MV concentration is believed to be one of the underlying mechanisms 
involved in Scott syndrome, a rare haemorrhagic disorder (Morel et al., 2011); 
whereas ageing, an independent risk factor for cardiovascular disease, has 
been linked to a reduced basal endothelial microvesicle (EMV) concentration 
(Forest et al., 2010). 
 Based on the above mentioned research, it is reasonable to believe that 
MVs concentrations have a physiological functional range that helps maintain 
homeostasis, outside which they may induce a pathological phenotype. This 
concept, however, may be too simplistic to explain the multifaceted roles these 
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subcellular vesicles play, as they have also been reported to promote a dose-
dependent protective phenotype in cultured endothelial cells (Kim et al., 2004), 
and have been speculated to increase in the circulation as a compensatory 
mechanism under certain conditions (Dimassi et al., 2016). These data 
associated with the fact that physical exercise (which brings about well-known 
benefits for the vascular system) can stimulate a temporary appearance of MVs 
in the circulation during recovery. This implies that these vesicles may play 
varied roles in the cardiovascular system. In this chapter, a review of the current 
literature about the interplay between MVs, the vascular endothelium and 
exercise, will be presented in order to provide the rationale for the studies of this 
thesis.  
 
2.1.1. Quantification and phenotyping of microvesicles 
 By standard definition, MVs are anucleated cell-derived particles ranging 
between 0.1 to 1 µm in diameter with no synthetic capabilities (Freyssinet, 
2005; Hargett & Bauer, 2013). Although some size overlap exists, extracellular 
vesicles smaller than 0.1 µm may be considered exosomes, while those larger 
than 1 µm fall within the group termed apoptotic bodies, both of which differ 
from MV in their formation process and function (Curtis et al., 2013). The 
current understanding is that MVs may serve as biomarkers of cellular state 
since they carry parent-cell specific proteins which may change according to 
stimulatory conditions (Jimenez et al., 2003). 
 Studies aiming to investigate cell-derived MVs have applied a variety of 
techniques. Studies employing electron microscopy for MV visualisation were 
very useful in characterising their release (Webber & Johnson, 1970; Cantaluppi 
et al., 2012) (Figure 2-1). However, the primarily qualitative and time consuming 
nature of this technique forced researchers to rely on different methods for high 
throughput quantitative measurements. To overcome shortcomings related to 
the clinical quantification of MVs, researchers have frequently opted for flow 
cytometry. This technique has become the most common method for MV 
quantification, due to its rapid processing, enabling researchers to extract a 
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large amount of information from a single sample. Flow cytometry, however, is 
not without limitations and is beset with sensitivity issues since traditional 
cytometers frequently demonstrate a limit of detection for single calibration 
beads (that have greater refractive index than MVs) between 200-300 nm in 
diameter, and smaller vesicles can be misidentified as single events (van der 
Pol et al., 2012). This gave rise to the “iceberg” hypothesis, which suggests that 
MV quantification is underestimated by traditional cytometers (Harrison & 
Gardiner, 2012). Fortunately, technological progress in this field has facilitated 
the commercialisation of cytometers with improved spatial resolution, and 
enabled the development of image flow cytometry technology. The sole 
commercial devise is marketed as the ImageStreamX® by Amnis Corporation, 
and combines the throughput of flow cytometry with the imaging capability of 
microscopy. A recent publication by Headland et al. (2014) reported a striking 
capacity of the ImageStreamX® Mark II in identifying events as small as 20 nm, 
when side scatter (SSC) signals were analysed combined with 60x camera 
magnification. If this applies to biological fluids, the quantification events within 
the whole size spectrum of MVs would be possible, but this possibility still 
demands further confirmatory data. 
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Figure 2-1. Example of transmission electron microscopy images of cell-derived microvesicle 
(MV) (A and B), and of image flow cytometric MV gating (C). Cell plasma membrane 
reorganisation results in shedding of microvesicles (A), which are round-shaped in suspension 
(B). A and B were adapted from other authors (Cantaluppi et al., 2012) 
 
 The expression of unique antigens on the surface of MVs permits the 
determination of their cell source. For example, platelet derived microvesicles 
(PMV) can be identified by the presence of platelet proteins such as 
glycoprotein IIb (CD41) or glycoprotein Ibα (CD42b) (Shantsila et al., 2010; 
Headland et al., 2014). Those of endothelial origin do not express exclusive 
platelet antigens but may carry platelet-endothelial cell adhesion molecule 
(CD31), or E-selectin (CD62E) when shed during apoptotic or activation 
processes, respectively (Jimenez et al., 2003); whereas monocyte 
microvesicles have been identified by the expression of the lipopolysaccharide-
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receptor (Sossdorf et al., 2011; Headland et al., 2014). Some early approaches 
in the identification of MVs limited phenotyping to vesicles that expressed 
phosphatidylserine (PS) (Sossdorf et al., 2010, 2011), owing to the concept that 
MV formation always involved an inversion of the plasma membrane structure 
with negatively charged phospholipids, including PS, apparent on the outer 
leaflet of the membrane. Recent data, however, challenges the definition that 
MVs must present anionic phospholipids, since almost 80% of MVs derived 
from unstimulated platelets have been shown to not stain positively for annexin-
V (Connor et al., 2010). Hence, the quantification of MVs in some more recent 
publications has been based exclusively on the expression of cell-derived 
antigens (Guiraud et al., 2013; Lansford et al., 2015), with annexin-V+ MVs 
suggested to reflect a specific pro-coagulant subpopulation (Connor et al., 
2010).  
 Several other methods for extracellular vesicle detection exist, including 
Raman spectroscopy, and the recently developed nanoparticle tracking analysis 
(van der Pol et al., 2014b). The antigenic MV properties have also allowed the 
adaptation of antibody capture assays to immobilise and quantify these 
extracellular vesicles. Researchers have been successful in quantifying certain 
circulating MV populations using an ELISA approach (Curtis et al., 2009; 
Maruyama et al., 2012), which is promising because it may enable the 
determination of MVs routinely in more clinical settings. Nevertheless, it is most 
likely that flow cytometry will remain the dominant research technique for 
circulating MV quantification in the upcoming years, due to its already well 
established protocols and relative simplicity. 
 
2.1.2. Mechanisms of microvesicle formation 
 The production of MVs is initiated by a combination of orchestrated 
events. It has been recognised that, under stimulation of a myriad of agonists 
(Table 2-1) human cells undertake recruitment of sequential pathways generally 
resulting in cytoskeleton proteolysis and cell shrinkage, leading to the blebbing 
of MVs (Chang et al., 1993; Morel et al., 2011). Since extracellular vesicles of 
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platelet origin were the first identified and constitute the predominant 
subpopulation in human plasma, most early investigations regarding their 
underlying mechanisms of generation were based on PMVs, nonetheless more 
recent work has focused on the agonists responsible for the formation of EMVs. 
 
Table 2-1. Example of stimuli related to microvesicle formation 
Stimulus   
Platelet 
Microvesicle 
Endothelial 
Microvesicle 
 
Reference 
High shear stress 
 
+ -  
Miyazaki et al. (1996), 
Reininger et al. (2006), 
Vion et al. (2013b) 
 
Low shear stress 
 
- +  
Vion et al. (2013b) 
 
Wall stretching 
 
? +  
Vion et al. (2013a) 
 
TNF-α 
 
? +  
Jimenez et al. (2003) 
 
IL-1α  ? +  
Abid Hussein et al. (2008) 
 
IL-6 
 
+ ?  
Nomura et al. (2000) 
 
C-reactive protein 
 
? +  
Wang et al. (2007) 
 
Angiotensin II 
 
? +  
Burger et al. (2011) 
 
Thrombin   + +  
Brill et al. (2005) 
Sapet et al. (2006) 
Noradrenaline  + ?  Tschuor et al. (2008) 
TNF-α, tumor necrosis factor α; IL-1α, interleukin-1α; IL-6, interleukin-6; + increase; - no change; ? 
unknown. 
 
 An intact platelet membrane presents asymmetric phospholipid 
distribution with negatively charged varieties, such as PS, located on the inner 
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leaflet, whereas neutral phospholipids are found on the outer membrane leaflet. 
Amongst platelets, PS serves as a catalytic site for thrombin generation, which 
explains in part the potent pro-coagulant activity of MVs expressing PS (Abid 
Hussein et al., 2008; Connor et al., 2010). Hence, to maintain proper cellular 
function and to regulate vascular haemostasis, this irregular membrane 
distribution is required and can be altered when necessary. The abundance of 
PS on the cytosolic leaflet of the cell membrane is regulated by the 
aminophospholipid translocases flippase and floppase (Chang et al., 1993). 
Flippase are ATP-dependent proteins that transport PS to the inner membrane, 
whereas the floppase can disturb membrane asymmetry by outward 
translocation of this phospholipid. During cellular activation or apoptosis, a 
randomization in membrane phospholipid content occurs, resulting in an 
increased appearance of PS on the outer membrane, which coupled with 
cytoskeleton reorganisation through the activation of intracellular pathways, 
induce membrane remodelling and shedding of newly formed MVs that may 
express PS on their surface (Morel et al., 2011). 
The presence of PS on the MV surface can be detected by the binding of 
annexin-V, and this feature was initially considered an essential amongst MV 
populations, leading to the concepts that 1) their formation depended on the 
loss of cellular membrane phospholipid asymmetry with PS extrusion, and 2) 
that all MVs exposed this negatively charged phospholipid. However, PS 
exposure alone does not necessarily initiate vesiculation in platelets (Dachary-
Prigent et al., 1995), indicating that this event is linked to, but not a cause of MV 
formation. The intra-cellular pathways that eventually result in vesiculation are 
actually multifaceted and depend on the stimulatory agonist and cell type 
(Figure 2-2). The activation of calcium-dependent proteins was initially 
suggested as a central mechanism in platelet vesiculation, as Chang et al. 
(1993) observed an increase in PS translocation, and MV release from platelets 
when their cytoplasmatic Ca2+ concentrations were increased through agonist 
stimulation. Calcium chelating agents eliminated this agonist-induced PS 
migration to the outer membrane and PMV formation, reinforcing the 
involvement of a Ca2+-dependent pathway in these processes. This particular 
vesiculation pathway may be governed by the activation of Ca2+-dependent 
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proteases with subsequent cytoskeleton reorganisation. For example, Dachary-
Pringent et al. (1995) confirmed that Ca2+-ATPase inhibition, which elevates 
intracellular Ca2+, led to subsequent MV release from platelets, with specific 
blocking of 97 kDa Ca2+-ATPase protein blunting both calpain activity and 
platelet vesiculation. Furthermore when direct calpain inhibitors were applied a 
marked reduction PMV formation was observed (Fox et al., 1991). 
 
 
Figure 2-2. Example of agonists and pathways related to platelet microvesicle (PMV) and 
endothelial microvesicle (EMV) formation. In endothelial cells (bottom), low shear stress may 
activate the Ros homolog gene family, member A (RhoA)/Rho-associated, coiled-coil containing 
protein kinase (ROCK) pathway, and inhibit nitric oxide (NO) production, while some 
biochemical agents such as cytokines and hormones have been identified to activate Ca
2+
-
dependent proteases, and trigger reactive oxygen species production through membrane 
nicotinamide adinine dinucleotide phosphate-oxidase (NADPH oxidase), and an increase in all 
of these, but NO, pathways have been implicated in EMV formation (Sapet et al., 2006; Vion et 
al., 2013b). Spontaneous shedding of MV by non-activated platelets is dependent on function of 
integrin αIIbβ3, while both shear stress and biochemical agents can induce PMV formation 
through the caspase/calpain pathways and platelet arrest with by immobilised von Willebrand 
factor-glycoprotein Ibα bond, respectively (Fox et al., 1991; Chang et al., 1993; Cauwenberghs 
et al., 2006; Reininger et al., 2006). 
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 Other studies have identified additional agonist-dependent pathways in 
platelets and other cell types (Cauwenberghs et al., 2006; Sapet et al., 2006). 
Examining human microvascular endothelial cells, Sapet et al. (2006) have 
shown that caspase-2 blocking can prevent the release of EMV after thrombin 
stimulation, with no effect on basal EMV production, and Cauwenberghs et al. 
(2006) documented a role of integrin αIIbβ3 activity as a calcium independent-
stimulus of MV release from unstimulated platelets. These authors reported that 
the application of calcium chelator agents or calpain inhibitors had only minor 
effects on basal PMV formation, while integrin αIIbβ3 blockade abolished 
spontaneous shedding of MV from non-active platelets. The fact that this 
integrin can also stimulate calpain activity suggests it has alternative calpain-
dependent and independent effects leading to MV release. 
Haemodynamic forces are also known to influence the release of MVs, 
with elevated shear stress shown to act as an agonist inducing platelet 
vesiculation (Miyazaki et al., 1996; Reininger et al., 2006). As described by 
Reininger et al. (2006), stimulation with increasing shear forces caused ex vivo 
platelet attachment and immobilisation with von Willebrand factor. There was 
also successive tethering to membranes attributable to hydrodynamic drag, and 
PMV formation in a von Willebrand factor-glycoprotein Ibα bond-dependent 
pathway. 
The potential for vascular shear stress to modulate endothelial cell 
function and vascular health is well known, and EMV shedding seems to reflect 
the reaction of endothelial cells to shear forces in vitro. Studying human 
umbilical vein endothelial cells (HUVECs) under different shear forces produced 
by a cone-and-plate viscosimeter, Vion et al. (2013) observed low vesiculation 
when cells were exposed to high shear stress. This pattern was altered under 
modified settings with a drastic increase in EMV release under low shear and 
no shear experiments. The blocking of Rho-associated protein kinases 
hampered this EMV formation, showing that this pathway may be implicated in 
the low shear-mediated MV production from endothelial cells. These authors 
also observed that endothelial nitric oxide synthase (eNOS) inhibition by L-NG-
nitroarginine methyl ester resulted in EMV production even during high shear 
stress, demonstrating a putative role of shear-induced NO production in blunting 
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the shedding of EMVs. These data agree with in vivo results of Jenkins et al. 
(2013) demonstrating that disturbing upstream arterial haemodynamics and 
shear stress by venous congestion increased the appearance of circulating 
EMVs. In addition, studies report an increase in blood EMVs with prolonged 
inactivity or bed rest (Navasiolava et al., 2010; Boyle et al., 2013). 
In summary, the release of extracellular vesicles is achieved through 
different and sometimes complementary pathways. It is believed that MVs are 
formed through a general process involving membrane cytoskeleton 
reorganisation resulting in cell shrinkage, sometimes involving exposure of 
negatively charged membrane phospholipids, and ultimately leading to MV 
blebbing from the parental cell membrane. These events, however, appear to 
be highly dependent on the agonist and cell type investigated. 
 
2.2. Vascular endothelium and microvesicles 
2.2.1. Overview of endothelial cells 
 The vascular endothelium plays a major role in cardiovascular 
homeostasis and has been studied in situ for a long time, but the landmark for 
defining endothelial structural characteristics was the development of a method 
for culture of endothelial cells. According to Nathan and Jaffe (2004), many 
researchers have tried to culture these inner vascular cells, which were initially 
thought to be no more than fibroblasts by some scientists in the 1960’s. 
However, in their two seminal works published over the following decade Jaffe 
and colleagues demonstrated that HUVECs could be cultivated and grown in 
vitro, presenting distinct characteristics (Jaffe et al., 1973a; Jaffe et al., 1973b). 
Unlike fibroblasts and smooth muscle cells, cultured HUVECs presented a 
polygonal shape, Weibel-Palade bodies, and expressed antigens of the ABH 
blood system of the donor (Jaffe et al., 1973b). In addition, evidence was given 
that these cultured cells exclusively synthesised von Willebrand Factor (Jaffe et 
al., 1973a), a claimed endothelial marker at that time (Hoyer et al., 1973). 
These morphological and immunological criteria could differentiate the cultured 
cells from their previously presumed fibroblast or smooth muscle origin 
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(Nachman & Jaffe, 2004), opening new horizons for the study of the functions of 
the vascular endothelium. 
 Investigations characterising endothelial cells further expanded the 
unique knowledge of these cells in relation to vascular morphology and function. 
Today it is known that endothelial cells originate from haemangioblast cells and 
form a single layer of specialised epithelial cells that cover the innermost lining 
of vessels, acting as an active semi-permeable barrier between the blood and 
the surrounding tissues (Michiels, 2003; Aird, 2012). The mature endothelium 
exhibits a prominent nucleus, and has a polygonal shape in culture, even 
though different architectures are observed in situ as a consequence of its 
surroundings (Jaffe et al., 1973b; Elgjo et al., 1975). Regarding its subcellular 
structures, endothelial cells are usually characterised by the aforementioned 
Weibel-Palade bodies, and are rich in membrane invaginations named caveolae 
where more than 60% of eNOS has been found in rat lung microvasculature in 
situ (Rizzo et al., 1998). Additionally, the vascular endothelium is abundant in 
organelles, such as mitochondria, Golgi complexes and both smooth and rough 
endoplasmatic reticula (Elgjo et al., 1975), characteristics of highly metabolically 
active cells. 
 The functional endothelium produces a host of vasoactive substances 
that are generally divided into endothelial-derived relaxing and contracting 
agents. Particular interest has been placed upon the relaxing agent nitric oxide 
(NO), a gaseous molecule produced in endothelial cells by nitric oxide 
synthases and with a fundamental role in the regulation of vascular tone by 
decreasing vascular smooth muscle cell Ca2+ concentration (Blatter & Wier, 
1994). This and additional endothelial messengers are also known to inhibit 
platelet aggregation and smooth muscle cell proliferation (Michiels, 2003), 
allowing the endothelium to interact with the vascular components to protect 
against atherosclerosis and thrombus formation. A dysfunctional endothelium, 
however, is believed to be exposed to increased levels of oxidative stress 
(Eskurza et al., 2004; Donato et al., 2008), expresses greater amounts of pro-
inflammatory molecules (Donato et al., 2008), and vasoconstricting substances 
such as endothelin-1 (Donato et al., 2009) which, coupled with a decreased 
bioavailability of NO, induces a pro-atherogenic phenotype. 
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Hence, preserved vascular function plays a fundamental role in 
cardiovascular protection (Schächinger et al., 2000; Inaba et al., 2010). Several 
environmental stimuli including physical inactivity and smoking disturb 
endothelial function (Celermajer et al., 1993; Navasiolava et al., 2010; Boyle et 
al., 2013), whereas exercise training provides a potent stimulus to counteract 
endothelial dysfunction (Jensen-Urstad et al., 1999; DeSouza et al., 2000; 
Tanaka et al., 2000; Walsh et al., 2003). Because the vascular endothelium 
plays a central role in the control of vascular health, it must promptly respond to 
alterations in the vascular milieu, including changes in MV concentrations. 
 
2.2.2. Microvesicle – endothelial interactions 
 The location of endothelial cells, in direct exposure to blood constituents, 
makes the vascular endothelium a key sensor of variations in the environment, 
including alterations in levels of circulating MVs. The actual effects of MV upon 
the endothelial layer are diverse and dependent on the MV source. Circulating 
MVs can be seen as travelling intercellular messengers, able to reprogram 
target cells. Their effects can be accomplished by interacting with the recipient 
cell by at least one of three main ways (Figure 2-3): (1) Circulating MVs can 
bind to the cell membrane and interact with surface receptors; (2) can fuse with 
the plasma membrane with subsequent release of their cargo within the cell; or 
even (3) be internalised by the target cell to promote intracellular effects (Mause 
et al., 2010). Regarding endothelial cell-microvesicle interactions, the binding of 
PMVs on the surface of cultured endothelia seems to be debatable (Merten et 
al., 1999), but internalisation of MVs has been reported, by demonstrating the 
presence of these vesicles within the cytoplasmatic space of recipient HUVECs 
(Terrisse et al., 2010; Dasgupta et al., 2012). The treatment of PMVs with 
annexin-V conjugates or integrin-blocking agents blunted their uptake by 
HUVECs, indicating an important function of PS and platelet integrins in PMV 
recognition and internalisation by endothelial cells (Dasgupta et al., 2012). 
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Figure 2-3. Illustration of potential microvesicle-cell interactions. Microvesicles can stimulate 
recipient cells by direct binding on the cell surface (A), fusing with the plasma membrane (B) or 
after being internalised into the cytosol (C) (Mause et al., 2010). 
 
  The various effects of MVs upon recipient cells is not surprising, owing 
to their ability to deliver bioactive lipids, enzymes, and messenger ribonucleic 
acids from their parental cell (Kim et al., 2004; Morel et al., 2011; Horn et al., 
2013; Dimassi et al., 2016). In relation to the vascular endothelium, it has been 
demonstrated that lymphocyte-derived MVs may suppress in vivo and in vitro 
angiogenesis by downregulating the endothelial expression of vascular 
endothelial growth factor (VEGF) receptors coupled with increased superoxide 
anion production (Yang et al., 2008), and pathological levels of EMVs may have 
paracrine effects resulting in decreased NO bioavailability through the 
production of reactive oxygen species by target endothelial cells (Brodsky et al., 
2004). Also, EMVs produced under tumor necrosis factor alpha (TNF-α) 
stimulation can display pro-inflammatory potential as determined by an 
increased release of intercellular adhesion molecule-1 from recipient endothelial 
cells (Curtis et al., 2009). Supporting this process, an interesting study by 
Boulanger et al. (2001) demonstrated that circulating MVs obtained from 
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patients with a previous myocardial infarction reduced acetylcholine-induced 
endothelial mediated dilation in situ and similar results were found with 
circulating MVs from pre-eclamptic women (Vanwijk et al., 2002). Other 
manipulations involved incubating aortic rings of rodents with EMVs isolated 
from cell cultures obtained similar results (Brodsky et al., 2004). 
 The above mentioned findings lead to the theory that circulating MVs 
may be detrimental for the vascular endothelium, but these extracellular 
vesicles have also been reported to bring about positive responses. For 
example, experimentally-induced limb ischaemia increases the concentration of 
MVs expressing skeletal muscle and endothelial antigens within local muscle 
homogenates of mice, and these MVs potentiate progenitor cell differentiation 
into an endothelial phenotype and subsequent angiogenesis within limbs 
(Leroyer et al., 2009), which is relevant for understanding some of the exercise 
responses of interest for this thesis. MVs of platelet origins have also been 
linked to endothelial stimulation. Kim et al. (2004) demonstrated that PMVs 
protect HUVECs from apoptosis, and there is evidence indicating that PMVs 
bring about angiogenesis in vitro (Kim et al., 2004; Brill et al., 2005), and in vivo 
(Brill et al., 2005). These findings are supported by results showing that plasma 
MVs from healthy individuals may serve as a circulatory source of active eNOS 
(Horn et al., 2013) and that PMVs carry VEGF (Brill et al., 2005), both of which 
are essential for proper endothelial function and the process of angiogenesis. 
 This apparent discrepancy between the roles of MVs may be related to 
the events leading to their formation under pathological and non-pathological 
conditions. For instance, spontaneously produced MVs found in the blood of 
healthy donors did not impair endothelial function in the studies by Boulanger et 
al. (2001) and Vanwijk et al. (2002). Likewise, EMVs released naturally by 
unstimulated cells were not involved in the formation of a pro-inflammatory 
phenotype amongst recipient endothelial cells (Curtis et al., 2009). This 
supports the hypothesis that MV functions vary not only depending on their 
source, but also on their stimulus of formation, with physiological challenges 
probably resulting in the production of qualitatively distinct MVs compared to 
those formed under pathological stresses. 
19 
 
 
2.3. Exercise and microvesicles 
2.3.1. Circulating microvesicle appearance with exercise 
 Acute exercise brings about a myriad of physiological adjustments, so 
that homeostasis can be maintained at a much higher metabolic demand than 
resting conditions. Repeated exercise over several weeks induces chronic 
adaptations in many physiological systems, including functional (DeSouza et al., 
2000; Walsh et al., 2003; Rakobowchuk et al., 2008; Schaun et al., 2011) and 
structural (Tanaka et al., 2000; Rakobowchuk et al., 2008; Rakobowchuk et al., 
2013) vascular adaptations. Cellular vesiculation seems to be affected by acute 
exercise, with several investigations reporting increased plasma concentrations 
of certain MVs after exercise (Table 2-2). Sossdorf et al. (2010) were among the 
first to demonstrate that cycling stimulates the appearance of PMVs in the 
circulation during recovery, a finding that was later confirmed during subsequent 
investigations (Chaar et al., 2011; Sossdorf et al., 2011; Maruyama et al., 
2012). Other studies reported that EMVs may also be responsive to an exercise 
stress (Sossdorf et al., 2011; Kirk et al., 2013; Lansford et al., 2015), although 
the magnitude of the response is often smaller compared to PMVs, whereas 
those MVs derived from other cell sources, such as erythrocytes and 
monocytes, remaining relatively stable (Sossdorf et al., 2010; Chaar et al., 
2011; Sossdorf et al., 2011).  
 The increase in intravascular [PMV] and [EMV] after exercise, however, 
is not a consistent finding (Mobius-Winkler et al., 2009; Sossdorf et al., 2010; 
Chaar et al., 2011; Guiraud et al., 2013; Ross et al., 2014; Wahl et al., 2014). 
For example, Guiraud et al. (2013) reported that the plasma concentration of 
these MVs remained unaltered after exercise in CAD patients, but more recent 
work demonstrated that CAD patients may actually lack a response of MVs to 
dubutamine infusion (a stress test that partially mimics exercise) with an 
elevation in their plasma concentrations possibly being a normal physiological 
adjustment in otherwise healthy individuals (Augustine et al., 2014). Moreover, 
Sossdorf et al. (2011) reported that elevation in EMVs observed after exercise 
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was limited to trained individuals, and even a decrease in this MV population 
has been observed after exercise (Wahl et al., 2014), which is difficult to 
explain. 
 Therefore, based on the aforementioned work it seems that PMVs are 
the most responsive circulating MV population with currently 4 out of 5 studies 
involving healthy humans reporting an increase in their concentration after 
exercise. However, only 3 out of 8 studies under similar conditions support this 
finding when examining EMVs. 
 
21 
 
Table 2-2. Studies investigating shedding of microvesicles with exercise 
Study Participants 
MV 
phenotype Method 
Blood sample 
timing 
Exercise 
mode Exercise protocol Main results 
Mobius-
Winkler et 
al. (2009) 
18 healthy 
men 
CD42b
- 
MV, 
EMV 
Flow 
cytometry 
Before 
During 
after (until 24h) 
Cycling 4h at 70% of anaerobic threshold  No change 
Sossdorf 
et al. 
(2010)  
16 healthy 
men 
PMV, EMV, 
MMV 
Flow 
cytometry 
Before 
After: 0 min; 45 
min; 2h 
Cycling 
1.5h at 80% of anaerobic 
threshold 
↑ PMV at 0 min, 45 min and 2h 
post protocol; 
↑ PMV pro-coagulant activity 
after exercise 
Sossdorf 
et al. 
(2011)  
8 untrained, 
and 8 trained 
men 
AnnV
+
 MV, 
PMV, EMV, 
MMV 
Flow 
cytometry 
Before 
After: 0 min; 45 
min; 2h 
Cycling 
1.5h at 80% of anaerobic 
threshold 
Untrained:  ↑AnnV
+
 MV and 
PMV until 2h after exercise; 
Trained: ↑ PMV, EMV and MMV 
at 45min; and AnnV
+
 MV until 
2h after protocol 
Chaar et 
al. (2011) 
7 healthy 
men 
AnnV
+
 MV, 
PMV, EMV, 
MMV, 
RBCMV, 
PMNMV 
Flow 
cytometry 
Before 
After: 0 min; 2h 
Cycling 
3 maximal ramp tests, with 10 
min recovery between trials 
↑ AnnV
+
 MV; PMV and PMNMV 
after the protocol 
Mayurama 
et al.  
(2012) 
9 men, and 9 
women 
PMV ELISA 
Before 
After: 0 min; 1h 
Running 
Bruce treadmill protocol until 
85% of the estimated maximum 
heart rate 
↑ PMV after the protocol 
Guiraud et 
al. (2013) 
19 physical 
active CAD 
male 
patients 
EMV, PMV 
Flow 
cytometry 
Before 
After: 20 min; 24h; 
72h 
Cycling 
HI interval exercise and 
isocaloric MI exercise (no details 
given about protocols) 
No change 
Kirk et al. 
(2013) 
7 healthy 
men 
EMV 
Flow 
cytometry 
Before 
After: 0 min; 1.5h; 
3h 
Cycling 
10x15 sec sprints at 120% PPO 
and 45 s of active recovery 
under NaHCO3 supplementation 
or placebo.  
↑ EMV at 1.5 h compared to post 
0 min 
 
                                     
(Continue) 
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Ross et al. 
(2014) 
13 trained 
male 
EMV 
Flow 
cytometry 
Before 
After: 10 min; 2h; 
24h 
Resistance 
exercises 
3 resistance exercise circuits at 
15RM 
No change 
Wahl et al. 
(2014) 
12 male 
endurance 
athletes 
PMV, EMV, 
MMV 
Flow 
cytometry 
Before 
After: 0 min; 1h; 
3h  
Cycling 
120 min at 55% PPO; 4x4 min at 
90-95% PPO with 3 min active 
rest, or 4x30 s all out exercise 
with 7.5 min active rest 
Reduction in PMV, EMV and 
MMV  1h and 3h after protocols 
Lansford 
et al. 
(2015) 
9 men and 9-
8 women 
EMV and 
CD34
+ 
MV 
Flow 
cytometry 
Before and within 
5 min after 
Cycling 
Continuous exercise at 60 – 70% 
of V̇O2peak until total energy 
expenditure equivalent to 598 
kcal (~40-60 min) 
Males: ↑ EMV after the protocol 
Females: ↑ CD34
+
 MV after the 
protocol 
No changes when dataset from 
both sexes were analysed 
together 
CAD, coronary artery disease; AnnV, annexin-V; MV, microvesicle; EMV, endothelial microvesicle; PMV, platelet microvesicle; MMV, monocyte microvesicle; RBCMV, red blood cell 
microvesicle; PMNMV, polymorphonuclear cell microvesicle; ELISA, enzyme-linked immunosorbent assay; HI, high intensity; MI, moderate intensity; 15RM, 15 repetition maximum; 
PPO, peak power output; NaHCO3, sodium bicarbonate; V̇O2peak, peak oxygen uptake; ↑, increase. 
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2.3.2. Circulating microvesicle responses with exercise 
The proper characterisation of a physiological phenomenon requires the 
description of its kinetics. However, the time-course of MV appearance in the 
circulation with exercise has not been systematically characterised. So far, 
Mobius-Winkler et al. (2009) were the only researchers to investigate MV 
shedding during exercise and reported no changes in [EMV] during 4 h of 
cycling and subsequent recovery. This lack of information limits our current 
knowledge of MV dynamics during exercise and the understanding of the 
underlying mechanisms of formation.   
In relation to the post-exercise recovery period, 4 studies found no 
increase in any MV population investigated (Mobius-Winkler et al., 2009; Ross, 
2011; Guiraud et al., 2013; Wahl et al., 2014), with the remaining studies 
reporting augmented concentrations of at least one population of MV after 
exercise (Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf et al., 2011; 
Maruyama et al., 2012; Kirk et al., 2013; Lansford et al., 2015). The most 
consistent results were observed in relation to PMVs and EMVs. It seems that 
these two MV populations may exhibit a fast appearance rate immediately after 
exercise, with peak concentrations observed sometime within 2 h of the 
exercise session (Sossdorf et al., 2010, 2011; Maruyama et al., 2012). Few 
researchers have explored [PMV] or [EMV] responses beyond 2 h into recovery, 
but those who did, observed values that were lower (Wahl et al., 2014) or 
similar to baseline at 3 h (Guiraud et al., 2013), 24 h (Guiraud et al., 2013; Ross 
et al., 2014) and 72 h (Ross, 2011). Sossdorf et al. (2011) found that the 
training status of the participants may influence the response of some MV 
populations, however a detailed mechanistic understanding has not been 
provided and needs to be addressed. 
 Although limited information is currently available regarding the kinetics 
of MV formation with exercise, it seems reasonable to hypothesise based on the 
current literature that a progressive elevation in these tiny circulatory vesicles 
start to occur during exercise, peaking around 1-2 h post-exercise, and probably 
returning to baseline within 3 h of the session (Figure 2-4). The time-course of 
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circulating MVs, however, requires investigation, particularly the exercise 
responses and will be a major focus of this thesis. 
 
 
 
Figure 2-4. Theoretical model of microvesicle shedding kinetics with exercise. Based on the 
current literature, I proposed that the microvesicle response to exercise will peak within 2 h of 
post-exercise recovery. The time-course of appearance during exercise remains unknown. 
 
2.3.3. Exercise intensity and microvesicles 
 Intensity, alongside volume, is considered one of the most important 
variables governing physiological responses to exercise. For a fixed volume 
(e.g. time or repetitions) higher exercise intensities require greater energy 
expenditure and metabolic demand, with parallel cardiorespiratory adjustments 
(Pritzlaff et al., 2000; Lansley et al., 2011). Repeated exercise sessions will 
eventually be translated into long-term training adaptations, and the current 
guidelines of the American College of Sports Medicine indicates that a minimal 
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exercise intensity of 45% of oxygen uptake reserve or ~45% of heart rate (HR) 
reserve is required to bring about improvements in maximal aerobic capacity of 
young healthy and relatively active individuals, whereas even lower intensities 
may suffice to improve physical fitness in less fit individuals (Garber et al., 
2011). The effect of exercise intensity on the acute release of MVs, however, 
has not received much attention, with only two recent studies shedding some 
light upon this topic. 
Wahl et al. (2014) had cyclists/triathletes perform a high volume 
continuous exercise session (2 h cycling at 55% of peak power output (PPO)), 
and two interval exercise sessions (at submaximal or supramaximal intensities 
relative to PPO), and observed similar responses amongst all conditions 
suggesting no influence of intensity. However, this was the sole investigation in 
which a reduction in the concentration of MVs was observed with exercise 
making it difficult to interpret these findings. Guiraud et al. (2013) also 
compared the concentration of circulating MVs in response to either heavy 
intensity interval exercise or lower intensity continuous exercise in CAD patients 
and reported a lack of change after any exercise protocol. However, as 
mentioned earlier this population has been shown to display reduced 
vesiculation responses to cardiac stress tests (Augustine et al., 2014) which 
limits the extrapolation of these results to healthy individuals. Furthermore, a 
drawback of these studies was that independent variables other than exercise 
intensity, such as different exercise:rest ratios and total exercise duration, were 
also different between exercise sessions. Thus, it is reasonable to conclude that 
these studies had a number of confounding factors that could have influenced 
their results. 
 Analysis of individual studies leads to inconsistent outcomes. While an 
augmentation of MV release was found in the two reports where participants 
performed maximal or near maximal incremental tests (Chaar et al., 2011; 
Maruyama et al., 2012), those involving submaximal prolonged exercise are 
contradictory (Walsh et al., 2003; Mobius-Winkler et al., 2009; Sossdorf et al., 
2010, 2011; Guiraud et al., 2013). For example, Sossdorf et al. (2010, 2011) 
found shedding of MVs after 1.5 h of continuous cycling at 45% of PPO, 
whereas Mobius-Winkler reported no response with 4 h at 70% of the anaerobic 
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threshold, and a session performed at 55% PPO was reported to even 
decrease MV concentrations during the recovery period (Wahl et al., 2014). 
Conflicting results have also been observed after heavy intensity interval 
exercise (Walsh et al., 2003; Guiraud et al., 2013; Kirk et al., 2013). The 
reasons for such inconsistencies are elusive, but may relate to differences in 
the exercise protocols, as well as pre and post-analytical procedures for MV 
quantification as no standard procedure currently exists. Hence, it seems that 
further experiments are required to conclusively determine the influence of 
exercise intensity on the appearance of circulating MVs. 
 
2.3.4. Putative exercise stimuli for microvesicle shedding 
 The onset of rhythmic exercise brings about respiratory, haemodynamic, 
and neurohumoral responses to cope with greater cardiorespiratory, metabolic 
and thermoregulatory demands, so that enhancement of minute ventilation, 
cardiac output (Q̇), and sympathetic outflow occurs in an intensity-dependent 
manner (Mortensen et al., 2008; Laughlin et al., 2012). As a consequence, 
exercise may promote the increase of several factors that have been shown to 
act as agonists of PMV and EMV release in vitro and may be hypothesised to 
be involved with the increased appearance of these MVs after exercise. 
 Cell culture experiments have provided insight regarding the impact of 
mechanical forces on platelet and endothelial cell MV formation, but studies in 
human models are still needed to integrate and better understand these 
responses in a complex physiological system. During exercise, the rise in 
metabolic demand requires a proportional oxygen supply to working muscles, 
which is attained through elevations in local blood perfusion and lead to a 
marked increase in vascular shear stress in the circulation of exercising limbs 
(Credeur et al., 2010; Wray et al., 2011). Augmented exercising limb perfusion 
accounts for the majority of the increase in Q̇, but if exercise is prolonged an 
increase in shear stress may be observed even in arteries feeding non-active 
limbs (Tanaka et al., 2006; Tinken et al., 2010; Padilla et al., 2011b), probably 
to facilitate heat dissipation from the skin. The systemic haemodynamic 
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response to exercise substantiates shear stress as a potential agonist for PMV 
formation, since ex vivo platelets have been shown to release MVs after shear 
stimulation (Miyazaki et al., 1996; Reininger et al., 2006). 
 In contrast to platelets, data from endothelial cell work suggest that low 
shear stress increases the release of EMVs (Vion et al., 2013b), likely reflecting 
pathological vascular remodelling. That makes sense, since an imbalance 
between pathologic and physiologic shear stress has traditionally been 
considered one of the major elements implicated in atherosclerotic plaque 
formation, even though a recent review has questioned the robustness of the 
classical shear stress theory and its relation with atherosclerotic plaque 
development (Peiffer et al., 2013). Current in vivo studies focusing on EMVs as 
biomarkers of vascular damage support this idea by demonstrating that 
experimentally-induced disturbed blood flow (BF) is coupled with increases in 
circulating [EMV] in healthy individuals (Jenkins et al., 2013), and that vascular 
shear stress correlates negatively with the [EMV] in renal failure patients 
(Boulanger et al., 2007). Hence, because shear stress increases with exercise, 
and EMV release has been reported to be inhibited through a NO-related 
pathway under high shear forces (Vion et al., 2013b), it seems logical that 
increases in [EMV] observed in some studies after exercise is mediated by a 
shear-independent mechanism. Alternative, elevated transmural pressures 
during exercise could be a stimulatory mechanism for EMV release, since 
cultured pulmonary endothelial cells have been shown to shed MVs during 
progressively greater cyclic stretching (Vion et al., 2013a). However, in vivo 
evidence is lacking. 
Investigation of the effect of shear stress on MV formation with exercise 
is frequently restricted by intrinsic issues related the measurements of vascular 
shear forces during cycling or running due to movement of active limbs. In this 
context, exercise models engaging a limited muscle mass may be useful. The 
single leg knee extensor exercise engages a small amount of muscle mass (the 
quadriceps muscles) with the rest of the body remaining relatively stable. The 
experimental position enables easier access to lower limb major vessels in 
comparison to cycling or running (Andersen et al., 1985), while eliciting 
significant local haemodynamic adjustments. For example, dynamic knee 
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extensor exercise can increase thigh perfusion to 7-8 l.min-1, a relatively high 
value compared to ~10 l.min-1 attained for the whole leg during maximal cycling 
(Mourtzakis et al., 2004; Mortensen et al., 2005; Calbet et al., 2007; Mortensen 
et al., 2008). Whether exercise engaging only a small muscle mass is a 
physiological stimulus capable of increasing MV concentration in the circulation 
is unknown. 
 A limitation with exercise models, however, relates to the increased 
metabolic demand and subsequent large humoral adjustments, which may be 
confounding factors when determining the sole influence of vascular shear 
stress on MV formation in humans. An alternative approach to this question 
could involve haemodynamic manipulations with slight metabolic influence 
through passive heat stress (Pearson et al., 2011). Resting limb BF can be 
easily doubled with passive heating (Padilla et al., 2011b; Pearson et al., 2011). 
In addition, local BF manipulations are possible through regional limb heating 
and cooling (Chiesa et al., 2015), with the benefits of small relative increases in 
circulating catecholamines (Kim et al., 1979; Pearson et al., 2011; Chiesa et al., 
2015; Gagnon et al., 2015), which are known stimulants of PMV formation. One 
could speculate that the thermal stress could trigger platelet activation and MV 
release (Bouchama et al., 2008), but evidence for ex vivo activation of platelets 
by temperature per se has not been supported between 37° C and 42° C 
(Gader et al., 1990; Maurer-Spurej et al., 2001), and seems to occur only when 
incubation temperature reaches values above those tolerable by conscious 
humans (43° C) (Gader et al., 1990). This suggests that mild to moderate 
passive heat stress may serve as a method to explore the relevance of vascular 
shear stress in PMV formation in healthy humans. 
 Several biochemical factors, including cytokines, inflammatory agents 
and hormones, can also stimulate vesiculation in different cells. C-reactive 
protein (CRP) may increase after exercise sessions (Shojaei et al., 2011), and it 
has been shown to induce EMV formation in vitro (Wang et al., 2007b), as does 
thrombin (Sapet et al., 2006), and angiotensin II (Burger et al., 2011). Hepatic 
synthesis of CRP can occur through cytokine stimulation, mainly by interleukin 
(IL)-6 (Kasapis & Thompson, 2005). Hence, even if CRP has been found to act 
directly on endothelial cells by inducing EMV blebbing, it is conceivable that this 
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inflammatory protein may work in synergy with cytokines within a living 
organism. 
Cytokines are involved in the acute response to exercise and IL-6 is the 
most responsive (Figure 2-5), displaying intensity and volume dependent 
increases in blood levels as exercise progresses (Scott et al., 2011, 2013). 
Depletion of skeletal muscle glycogen stores is suggested to stimulate the 
expression of this cytokine in contracting muscles (Pedersen et al., 2001; 
Steensberg et al., 2001), which can reach the circulation and potentially 
increase glucose and free fatty acid release by the liver to support the greater 
substrate requirements of exercise (Pedersen et al., 2001; Glund et al., 2007). 
Besides its effects on the control of glucose homeostasis, IL-6 released during 
exercise is believed to modulate part of the anti-inflammatory/inflammatory 
balance to exercise by, for example, stimulating the delayed rise in circulating 
IL-1 receptor antagonist after the end of exercise (Scott et al., 2011) and 
enhancing the hepatic release of CRP (Petersen & Pedersen, 2005). Moreover, 
IL-6 has been reported to directly stimulate PMV formation ex vivo (Nomura et 
al., 2000), and might indirectly cause MV formation through the action of CRP 
observed in endothelial cells (Wang et al., 2007b). The influence of exercise on 
circulating TNF-α concentrations is less clear (Kasapis & Thompson, 2005), but 
this cytokine has been used as a agonist to induce endothelial MV release in 
culture (Jimenez et al., 2003). In any case, no information is currently available 
regarding whether the cytokine and/or inflammatory responses drive MV 
formation with exercise. 
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Figure 2-5. Schematic cytokine response to exercise (A), and subsequent influence on C-
reactive protein (CRP) stimulation (B). IL interleukin; MIP-1β macrophage inflammatory protein 
1β; TNF-α Tumour necrosis factor α; sTNF-αR soluble TNF-α receptor. Adapted from Pedersen 
(2000), and Petersen and Pedersen (2005). 
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Taken together, results from in vitro experiments indicate that several 
physiological haemodynamic and biochemical adjustments that are known to 
take place during exercise might trigger the shedding of PMVs and EMVs in the 
circulation of exercising humans (Figure 2-6). Whether an association between 
changes in MV concentrations and these putative agonists exists during 
exercise, however, still needs to be demonstrated. 
 
 
Figure 2-6. Hypothetical exercise-induced stimuli for platelet (PMV) and endothelial 
microvesicle (EMV) release. High vascular shear stress, certain cytokines and catecholamines 
are all putative stimuli for PMV production in response to exercise, whereas EMV formation may 
be stimulated by vascular cyclic stretching, as well as inflammatory cytokines and proteins 
(Miyazaki et al., 1996; Nomura et al., 2000; Jimenez et al., 2003; Reininger et al., 2006; Wang 
et al., 2007b; Tschuor et al., 2008; Vion et al., 2013a; Vion et al., 2013b). Figure produced using 
Servier Medical Art (www.servier.com). 
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2.4. Physiological function of exercise-derived microvesicles 
 Based on the above mentioned work, it seems logical that MVs produced 
during exercise would exhibit a variety of biological activities. However, very 
little information currently exists in this regard, with available research focusing 
exclusively on the potential involvement of MVs in haemostasis.  
Platelets play a major role in haemostatic control, and the involvement of 
PMVs in this process has now been widely appreciated (Wolf, 1967; Connor et 
al., 2010; Shantsila et al., 2010). MVs may support coagulation by exposing 
haemostatic proteins in their outer membrane, such as tissue factor (Sossdorf 
et al., 2011). Since PS may serve as a direct catalytic surface for thrombin 
formation, MVs harbouring PS on their outer leaflet can also support 
coagulation (Connor et al., 2010), and an elevation in blood MV content would 
be expected to increase the blood thrombotic potential. Indeed, circulating MVs 
isolated after cycling have shown increased coagulation activity (Sossdorf et al., 
2010, 2011). One could assume that this was simply mediated by the greater 
concentration of circulating PMVs and other MVs post-exercise, but it worth 
noting that the MV kinetics and coagulant activity followed a different time-
course, indicating that qualitative modifications in exercise-derived MVs may 
have also taken place. This finding agrees with the fact that thrombotic 
stimulation can occur during exercise (El-Sayed et al., 2000; Yegutkin et al., 
2007; Maruyama et al., 2012), but it is also important to recall that fibrinolysis 
may also be stimulated even during moderate efforts in healthy humans, 
thereby counteracting the risks of coagulation during exercise (El-Sayed et al., 
2000). 
 Therefore, the present literature provides evidence that MVs are involved 
in the complex haemostatic regulation in response to exercise. Further 
biological roles of these extracellular vesicles in the context of exercise are 
unknown, but since exercise training is a powerful physiological stimulus 
leading to a healthy vascular phenotype and that exercise may acutely increase 
the concentration of MVs in the circulation, it seems reasonable to theorise that 
exercise-produced MVs may distinguish themselves from those found with 
pathologic conditions and ultimately promote beneficial endothelial responses.  
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2.5. Conclusion 
 Cell-derived MVs have received growing attention in the scientific community 
due to their potential to serve as biomarkers of intracellular events and their innate 
biological activities. These extracellular vesicles had initially been thought to be a 
simple consequence of pathological disorders, and subsequently believed to play a role 
in maladaptation. More recent evidence has shown that MVs are not necessarily 
harmful, and are actually necessary for proper physiological function. Exercise seems 
to be a potent inductor of PMV, and possibly EMV, appearance in the circulation, but 
little information is available regarding their time-course of release and stimulus of 
formation particularly during exercise. However, in vitro and in vivo data combined 
suggest that vascular shear stress alongside certain biochemical agonists may trigger 
the release of MVs in response to exercise. Finally, a body of evidence indicates that 
these small particles may play a role in the complex haemostatic control with exercise, 
but the overall relevance of exercise-derived MVs requires further investigation. 
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3. Chapter 3 - Thesis Aims and Hypotheses 
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 The general aims of this thesis were to investigate the dynamics of 
circulating PMVs and EMVs under different exercise stresses, to gain insights 
into putative mechanisms involved in their formation in vivo, and to explore the 
role of MVs produced during exercise as candidate mediators of endothelial 
responses in vitro. To do so, a sequence of human and cell culture-based 
experiments were performed as follow: 
 
Study 1. Time-course of circulating microvesicle appearance 
during moderate and heavy intensity exercise and subsequent 
recovery 
Study aims: Considering the need to characterise MV responses to traditional 
exercise sessions, the specific aim of study 1 was to describe the time-course 
of MV appearance in the circulation during and after heavy and moderate 
intensity prolonged cycling, since exercise intensity modulates the magnitude of 
change in putative agonists related to MV release. A secondary aim was to 
establish relationships between MV responses with haemodynamics and 
biochemical variables known to stimulate MV formation in vitro to gain insights 
into the role of these factors in the MV turnover during exercise and recovery. 
Research hypotheses: In this study it would be expected to observe 1) an 
increase in plasma [PMV] during and after exercise, which is modulated by 
exercise intensity. 2) PMVs are expected to return to baseline in the late post-
exercise recovery, and the concentration of PMVs during exercise are expected 
to correlate with changes in 3) vascular shear rate (SR), as well as plasma 
concentrations of 4) noradrenaline and 5) IL-6; whereas 6) circulating EMVs 
were expected to remain stable with submaximal exercise. 
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Study 2. Arteriovenous microvesicle dynamics with heat stress 
and exercise engaging a large or small muscle mass 
Study aims: Platelets and endothelial cells have been shown to shed MVs 
under a variety of physiological stresses, including after exercise, but their 
arteriovenous dynamics and stimulus of formation with exercise are unknown. 
Hence, the aim of this study was to explore the dynamics of PMVs and EMVs in 
the arterial and venous circulation of exercising men, and to further examine 
whether changes in MVs would be closely related to alterations in vascular 
shear stress with passive heat stress, exercise and combined heat stress and 
exercise.  
Research hypotheses: In relation of PMVs it is hypothesised that 1) circulating 
[PMV] would increase during whole-body passive heat stress and exercise; and 
that 2) localised increases in shear stress would coincide with local increases in 
venous PMVs during heating and exercise. On the other hand, 3) [EMV] would 
remain stable during passive heat stress but increase with very heavy large 
muscle mass exercise, when several endocrine factors are stimulated. 
  
Study 3. Impact of circulating microvesicles produced during 
exercise upon endothelial cells: in vitro insights 
Study aims: With exercise-derived MVs postulated in this thesis to play a 
positive role in endothelial cell adaptations, the aim of this study was to test 
whether incubation of HUVECs with MVs obtained during an exercise bout 
would stimulate migration, proliferation, wound-healing and morphological 
changes of endothelial cells. 
Research hypothesis: Circulating MVs obtained during exercise would 
stimulate cultured human endothelial cells to 1) proliferate, 2) migrate, 3) heal 
from a scratch-wound, and 4) form structures related to angiogenesis in vitro at 
a greater extent than MVs obtained at rest. 
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4. Chapter 4 - General Methods 
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4.1. In vivo studies 
4.1.1. Ethical approval 
 Ethical approval for each human study was obtained from Brunel 
University London Research Ethics Committee prior to the start of each study 
(Appendix I – Ethical Approval). 
 
4.1.2. Participant recruitment 
 Healthy young men were recruited for in vivo experiments of this thesis. 
Participation in all studies was entirely voluntary and participants were informed 
about risks and procedures of the experiments, and were encouraged to ask 
questions regarding the respective studies. Verbal and written consent 
expressing interest in partaking in the research was obtained prior to the 
beginning of each study (Appendix II - Informed Consent) and a self-completed 
health questionnaire (Appendix III – Health Questionnaire) was completed by all 
participants. Volunteers with known cardiovascular, metabolic, and/or endocrine 
diseases were excluded. 
 
4.1.3. Anthropometry 
 Anthropometric data were acquired prior to each study with participants 
wearing only light clothes, without shoes. Body mass was obtained with a digital 
scale (model 798, SECA, Germany) at 0.2 kg resolution and height was 
measured to the nearest 1 mm with a stadiometer (model 798, SECA, 
Germany). Body mass index was calculated by dividing body mass (in kg) by 
the squared height (in m) of each participant. 
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4.1.4. Maximal incremental test and spirometry 
 Maximal incremental tests were performed prior to main experimental 
visits using cycle ergometers or a custom-build knee extensor machine, 
according to the specific study. In general, after warming up in the test position 
participants performed a ramp or step incremental workrate test until volitional 
failure. Simultaneous breath-by-breath pulmonary gas exchange and ventilation 
were recorded using a metabolic cart (Quark B2, Cosmed, Italy) in chapter 5 
and chapter 6. The metabolic cart was calibrated before each test according to 
manufacturer’s instructions, using certified gases of known O2 (5%) and CO2 
(15%) concentrations. Oxygen uptake (V̇O2) and carbon dioxide production 
(V̇CO2) were assessed by paramagnetic, and non-dispersive infrared gas 
analysers, respectively. Data analysis was performed on 10 second moving 
average curves and the maximum oxygen uptake (V̇O2max) was considered the 
highest value obtained during the incremental test. Concomitant HR 
measurements were recorded via a telemetric device (T31, Polar Electro, 
Finland). It is appreciated here that one can exercise at much higher workrate 
than that observed at V̇O2max, but for the sake of this thesis the term PPO will 
be used to refer to the power output attained at volitional fatigue during the 
maximal incremental test. 
 
4.1.5. Principles of ultrasonography for cardiovascular measurements 
 Ultrasound devices are powerful machines used in clinical and research 
cardiovascular assessments and they work on the principle that transmitted 
ultrasound waves (usually between 2-15 MHz) can be reflected in human 
tissues as a consequence of change in ultrasound impedance between tissue 
boundaries. Returning echoes at specific frequency bands can then be captured 
and converted back to electric signal by a transducer (or probe) and displayed 
as 2D brightness mode (B-mode) ultrasound images. Typically, ultrasound 
probes are composed of piezoelectric crystals, which can transduce changes in 
voltage to generate mechanical waves (sound), and vice-versa. When 
transmitted waves travel through reflecting interfaces the returning echo signal 
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amplitude will depend on several variables, including the acoustic impedance 
difference between boundaries, ultrasound beam path angle, and tissue depth. 
For example, the greater the impedance difference, the bigger the echo 
reflection between tissues (Thrush & Hartshorne, 2010b). 
 The intensity of the returning echo can be reduced by a process known 
as attenuation, which increases as a function of depth and wave frequency. Due 
to the loss of signal energy because of ultrasound attenuation, high ultrasound 
frequencies have low penetration capacity and are used mostly for superficial 
tissue scanning. On the other hand, the axial resolution is increased as 
transmitted frequency increases, so the capacity to resolve between boundaries 
is improved (spatial resolution increases). As a consequence, most human 
superficial arteries can be investigated with ultrasound frequencies between 
7.5-12MHz, whereas deeper structures such as abdominal organs can only be 
visualised using lower ultrasound frequencies but at the cost of spatial 
resolution.  
 The attenuation at different tissue depths can be corrected by fine 
adjustments of time gain compensation, which enables control of the 
amplification of the returning signal at specific time delays. Since it is known 
that deeper structures result in more attenuated signals and longer returning 
echoes, it is possible to increase the amplification of longer duration pulses so 
the displayed signal is compensated on the screen. This is possible because 
the generation of ultrasound image is based on received signal time delay and 
intensity. As the sound travels and reflects on a surface there will be a time 
delay until the echo reaches the transducer. This time between transmission 
and reception of the signal (t) depends on the velocity of the ultrasound (c) 
(generally assumed as 1540 m.s-1 in soft tissues) enabling the calculation of the 
horizontal distance of a reflective structure as given: 
 
𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 =
𝑡 ∙ 𝑐
2
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 Hence, B-mode images can be reconstructed by expressing the returning 
signal intensities in grayscale on the screen based on their return times (Figure 
4-1). 
 
 
Figure 4-1. Example of probe transmitted wave and received specular reflection used to 
generate ultrasound images. Note that deeper structures result in longer returning times. The 
reflected energy is reduced due to signal attenuation. Adapted from Thrush and Hartshorne 
(2010b)  
 
 For blood velocity measurements the Doppler principle is applied. The 
Doppler effect was proposed by Christopher Doppler in middle of the 19th 
century and describes the change in sound wave frequency that occurs when 
the observer and/or the source of sound move towards or away from each other 
(Thrush & Hartshorne, 2010a). A typical example is usually given by an 
ambulance siren (source of sound) and a person (observer) outside the vehicle. 
If the observer remains stationary the sound wave length will reduce as the 
ambulance moves toward the person, increasing the wave frequency; whereas 
the wave length will increase (thus reducing sound wave frequency) as the 
source of sound moves away from the observer, explaining the change in 
audible sound when the siren passes by the observer. Conversely, movement 
of the observer can also influence the audible sound. In vascular 
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ultrasonography, the Doppler effect resulting from ultrasound interaction with 
clusters of moving erythrocytes enables the determination of the Doppler signal 
after demodulation and further analysis of its spectrum for quantification of 
blood velocity by the Doppler shift frequency, which is the difference between 
the transmitted frequency and the returning frequency and can be expressed 
as: 
 
𝐷𝑜𝑝𝑝𝑙𝑒𝑟 𝑠ℎ𝑖𝑓𝑡 =  
2 ∙ 𝑉 ∙ 𝐹𝑡 ∙ 𝐶𝑜𝑠𝜃
𝑐
 
    
 With V representing velocity of red blood cells; Ft the transmitted 
ultrasound frequency; Cosθ the angle of insonation; and c the velocity of 
ultrasound in the blood (typically assumed to be 1570 m.s-1). The constant 2 
refers to two Doppler effects, as first the transducer act as the source of sound 
and then as the observer of the returning waves reflected in the blood. As can 
be noted, changes in the insonation angle have important impact on the final 
result. Accordingly, if the wave beam is perpendicular to the blood (90°) the 
cosine is 0 and no velocity information can be obtained, whereas maximal 
information would be obtained if the probe were positioned parallel to the BF 
(cosine = 1). The latter condition is difficult to attain because ultrasound 
recordings are generally performed adjacent to the skin, limiting the ability to 
minimize the insonation angle due to anatomical limitations. Furthermore, if 
positioning the probe at 0° of BF direction were possible it would also result in 
no longitudinal B-mode imaging of the vessel, which is needed for several 
haemodynamic calculations. Thus an isonation angle of 60° or less is usually 
accepted as appropriate for blood Doppler measurements. 
  
4.1.6. Limb haemodynamics 
 Measurements of limb BF and SR were made using a Doppler 
ultrasound device (Vivid 7, GE Logic, UK) according to the principles described 
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above, except during experiment 1 in chapter 6 where leg BF during cycling 
was obtained using the thermodilution technique (detailed in that specific 
chapter method section). Longitudinal duplex B-mode and pulsed-wave Doppler 
recordings were made at 22.3 frames per second and 8.5 MHz for B-mode; and 
4.4 MHz for Doppler measurements, with a multi-frequency linear array 
transducer coated with water-soluble gel. The B-mode depth and probe position 
were adjusted to maximise image quality for each individual while keeping the 
Doppler insonation angle as low as possible (never greater than 60°). Doppler 
sample volume was adjusted to cover as much lumen as possible without 
extending beyond the vascular borders (Figure 4-2). Recordings were 
performed with participants seated upright or in a semi-recumbent position. 
Measurements at the brachial artery (BA) were made ~5-10 cm proximal to the 
antecubital fossa, whereas the common femoral artery, referred hereinafter as 
femoral artery (FA), was evaluated approximately 3 cm proximal to its 
bifurcation into deep profunda and superficial femoral arteries. Information from 
the FA was not recorded during cycling since the lower limb movement limits 
appropriate data acquisition. 
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Figure 4-2. Example of duplex brightness mode and pulsed-wave Doppler from a common 
femoral artery. The arterial diameter and the mean blood velocity are derived from the 
ultrasound recording for calculation of blood flow and shear rate.  
 
Off-line analyses were determined using specialised software (EchoPac, 
GE Logic, UK) on a personal computer workstation to obtain arterial diameters 
and Doppler blood velocities for further BF and SR calculations. Vessel 
diameter was traced manually from images acquired at end diastole at a site as 
close as possible to the Doppler sample volume. After visual inspection for 
quality spectral parameters, a 10 s weighted mean was obtained from the 
Doppler spectra for blood velocity measurement, with BF and SR calculated 
using the following equations (Credeur et al., 2010; Jenkins et al., 2013; Chiesa 
et al., 2015): 
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𝐵𝑙𝑜𝑜𝑑 𝑓𝑙𝑜𝑤 = 𝑉𝑚𝑒𝑎𝑛 ∙ 𝜋 ∙ (
𝐷2
4
) ∙ 60 
 
𝑆ℎ𝑒𝑎𝑟 𝑟𝑎𝑡𝑒 =
4 ∙ 𝑉𝑚𝑒𝑎𝑛
𝐷
   
 
 Where Vmean is the weighted time-averaged mean Doppler velocity; and 
D is diastolic vessel diameter. At least 3 recordings were acquired at each time 
point with results averaged to obtain the final BF and SR values. Within-subject 
coefficient of variation of data obtained at rest in different days was 11% for BA 
BF, 6% for FA BF, 15% for BA SR, and 12% for FA BF (n = 9). 
   
4.1.7. Cardiac output 
 In chapter 5, cardiac B-mode recordings using the same ultrasound 
device mentioned above were used for stroke volume (SV) and Q̇ calculations. 
Apical four-chamber images were obtained with a phased array probe at 3.6 
MHz and the frame rate was always greater than 60 frames per second, as 
adapted from echocardiographic recommendations (Lang et al., 2006). To 
assist cardiac scanning, participants lay in the semi-decubitus position or were 
tilted during cardiac scanning periods when positioned on the semi-recumbent 
bike. Measurements were made between the 4th and 5th intercostal space along 
the mid-axillary line with the probe index marker rotated to the right (3 o’clock). 
A four-chamber view was assumed appropriate when all cardiac chambers 
were properly visualised alongside the septa, as well as the tricuspid and the 
mitral valves (Figure 4-3). When appropriate positioning and image quality were 
attained, the B-mode depth was adjusted to improve image quality and frame 
rate for data analysis. Complete cardiac cycles were recorded and participants 
were instructed about breathing manoeuvres to help data acquisition, which 
were most often required during exercise.  
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Figure 4-3. Apical four-chamber view at end diastole (A), and systole (B) used for stroke 
volume quantification. Due to probe positioning on apical plane and the basic acoustic wave 
reflection principle of echography, the images seem rotated rightwards. Hence the left ventricle 
(LV) is visualised on the right top of the image, and left atria (LA) on the bottom. The right 
ventricle (RV), and right atrium (RA) are shown in the left side.  
  
Off-line analysis was performed again using the EchoPac PC station. 
The left ventricular endocardial cavity area was manually traced at end diastole 
and systole to enable ventricular volume calculation by the modified single 
plane Simpson’s disc method. This method takes into account the geometrical 
changes in the ventricular shape, as a stack of discs of different sizes. The 
traced area is divided into disc sections of same height and known diameter, so 
the ventricular volume can be calculated as the sum of the disc volumes as 
described below: 
 
𝑉𝑒𝑛𝑡𝑟𝑖𝑐𝑢𝑙𝑎𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 =  ∑
𝑙
𝑛
∙ [𝜋 ∙ (
𝑑
2
)
2
] 
 
 Where l is base to apex length; n is number of discs; and d is disc 
diameter. The SV was obtained by subtracting ventricular end systolic volume 
(ESV) from end diastolic volume (EDV), whereas Q̇ was the product of SV 
LV 
LA 
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multiplied by HR. At least three cardiac cycles were analysed for each 
measurement. The between day within-subject coefficient of variation of Q̇ 
obtained at rest was 5% (n = 6). 
 Participants’ Q̇ could not be obtained by echocardiographic 
measurements in chapter 6, but it was calculated using alternative approaches. 
In experiment 2, SV was acquired estimating aortic flow from direct intra-arterial 
radial pressure wave-forms applying the Modelflow method provided by 
BeatScope software (FMS, Netherlands), and HR was obtained by the analysis 
of the pressure-wave. In the first experiment, only baseline measurements 
could be obtained using the Modelflow method. Thus, Q̇ during passive heat 
stress and exercise was calculated relying on Fick’s equation using estimations 
of systemic O2 extraction from directly measured limb O2 extraction values (data 
not shown). This was based on the assumption that systemic and exercising 
limb O2 extractions are strongly related (Mortensen et al., 2005; Mortensen et 
al., 2008). Hence, linear regression equations were used to estimate systemic 
O2 extraction during heat stress and combined heat stress and exercise (A = 
1.7322B - 76.126), and control exercise (A = 1.43B - 44.7), with variable A 
referring to systemic O2 extraction and B denoting limb extraction. Estimated Q̇ 
was subsequently calculated according using Fick’s principle (Q̇ = V̇O2 / a-v O2 
dif; where a-v O2 dif refers to arteriovenous difference for oxygen). Systemic 
V̇O2 was obtained using a metabolic cart (Quark B2, Cosmed, Italy). 
 
4.1.8. Catheterisation and blood sampling 
 Blood sampling was carried out by arterial and/or venous access. Arterial 
catheterisation was performed by experienced clinicians in the BA or radial 
artery with the Seldinger technique, after local anaesthesia (2% lidocaine). 
Venous catheterisation was performed in an antecubital vein or in the common 
femoral vein. Samples were obtained without stasis in agreement with 
published recommendations for circulating MV acquisition. Before and after 
sample withdraw, the catheters were flushed with 0.9% sodium chloride solution 
(BD PosiFlush, Becton, Dickson and Company, USA) to maintain patency. The 
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first 3 ml of blood were discarded, and the collected blood was immediately 
mixed gently in tubes containing 0.129 mol·l-1 sodium citrate (Sigma-Aldrich, 
USA), and/or 8 mg ethylenediaminetetraacetic acid (EDTA) (Sarstedt, 
Germany). 
 Immediately after sample acquisition, platelet-rich plasma was prepared 
after whole blood centrifugation at 3,000 x g at 4°C for 10 min. Plasma from 
EDTA samples were aliquoted in tubes and then stored at -80°C for further 
analysis. Since platelet contamination can cause de novo formation of ex vivo 
MV, the supernatant from sodium citrate tubes was aliquoted into 1.5 ml vials 
and underwent a second centrifugation step at 15,000 x g and 4°C for 10 min to 
obtain platelet-poor plasma (PPP). The MV containing supernatant was 
removed carefully to avoid disturbing the platelet pellet and aliquoted in new 
vials for storage at -80°C until further experiments or analysis. 
  
4.1.9. Imaging flow cytometry overview 
Flow cytometric analysis of MV is one of the most common methods in 
the current literature and was the chosen technique for this thesis. Although 
predecessors of the modern flow cytometer had already been developed, the 
term “flow cytometry” was only introduced later during the mid-1970’s (Zuba-
Surma et al., 2007). Flow cytometry (cytometry from the Greek roots kutos: 
vessel, container, or cell - in biology; and metron: to measure) refers to the 
measurement of cells under flow conditions (Shapiro, 2003), which can be done 
by combining a cell suspension with a laminar flow sheath stream. Cells are 
interrogated in the flow chamber by light sources, with the cells inducing forward 
scattering (FSC) and side scattering (SSC, or right angle scatter) of the light. 
The scattered light is detected by FSC and SSC detectors, and this provides 
information about the cells or particles within the sample. Fluorescence signals 
can also be detected after sequential low-high band pass filtration and signal 
decomposition, if fluorophore-stained samples are used. 
Although powerful devices, traditional flow cytometers lack capacity for 
acquiring images of collected events, but innovative imaging flow cytometers 
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such as the ImageStreamX® Mark II (Amnis Corporation, USA) incorporate the 
remarkable feature of a fluorescence microscope within a flow cytometer 
(Figure 4-4), allowing visualisation at high throughput of individual events in the 
fluid path. This was made possible through intricate engineering that replaced 
photomultiplier detectors for charged-couple device cameras in the new imaging 
devices. This unique feature makes the ImageStreamX® a distinct data 
collection tool. Furthermore, the integrated IDEAS software (Amnis Corporation, 
USA) allows a myriad of analysis, ranging from typical object counts and 
population quantification by fluorescent signal intensity, to more sophisticated 
analysis such as the imaging of cellular protein co-localisation. 
  
 
Figure 4-4. Overview of the ImageStream
X
® Mark II flow cytometer system. The sample is 
hydrodynamically aligned in the flow chamber, running individually through the sheath path (1). 
Objects (e.g. microvesicles) are transilluminated as they cross the bright light illuminator 
generating forward scatter information (2), whereas side scatter, and fluorescent data are 
derived from a laser illuminator (3). The deflected light is decomposed into different spectral 
bands by the spectral decomposition element, reaching the charge-coupled device cameras at 
different angles, where the object information is recorded (4). Adapted from Amnis Corporation 
ImageStream
X
® Guide, available at www.amnis.com.  
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The ability to discriminate between MVs of different origins currently 
relies on specific surface antigens to which fluorescent-conjugated antibodies 
can specifically bind. Antibodies are immunoglobulins produced by B cells in 
response to specific antigen-containing pathogens and help the immune system 
by various mechanisms, with the most outstanding characteristic of tagging 
foreign corpses for destruction. These Y-shaped proteins possess an antigen-
binding site (or paratope) on top of their variable region on the heavy and light 
polypeptide chains (Figure 4-5, top). The selective antigen-antibody binding 
occurs when a specific region of the antigen known as an epitope interacts with 
the antibody paratope forming antigen-antibody complexes (Gleeson & Bosch, 
2013). This specific binding capacity led to the development of commercially 
available antibodies (usually as immunoglobulin G class) to label cells and 
particles for biochemical analysis. 
As mentioned in previous chapters, CD41 and CD62E are makers 
expressed by platelet and endothelial derived MVs, respectively. So 
fluorochrome conjugated anti-CD41 and anti-CD62E antibodies are common 
choices for the measurement of these MV subpopulations by flow cytometry. 
Each fluorochrome can be excited by light at defined wavelengths, absorbing 
energy and reacting by emitting light at a longer wavelength when electrons 
return to the ground state. This emission of light allows the quantification and 
discrimination between positive and negative events in flow cytometry.  
An intrinsic issue associated with the use of fluorescent antibodies is 
non-specific binding. Even though the paratope and the epitope are supposed 
to selectively bind to each other, antibodies may also react non-specifically 
generating false-positive events. This process known as non-specific binding 
may happen for a variety of reasons, but a common cause is the interaction of 
the antibody fragment crystallisable (Fc) domain to the Fc receptor region of a 
molecule (Figure 4-5, bottom) (Hulspas et al., 2009). Pre-incubating samples 
with Fc receptor blockers is thought to diminish this phenomenon, but one 
needs to bear in mind that a degree of non-specific binding will be present even 
after blocking techniques. 
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Figure 4-5. Schematic Y-shaped antibody structure, and antigen-antibody interactions. Top: 
The antigen binding site (paratope) is found in the variable region of the immunoglobulin, but 
the fragment crystallisable (Fc) domain may also interact with Fc receptors in the sample, 
resulting Fc-mediated antibody binding and false positive events. Bottom: The antibody 
paratope binds to the specific epitope region on the antigen allowing the identification of positive 
events if a fluorochrome conjugated antibody is stimulated at its specific wavelength (A). Non-
specific interactions between the Fc receptor and the Fc domain in the antibody may increase 
the number of false positive events (B). 
 
Although imaging flow cytometers are powerful devices for both 
photometric and morphometric analysis and present a much lower detection 
size limit compared to traditional cytometers, they also possess intrinsic 
limitations. For example, results from objects under analysis are derived from 
an automated mask placed upon the event. A mask defines the region from 
where specific feature information will be derived, and therefore inappropriate 
masking markedly impacts the features of the object under analysis, such as 
52 
 
diameter, area and aspect ratio (Figure 4-6). Misalignment of the object in the 
focal plane may also influence the results by generating blurred images that 
may overestimate the particle size, and intrinsic sample characteristics such as 
the objects contrast also can affect the acquired results. With this in mind, 
researchers must be aware of the device focal plane, sample flow velocity, and 
alignment during the data collection in order to minimise the acquisition of 
inappropriate events. 
 
 
Figure 4-6. Example of a microvesicle event obtained through image flow cytometry and the 
influence of different masks on the determination of object features of a single microvesicle. A = 
no mask; B = Appropriate mask covering the entire object; C = inaccurate mask resulting in 
overestimated microvesicle features. 
 
 Due to the variety of techniques available for extracellular vesicle 
quantification, an important aspect in MV research is the agreement between 
measurement methods. van der Pol et al. (2014) examined the ability of five 
common methods for MV quantification, including traditional flow cytometry, to 
discriminate between particle diameter and concentration, using a known 
mixture of polystyrene calibration beads (from ~46 to 596 nm of diameter) and 
MV-rich biological fluids (urine). Compatible with the “iceberg theory” discussed 
in chapter 2, traditional cytometry underestimated unstained vesicle 
concentration by approximately 18-fold compared to dedicated submicrometer 
particle flow cytometry, and almost 300 fold in relation to the reference 
transmission electron microscopy, which resulted primarily from differences in 
the minimal detectable vesicle size capabilities of each technique (van der Pol 
et al., 2014a). This demonstrates that agreement between absolute MV 
concentration values obtained using different methods is limited by the 
resolution capacity of the employed techniques. Hence, because the imagining 
flow cytometry technology used in the current thesis provides enhanced size 
detection capacity compared to standard flow cytometry (Headland et al., 2014), 
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greater absolute MV concentrations were expected and observed in this thesis 
when compared to research using traditional flow cytometry.      
 
4.1.10. Microvesicle quantification 
 On the day of analysis, PPP samples were thawed at room temperature, 
and 1.5 µl of PPP were pre-incubated for 10 min with 0.8 µl of TruStain Fc 
receptor blocker (BioLegend, USA). Next, samples were incubated in the dark 
for 25 min with PE conjugated anti-human CD62E (100 ng), and PE/Cy5 anti-
human CD41 (10.2 ng) fluorescent antibodies (both from BioLegend, USA). 
Samples were then diluted in 195 µl of 0.2 µm filtered phosphate buffered saline 
(PBS) (Sigma-Aldrich, Germany) and centrifuged for 15 min at 17,960 x g and 
4°C. This washing step was necessary to reduce the relatively high signal 
background arising from unbound CD62E. Following centrifugation, 170 µl of 
supernatant were carefully removed and the MV pellet was resuspended in an 
additional 30 µl PBS before analysis. Single-stained samples were analysed for 
each fluorochrome to set a compensation matrix for each sample. 
 The concentration of MVs was quantified using the ImageStreamX® Mark 
II flow cytometer (Amnis Corporation, USA) using the INSPIRE software (Amnis 
Corporation, USA), with 60 x magnification, 488 nm laser intensity at 100 mW, 
SSC laser intensity at 1.64 mW, using the lowest flow rate available to increase 
sensitivity while reducing the chance of doublet events. Laser intensities were 
determined through pilot experiments in order to maximize signal intensity but 
avoiding pixel saturation. Both FSC and SSC were acquired (on channels 1 and 
6, respectively) and the fluorescent signal from each fluorochrome/marker was 
recorded in their specific wavelength channels. All events were collected, but 
sample acquisition was limited to no less than 1,000 events in PMV region. This 
gating strategy for data collection is a potent tool within the INSPIRE software, 
as it enhances the precision of the events of interest. The a priori choice for the 
PMV instead of EMV gate relied on previous evidence indicating that PMV are 
more responsive to an exercise stimulus than EMV. 
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 Following acquisition, data were analysed off-line using IDEAS software 
(version 6.1, Amnis Corporation, USA). After single-staining compensation 
matrix correction of all files, an upper limit size threshold was delimited in a FSC 
by SSC dot plot based on 1 µm diameter calibration beads (Fluoresbrite, 
Polysciences, USA) to exclude non-MV events. Objects inside the size 
threshold were gated based on SSC intensity vs PE/Cy5 mean fluorescence 
intensity (for PMV), or PE mean fluorescence intensity (for EMV) (Figure 4-7). In 
the ImageStreamX® Mark II at 60 x magnification MVs present a very low 
distinct SSC, and form a linear cluster at low to moderate fluorescence 
intensities whereas flow calibration beads and other unlabelled events in the 
sample show a moderate to high SSC without fluorescence (Headland et al., 
2014). A threshold for positive events was set in each file based on the 
fluorescence minus one method (Hulspas et al., 2009). 
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Figure 4-7. Illustration of gating strategy applied for image flow cytometric quantification of microvesicles (MVs). Calibration beads doublets presenting low 
mask aspect ratio are initially excluded (1), and 1 µm size calibration beads are used to determine a MV upper size gate (2) based on forward (FSC) 
and side scatter (SSC) features. This gate is applied in in platelet-poor plasma samples (3) to exclude large non-microvesicle events, and the 
quantification of MVs is performed based on SSC and fluorescence intensity dot-plots (4), where MVs agglomerate with small SSC but moderate 
fluorescence intensity (Headland et al., 2014). Fluorescence minus one stained samples are used to set a fluorescence threshold for positive events, 
with those falling leftward the threshold representing ImageStream speed beads, and MVs negative for the antibody of relevance.  
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 The ImageStreamX® Mark II quantifies the total sample volume used 
during analysis by way of a syringe pump used to inject the sample, hence the 
concentration of MVs was calculated by the software (in events·ml-1) without the 
need for calibration beads as with other flow cytometer devices. Dilution factor 
corrections were performed after data acquisition to account for pre-analytical 
steps. Data obtained at rest in different days displayed a within-subject 
coefficient of variation of 15%, and 11% for PMVs and EMVs, respectively. 
 
 
4.1.11. Enzyme-linked immunosorbent assay 
 The ELISA was developed in the 1970’s, and has become an important 
tool for immune system research and other fields of science. It is currently a 
standard method for the quantitative measurement of innumerable substances 
relevant to exercise physiology and sport sciences, such as hormones, 
cytokines, and even mRNA (Gleeson & Bosch, 2013). 
 Diverse types of ELISAs are commercially available, but the general 
principle of the assay relies on antigen-antibody binding interactions to 
immobilize pertinent molecules for further quantification. Concisely, antigens (or 
antibodies) are incubated with specific antibodies and enzyme-conjugated 
secondary antibodies (or antigens). An enzyme substrate is then added to the 
solution, which elicits a colour change by an enzymatic reaction and allows 
measurement of the relevant substance concentration by absorbance readings 
of light at specific wavelengths (Figure 4-8).  
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Figure 4-8. Sandwich and competitive enzyme-linked immunosorbent assay (ELISA) principles. 
In the sandwich ELISA the antigen of interest is added to a well-plate pre-coated with a specific 
capture antibodies (A), and then incubated with secondary enzyme-conjugated antibodies (B), 
followed by addition of the enzyme substrate solution (C) after appropriate washing steps. In 
competitive ELISA the antigens are incubated with enzyme-conjugated antigens (A) which 
compete for the specific capture antibodies (E) prior to adding the substrate solution (F). In 
either case the enzyme reacts with the substrate giving rise to colour change with resultant 
absorbance directly proportional to the antigen concentration in the sandwich ELISA, and 
inversely proportional to antigen concentration in the competitive version. 
 
 Sandwich ELISAs were used in the current thesis for soluble plasma 
molecule quantifications in chapter 5. Standards and samples were incubated in 
pre-coated microplates with immobilised mono-clonal antibodies against the 
relevant antigen, washed to remove unbound substances, incubated with 
specific enzyme-linked poly-clonal antibodies, and washed again. Next, the 
wells were incubated with the specific enzyme conjugates, followed by and 
substrate solution (and amplifier solution when relevant). Colour change 
reactions were stopped by addition an acid stop solution, and the light 
absorbance at relevant wavelength was determined using a plate reader (PB 
800, Biohit, Finland). Final concentrations of each sample were calculated 
based on regression analysis from the known concentration standard vs optical 
density curve. 
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4.1.12. Plasma volume change 
 Changing from a standing to the supine position, increasing hydrostatic 
pressure with exercise, and/or elevating sweating rates as a response to a rise 
in core temperature with exercise all cause plasma and blood volume to shift, 
which in turn affects the final concentration of plasmatic substances. As MV 
measured in the plasma were the main dependent variables in the human 
studies described in this thesis, correction for plasma shifts were performed in 
order to test whether increases in circulating MVs could be explained by 
reductions in plasma volume due to the interventions used in the thesis. 
Percentage of blood and plasma volume shifts were then calculated based on 
measurements of blood concentrations of haemoglobin (Hb) and the 
percentage of haematocrit (Hct) (Dill & Costill, 1974) as follow: 
 
𝐵𝑙𝑜𝑜𝑑 𝑉𝑜𝑙𝑢𝑚𝑒 𝐶ℎ𝑎𝑛𝑔𝑒 =  100 × (𝐻𝑏1 ÷ 𝐻𝑏2) − 100 
 
𝑃𝑙𝑎𝑠𝑚𝑎 𝑉𝑜𝑙𝑢𝑚𝑒 𝐶ℎ𝑎𝑛𝑔𝑒 = {(𝐻𝑏1 ÷ 𝐻𝑏2) × (100 − 𝐻𝑐𝑡2) ÷ [(100 − 𝐻𝑐𝑡1) − 1]} × 100 
 
 Where Hb1 and Hct1 stand for baseline Hb and Hct concentrations; with 
Hb2 and Hct2 referring to Hb and Hct of the next time-point of interest. 
Participants’ Hct was measured using standard sodium-heparinized capillary 
tubes (micro-haematocrit tubes, Hawksley, UK) and centrifugation 
(HaematoSpin 1400, Hawksley, UK) procedures, and [Hb] was obtained 
through photometric analysis (HemoCue® Hb 201+ System, HemoCue AB, 
Sweden) in chapter 5; whereas Hct and blood concentration of Hb were 
determined using a blood gas analyser (ABL800, Radiometer, Denmark) of 
heparinized samples in chapter 6. 
 
4.2. In vitro studies 
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 All cell culture experiments were performed under sterile conditions, in a 
laminar-flow cabinet. Pipette tips were autoclaved prior to use, and local 
sterilisation was performed by swabbing gloves, flasks, laboratory equipment, 
and the cabinet with 70% ethanol. Basic biosafety procedures were followed 
according to the laboratory standards, and cells were incubated at 37°C and 5% 
CO2, unless stated otherwise. 
 
4.2.1. Cell culture medium 
 Growth medium for cell culture was prepared with M199 supplemented 
with 20% foetal bovine serum (FBS); 1% penicillin-streptomycin; 0.5% of 3 g.l-1 
endothelial cell growth supplement; 2% of 1 mol.l-1 HEPES; 0.1% heparin; and 
0.2% pyruvate. The culture medium was stored for up to four weeks at 4°C, and 
warmed up to 36°C in a water bath before being applied to cultures. 
Experimental medium was assay dependent and is described in chapter 7. A list 
of materials used for cell culture experiments is provided in the appendices 
(Appendix IV – List of Cell Culture Supplies). 
 
4.2.2. Culture of human umbilical vein endothelial cells 
 Human endothelial cells are not easy to isolate because they are part of 
vessel walls and are not freely suspended in blood. A common method to 
investigate human endothelial responses in vitro is through the culture of 
HUVECs, which can be obtained for primary culture from human umbilical veins 
using collagenase. Once cultured, HUVECs attach to the substrate in a culture 
dish and change morphologically, forming a monolayer of polygonal shaped 
cells with a centrally located nucleus and present Weibel-Palade bodies and 
express von Willebrand factor (Hoyer et al., 1973; Jaffe et al., 1973b; Marin et 
al., 2001). Due to the availability of this cell lineage, HUVEC culture was the 
selected method for the in vitro experiments presented in this thesis. 
 HUVECs were obtained as a generous donation from Harefield Hospital, 
North West London, and stored in liquid nitrogen until required for experiments. 
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For culturing, vials were quickly thawed in warm distilled water, and cells were 
gently transferred into culture flasks (T75, Sarsted, Germany), followed by slow 
dilution in growth medium to dilute the cryoprotectant whilst avoiding osmotic 
damage (Freshney, 2010b). Culture flasks were then incubated in a 
temperature (37°C) and CO2 (5%) controlled incubation chamber, and all 
culture medium was changed 24 h after seeding the cells. Thereafter half 
medium changes were performed every 48-72 h. 
 Passaging was performed when monolayers became 60-80 % confluent 
using a 1:3 split ratio. To do so, the growth medium was removed and flasks 
were washed with 10 ml PBS. Then HUVECs were exposed to 1 ml of trypsin 
and incubated at 37°C for no longer than 2 min to detach adherent cells. 
Detachment was confirmed by microscopy and trypsin was deactivated with 
growth medium (supplemented with 20% FBS). Cells were transferred into 15 
ml tubes and centrifuged for 6 min at 300 g and 18°C. Following centrifugation, 
the supernatant was discarded and the cell pellet was resuspended, seeded 
into new culture flasks in growth medium for sub-culturing, or used for 
experiments. Experiments were performed with HUVECs between passage 3-6. 
  
4.2.3. Proliferation assay 
 Cell proliferation was measured using a modified tretazolium salt (MTT) 
assay. This colorimetric technique first developed by Tim Mosmann (1983) 
enables cell quantification as a consequence of the reduction of MTT to 
formazan crystals at an optical density of 570 nm. The MTT reduction to 
formazan is dependent on mitochondrial activity, and only occurs in living cells 
and increases in proportion to cell density (Mosmann, 1983) (Figure 4-9). A 
modified quicker MTT assay has been proposed in the presence of DMSO 
which solubilizes cells and absorbance readings can be acquired at 540 nm. 
 Cell densities were determined in a pilot experiment and the assay was 
performed by loading 50 µl of cell suspension (2,000 cells in MTT medium) into 
wells of gelatin pre-coated 96-well plates, followed by the addition of 50 µl of 
experimental medium. The plate was placed in the incubator for 48 h to allow 
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cells to proliferate. After incubation, 10 µl of MTT solution (12 mmol.l-1 diluted in 
PBS) was applied and gently mixed in each well. Cells were returned to the 
incubator for 4 h to allow formazan crystal formation, and then 80 µl of medium 
was removed from each well and replaced by 50 µl of DMSO to act as a 
solubilising agent. The plate was incubated again for an additional 10 min 
before absorbance readings were taken at 540 nm with a plate reader (ELx808, 
BioTek Instruments, USA). The average absorbance of quadruplicate wells was 
calculated for each condition, and results were expressed as a percentage of 
the negative control condition (i.e. MTT medium only). 
 
 
Figure 4-9. Representation of the proliferation MTT assay. Living cells convert tetrazolium salt 
(MTT) to formazan crystals, which increases light absorbance at specific wavelength. Thus, the 
greater cell density, the greater formazan production and respective light absorbance. Figure 
produced using Servier Medical Art (www.servier.com). 
 
4.2.4. Cell migration assay 
 Cells migrate towards higher concentrations of chemical agents during a 
process called chemotaxis, and a number of assays were developed to test the 
chemoattractant potential of drugs or chemical agonists based on this kinetic 
principle. A typical chemotaxis assay, such as Boyden chamber-based 
experiments, involves applying a cell suspension onto culture inserts inside 
culture dishes loaded with potential chemoattractants. The insert is separated 
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from the dish by a membrane that allows cells to migrate towards the 
chemoattractant through its pores. In the current thesis a chemotaxis chamber 
(AP48 48 wells, Neuro Probe, USA) was used to test whether or not MVs may 
act as a chemoattractant agent for HUVECs. This protocol assessed the ability 
of serum starved cells loaded in an upper chamber to migrate through a 
polycarbonate filter (exposed filter area = 8 mm2, pore diameter = 8 µm, pore 
density = 1,000 pores·mm-2) toward chemoattractant-containing lower chamber 
(Figure 4-10).  
 On the day of the experiment, cells were serum starved in migration 
medium for 1 h, and pelleted by centrifugation after removal from the culture 
dish using trypsin. The wells of the lower chamber were loaded with 27 µl of 
experimental medium supplemented with MVs or control chemoattractants to 
form a slight meniscus and a 1% gelatin pre-coated polycarbonate filter was 
carefully positioned over the lower chamber. The upper chamber was firmly 
assembled and wells were loaded with 50 µl of FBS-free experimental medium 
containing HUVECs (25,000 cells). The chemotaxis chamber was incubated for 
4 h at 37°C and 5% CO2. Following incubation cells were removed from the 
non-migrated side of the filter by washing it in PBS and drawing the filter against 
a wiper blade 3 times. Migrated HUVECs were fixed in methanol for 10 min, and 
the filter was allowed to dry before it was stained in Giemsa stain (1:10 in 
distilled water) for 1 h. After staining, the filter was gently washed in distilled 
water, placed on a slide coverslip for analysis with an upright microscope 
(Axioskop 2, Zeiss, Germany) at 20x magnification. Migrated cells were counted 
manually using the software ImageJ (version 1.48, National Institutes of Health, 
USA), with the aid of a cell counter plugin. The average of triplicate wells was 
calculated for each condition, and the results were expressed as a percentage 
of the 10% FBS control condition, since no cells migrated in the negative control 
condition. 
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Figure 4-10. Diagram of the Neuro Probe chemotaxis chamber (A), and basic principle of the 
migration assay (B). Cells are loaded in the upper chamber and can migrate through the porous 
filter when chemoattractants are present in the lower chamber (B). Adapted from the Neuro 
Probe chamber manual. 
 
4.2.5. Scratch wound-healing assay 
 Combined cell proliferative and migratory capacities can be investigated 
by tracking the closure of a cell free region by cell monolayers. Although a 
variety of assays are available (Valster et al., 2005; Kramer et al., 2013), a 
conventional and inexpensive method to track such responses is through the 
aptly described scratch wound-healing assay, in which a pipette tip is used to 
disrupt a continuous cellular monolayer by scratching the bottom of the well 
plate followed by imaging of the scratched area to track the wound closure 
(Liang et al., 2007) (Figure 4-11). 
 Before the experiment a straight reference line was draw using a fine pen 
tip on the underside of each well of the 96-well plates. Wells were coated with 
0.5% gelatin and incubated at 37°C. Cells were then cultivated in each well with 
100 µl of growth medium until an almost confluent monolayer was apparent. On 
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the day of the experiment, HUVECs were serum starved by gently washing the 
wells with PBS and incubating the plate for 4 h with FBS-free medium. After 
starvation, sterile pipette tips (1-200 µl) were used to create a straight scratch of 
the cell monolayer, and all medium was replaced by experimental medium. The 
cell free area was imaged at 10x magnification at baseline and after 3.5 h of 
incubation, using an inverted microscope (Axiovert 200M, Zeiss, Germany). The 
incubation period was selected based on pilot experiments, to ensure that the 
wound would not be completely closed by the second time-point (which was 
found to occur in some conditions between 4 and 6 h).  
 The wound closure was measured using the software ImageJ (version 
1.48, National Institutes of Health, USA). The cell free area was measured 
using polygonal selections, taking into account the reference line in the bottom 
of the wells. The closed area was calculated as the baseline cell free area 
minus the final cell free area measured after incubation. The average of 
quadruplicate wells was calculated and this was expressed as a percentage of 
wound closure relative to the negative control condition. 
 
 
Figure 4-11. Illustration of the scratch wound-healing assay. A cell monolayer is cultivated until 
become almost confluent (A). The cell monolayer is then disturbed through a scratch wound 
using a pipet tip (B). Cells migrate and proliferate towards the cell-free region, analogue to a 
wound-healing process (C). Figure produced using Servier Medical Art (www.servier.com). 
4.2.6. Tubule formation assay 
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 In the presence of angiogenic factors, endothelial cells seeded on 
basement membrane proteins disrupt the membrane and migrate towards 
various chemoattractants, where they proliferate and undertake cytoskeletal 
reorganisation to form new vessels. A well-established, simplified in vitro model 
to study the angiogenic potential of biochemical candidates is the tubule 
formation assay. When specific extracellular matrix proteins (commercially 
available as Matrigel® or Geltrex® for example) are used as a substrate, 
seeded endothelial cells may migrate, proliferate, and change morphologically 
forming tubule-like structures in the presence of angiogenic agents (Figure 
4-12). In order to investigate the putative angiogenic potential of exercise-
derived MVs, an adaptation of the angiogenesis assay using a thin layer 
substrate (Faulkner et al., 2014) was performed to quantify the formation of 
tubule-like structures. 
 In these experiments, 96-well plates were kept on ice and loaded with 78 
µl per cm2 of Geltrex® (Life Technologies, UK). To ensure even coating in each 
well, Geltrex® was spread using a sterile Eppendorf 0.5 ml combitip insert. The 
plate was placed into the incubator at 37°C for 30 min. Subsequently, serum 
starved cells (1 h) were suspended in experimental medium (M199 with 
penicillin-streptomycin and 0.5% FBS) and 50 µl were loaded into each well 
(10,000 cells per well). Then, 50 µl of conditioned medium (see specific 
methods section) were added to each well and the plate was incubated for 24 h. 
Wells were imaged after incubation using the Axiovert microscope at 5x 
magnification. The number of tubule-like structures and branching points of 3 
fields of view per well were quantified using ImageJ software (version 1.48, 
National Institutes of Health, USA). Results were averaged from triplicate wells, 
and expressed as a percentage of the negative control condition. 
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Figure 4-12. Example of tubule formation assay. An extracellular membrane protein solution is 
loaded into a culture plate (A), and endothelial cells are seeded onto the solidified membrane 
(B). In the presence of pro-angiogenic factors endothelial cells will change structurally to form 
tubule-like structures (C). The greater the tubule formation, the greater in vitro angiogenic 
potential of a drug or substance. Figure produced using Servier Medical Art (www.servier.com).   
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5. Chapter 5 - Study 1: Time-course of Circulating 
Microvesicle Appearance during Moderate and 
Heavy Intensity Exercise and Subsequent Recovery 
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5.1. Abstract 
 Exercise-induced increases in circulating PMVs have been observed 
after strenuous bouts of exercise, with less consistent results regarding EMVs. 
The dynamics of MV appearance and its causative mechanisms, however, are 
currently unknown. To characterise such phenomena, 9 physically active, 
young, healthy men (25 ± 4 years, mean ± standard deviation (SD)) had 
haemodynamic measurements and blood samples taken during a 4 h rest 
control trial, a moderate intensity exercise trial, and a heavy intensity exercise 
trial. Exercise visits comprised 1 h of cycling followed by 3 h of recovery. 
Plasma [PMV] and [EMV] were determined by imaging flow cytometry, whilst 
noradrenaline and interleukin-6 concentrations were measured by enzyme-
linked immunosorbent assay. Mean vascular SR was acquired at the brachial 
artery by duplex Doppler ultrasonography. Heavy cycling caused a ~2-fold 
increase in plasma PMVs, which remained elevated at 1 h of recovery (P < 
0.05), but no changes were found in EMVs (P ≥ 0.05). Circulating MV 
concentrations remained stable throughout the control visit. [PMV] at baseline 
and during exercise were correlated to changes in arm SR during exercise (P < 
0.05; R2 = 0.43), and to a lesser extent with plasma noradrenaline 
concentrations (P < 0.05; R2 = 0.21). In conclusion, circulating PMVs are likely 
to be increased in healthy humans during heavy intensity submaximal exercise, 
whereas [PMV] and [EMV] are unchanged during rest control. Moreover, this 
study demonstrates positive correlations between plasma PMVs, 
haemodynamics variables, and plasma noradrenaline concentrations during 
exercise, suggesting that elevations in vascular shear stress and 
catecholamines may be potential mechanisms underlying the exercise-induced 
plasma PMV appearance. 
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5.2. Introduction 
 Exercise is a physiological stress capable of stimulating vesiculation in a 
variety of cells, as observed by increases in circulating MV concentrations after 
running and cycling bouts (Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf et 
al., 2011; Maruyama et al., 2012; Kirk et al., 2013). MVs derived from platelets 
seem to be the most responsive subpopulation, with studies consistently 
reporting a rise in venous PMVs after exercise bouts (Sossdorf et al., 2010; 
Chaar et al., 2011; Sossdorf et al., 2011; Maruyama et al., 2012), but elevations 
in EMVs (Sossdorf et al., 2011; Kirk et al., 2013; Lansford et al., 2015) and 
those derived from monocytes (Sossdorf et al., 2011) have only been observed 
under certain conditions. However, exercise variables that modulate the release 
of MVs in response to exercise remain unknown.  
 Several haemodynamic and endocrine adjustments are influenced by the 
intensity of exercise. For example as exercise workload increases, greater 
perfusion is observed in the active-muscles (Rådegran, 1997; Saltin et al., 
1998; Calbet et al., 2007; Mortensen et al., 2008; Chiesa et al., 2015), which 
occurs mostly through a rise in blood velocity at arterial level (Rådegran, 1997) 
and leads to proportional increases in arterial vascular shear stress. Likewise, 
sympathoadrenergic activity has been classically linked to exercise intensity 
(Galbo et al., 1975), and the inflammatory response to exercise also seems to 
be dependent on intensity, as plasma cytokine levels tend to rise with relative 
workrate (Scott et al., 2011). Increases in shear stress, noradrenaline, and IL-6 
concentrations have all been shown to stimulate platelet vesiculation in vitro 
(Miyazaki et al., 1996; Nomura et al., 2000; Reininger et al., 2006; Tschuor et 
al., 2008), whereas endothelial cells seem to increase MV release under low 
shear conditions and in response to inflammatory cytokines (Jimenez et al., 
2003; Wang et al., 2007b; Vion et al., 2013b). Hence, relative exercise intensity 
may be an important exercise parameter influencing MV formation.  
 The time-course of blood MV appearance in response to exercise has 
been overlooked. Studies investigating circulating PMVs have only explored 
their appearance during post exercise recovery (Sossdorf et al., 2010; Chaar et 
al., 2011; Sossdorf et al., 2011; Maruyama et al., 2012). Taken together, the 
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results from these studies indicate that PMVs may reach peak values within the 
initial hour of recovery, but it is possible that an increase in the appearance of 
these MVs may become evident during exercise. The EMV responses to 
exercise are less clear, with inconsistent results reported in the literature 
(Mobius-Winkler et al., 2009; Sossdorf et al., 2010, 2011; Guiraud et al., 2013; 
Kirk et al., 2013; Ross et al., 2014; Wahl et al., 2014; Lansford et al., 2015), but 
submaximal exercise would be expected to induce smaller, if any, effect on this 
MV population. 
 The aim of this study, therefore, was to characterise the time-course of 
MV appearance during and after typical prolonged endurance exercise 
protocols. To do so, participants performed 1 h of moderate intensity and heavy 
intensity cycling bouts followed by 3 h of recovery with measurements 
throughout the experimental protocol on separate occasions. The a priori 
hypotheses were that [PMV], but not [EMV], would increase progressively 
during exercise and early recovery, according to exercise intensity; and that 
PMV changes during exercise would be related to haemodynamic (shear 
stress) and biochemical (e.g. noradrenaline and cytokines) mediators. 
 
5.3. Methods 
5.3.1. Participants 
 Nine young healthy males completed all five visits for this study. 
Participant characteristics are shown in Table 5-1. Volunteers were young lean 
men, mostly involved in recreational physical activities (self-reported). 
  
71 
 
Table 5-1. Study 1 participants’ characteristics 
Age (years) 
 
      25±4 
 Height (cm) 
 
    179±9 
 Body mass (kg) 
 
      80±12 
 BMI (kg
.
m
-2
) 
 
      25±2 
 V̇O2max (l
.
min
-1
) 
 
     3.3±0.7 
 HRmax (beats
.
min
-1
) 
 
    180±9 
 VT1 (l
.
min
-1
) 
 
     2.0±0.3 
 PPO (W)     259±37 
 
MI workrate (W) 
 
      94±18 
 HI workrate (W)     160±25 
 
Mean±SD for 9 participants; BMI, body mass index; V̇O2max, 
maximum oxygen uptake; HRmax, maximal heart rate; VT1, 
oxygen uptake at first ventilatory threshold; PPO, peak power 
output; MI, moderate intensity; HI, heavy intensity. 
 
5.3.2. Experimental design 
 After recruitment, all participants eligible for the study were familiarised 
with the cycle ergometer and additional experimental procedures. During this 
session, participants performed a maximal incremental exercise protocol to 
minimise possible learning effects at the subsequent maximal test visit. After at 
least 48 h of recovery following the familiarisation visit participants returned to 
the laboratory to have their V̇O2max and derived variables determined using a 
ramp incremental test on a semi-recumbent cycle ergometer (Angio, Lode, 
Netherlands, Figure 5-1) with continuous collection of expired gases using a 
metabolic cart (Quark B2, Cosmed, Italy). Briefly, the test started with 
participants cycling at 80 revolutions per min (rpm) at a power output of 25 W 
with a ramp slope of 25 W·min-1. They cycled continuously until the limit of 
exercise tolerance (i.e. the point when participants could not maintain a 
cadence ≥ 60 rpm for 3 continuous seconds). Participants then rested for 5 min 
and underwent a confirmatory step test to exhaustion at 5% above participants’ 
ramp PPO. This step protocol served as a validation procedure to confirm that 
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participants reached their V̇O2max (Rossiter et al., 2006). Data were analysed 
using 10 s moving average window and the V̇O2max was determined as the 
highest V̇O2 obtained during the incremental test. For VT1 determination a two 
criteria determination method was used, comprising the first deflection point in 
the V̇O2-V̇CO2 curve, and the point when the ventilatory equivalent of V̇O2 
increased without concomitant rise in the respective V̇CO2 equivalent (Caiozzo 
et al., 1982). 
 
 
Figure 5-1. Semi-recumbent ergometer used for the moderate and heavy intensity exercise 
trials. The Angio unit can be tilted for echocardiographic measurements during exercise 
 
The main experimental visits are summarised in Figure 5-2. Participants 
arrived at the laboratory in the morning, approximately 1.5 h after a light 
breakfast and rested for approximately 30 min while they were instrumented. 
The first measurement (0 min at Figure 5-2) took place around 20 min after 
cannulation. During the control day (CON) participants rested in a semi-
recumbent position throughout a 240 min period while blood samples and 
additional measurements were obtained. The two last days were the exercise 
visits, which were performed in a randomised order. At the moderate intensity 
exercise trial (MI), 60 min of cycling at 80% of the workrate relative to VT1 was 
performed followed by 180 min of rest (recovery period), whereas during the 
heavy exercise intensity trial (HI) the participants cycled at VT1 power plus 30% 
of the difference between the workrate relative to their individual VT1 and 
V̇O2max (i.e. delta concept). The delta method was selected for the heavy 
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intensity protocol because it has been shown to reduce the variability of 
physiological response between subjects (Lansley et al., 2011), and the 
classification of intensity domains as moderate and heavy exercise was based 
on previous definitions (Whipp & Rossiter, 2005). The three main experimental 
visits were separated by at least one week to reduce potential effects of blood 
drawing. 
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Control rest  
trial 
 
0  30  60 80 100 120  150  180  240 (minutes) 
↑* # ↑ # ↑* ↑* ↑* ↑*  ↑*  ↑*  ↑*Resting 
Resting  
Moderate intensity 
exercise trial 
0  30  60 80 100 120  150  180  240  (min) 
↑* # ↑ # ↑* ↑* ↑* ↑*  ↑*  ↑*  ↑* 
 
60 min at 80% of VT1 
(36 ± 2% PPO) 
 
Resting (recovery) 
Figure 5-2: Time frame of data collection in the main experimental trials of study 1. Control trial is depicted on top, whereas exercise trials are in the 
bottom. ↑ blood sample; * cardiac output, femoral and brachial artery blood flow; 
#
 cardiac output, and brachial artery blood flow; VT1, first ventilatory 
threshold; V̇O2max, maximal oxygen uptake; PPO, peak power output. 
Heavy intensity 
exercise trial 
0  30  60 80 100 120  150  180  240  (min) 
↑* # ↑ # ↑* ↑* ↑* ↑*  ↑*  ↑*  ↑* 
 
60 min at VT1 + 30%∆ between VT1 
and V̇O2max 
(62 ± 1% PPO) 
 
Resting (recovery) 
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5.3.3. Catheter placement and blood sampling 
Venous blood samples were taken at 9 time points to determine the time-
course of MV appearance in plasma at rest (Figure 5-2, top), as well as during 
and after moderate or heavy intensity exercise (Figure 5-2, middle and bottom). 
After arrival, participants rested in the supine position in a quiet room and an 
18-gauge cannula (BD Venflon, Becton, Dickson and Company, USA) was 
inserted into a superficial antecubital vein of the arm by a trained researcher. 
Samples were obtained without venous stasis and the first 3 ml of blood were 
discarded. Approximately 15 ml of blood was aliquoted and stored at each time 
point. A 0.9% sodium chloride solution (BD PosiFlush, Becton, Dickson and 
Company, USA) was flushed through the cannula to maintain patency following 
each blood draw. Hct, Hb, lactate, noradrenaline, and IL-6 concentration were 
also determined. 
 
5.3.4. Systemic haemodynamics 
 Arterial blood pressure and HR were recorded continuously using a 
photoplethysmography device (Finometer® Pro, Finapres Medical Systems, 
Netherlands) throughout the experimental trials. Beat-by-beat blood pressure 
was obtained from participants’ middle finger, and reconstructed BA pressure 
wave-forms were acquired after calibrating the finger pressure to BA pressure. 
Finometer® data was recorded using an acquisition board (PowerLab, 
ADInstruments, UK) and analysed using LabChart software (Labchart 6, 
ADInstruments, UK), where all signals were synchronised and inspected for 
quality. Participants’ MAP was calculated by the LabChart software from the 
systolic and diastolic blood pressure measurements. To avoid participant 
discomfort, the finger cuff was removed in most participants after the 80th min 
measurement, and then recalibrated 10 min before the next measurement (100 
min). This procedure was repeated for some participants between the 180th and 
240th min measurements. 
 Participants’ SV was calculated from apical four chambers 
echocardiographic measurements using a Vivid 7 ultrasound (GE, UK), as 
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described in the general method section. Measurements were obtained with 
participants lying in the semidecubitus position on their left side, which was 
accomplished by tilting the recumbent cycle ergometer during exercise. 
Echocardiographic measurements were made at the level of the 5th - 6th 
intercostal spaces aiming to obtain an apical four chamber view of the heart. 
Images were obtained using the cineloop function of the ultrasound, so a total of 
20 to 30 heart cycles were recorded and the end diastolic and end systolic left 
ventricular area were measured and tracked using the EchoPac software 
(version 112, GE, UK). Left ventricular volumes (EDV and ESV) were obtained 
by the modified single plane Simpson’s method of discs (Lang et al., 2006). At 
least three heart cycles were selected for analysis and SV was calculated as 
the difference between the EDV and ESV of the left ventricle. Q̇ was the result 
of HR multiplied by SV, and estimated Q̇ were obtained from the Finometer® 
Pro in situations where the echocardiographic recordings could not be obtained 
or were of low quality. 
 
5.3.5. Limb blood flow and shear rate 
 Upper and lower limb haemodynamics were assessed in resting limbs by 
vascular ultrasonography (Vivid 7 ultrasound, GE, UK). The left BA was 
assessed at rest, during leg exercise, and recovery to test whether systemic 
haemodynamic changes of the non-exercising limbs correlate with changes in 
circulating MV concentrations. The FA could not be assessed during exercise 
due to limitations imposed by lower limb movements. Arterial BF and vascular 
SR were calculated as described in the general method section, and leg BF was 
estimated during exercise as follow: Two leg BF = exercise Q̇ - (resting Q̇ + 
exercise or rest two arm BF). FA BF was estimated to be the same as baseline 
at 20 and 40 min of CON trial. 
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5.3.6. Quantification of circulating microvesicles 
 Circulating MVs were measured in citrated PPP by imaging flow 
cytometry. Briefly, after blocking samples for Fc receptor binding (Human 
TruStain FcXTM, BioLegend, USA), anti-human CD41 and CD62E monoclonal 
antibodies (BioLegend, USA) were applied. Samples were incubated in the dark 
for 30 min and then washed once with PBS to stop binding and reduce 
background fluorescence. After a 10 min centrifugation step the MV pellet was 
resuspended in PBS and samples were measured at the slowest acquisition 
rate and at 60x magnification using an ImageStreamX® Mark II flow cytometer 
(Amnis Corporation, USA). Analysis was performed using IDEAS software 
(version 6.1, Amnis Corporation, USA) as described in the general methods 
section. 
 
5.3.7. Plasma noradrenaline and interleukin-6 storage and analysis 
 Five ml of blood were added to EDTA containing tubes (Sarsterdt, 
Germany) and immediately centrifuged at 3,000 x g and 4°C for 10 min to 
obtain platelet-rich plasma. The plasma was aliquoted and stored at -80°C until 
analysis. Plasma noradrenaline and IL-6 concentration were measured by 
commercially available solid phase sandwich ELISA kits (Noradrenalin ELISA, 
IBL International, Germany, lot END159; Human IL-6 Quantikine, R&D 
Systems, USA, lot 330593) in duplicates, according to the manufacturer’s 
instructions. Noradrenaline and IL-6 concentrations were calculated with 
polynomial regression equations based on standard curves after averaging 
optical density measurements obtained at 430 nm (for noradrenaline) and 490 
nm (for IL-6) from duplicates. The mean coefficient of variation between 
duplicates was 9.7% for noradrenaline and 6% for IL-6. 
 
5.3.8. Whole blood haematocrit, haemoglobin, and lactate 
  One ml of the blood was immediately separated in a microcentrifuge 
tube to determine Hct, Hb, and whole blood lactate concentration. Standard 
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centrifugation (HaematoSpin 1400, Hawksley, UK) of sodium-heparinized 
capillary tubes (micro-haematocrit tubes, Hawksley, UK) was performed to 
determine Hct manually, whereas Hb concentration was obtained by 
photometric analysis (HemoCue® Hb 201+ System, HemoCue AB, Sweden), 
and lactate concentration was determined using a Biosen C-line analyser (EKF 
Diagnostics, UK) after daily calibration. 
 
5.3.9. Statistical analysis 
 All descriptive data are presented as mean ± standard error of the mean 
(SEM), unless otherwise stated. Changes in the dependent variables (MV 
concentration, haemodynamics, and additional blood variables) were compared 
by two-way repeated measures ANOVA, considering Time (9 levels – from 
baseline to 240 min) and Condition (3 levels – CON, MI, and HI trials) as 
independent variables. Post hoc tests were carried out if a significant F-ratio 
was observed for Time effect, Condition effect, or Time x Condition interaction. 
The Dunnett’s test for multiple comparisons was performed to compare within-
condition results vs baseline values. Between-condition comparisons across 
each time point were performed with a separate repeated measure ANOVA, 
with Bonferroni correction performed manually to adjust for the number of 
multiple comparisons. A within-subject repeated measure correlation was 
performed to study the relationship between circulating MVs, haemodynamic, 
and biochemical variables within each participant (Bland & Altman, 1995), with 
data displayed as a mean group average for presentation. Stepwise multiple 
linear regressions were performed to identify predictors of circulating MV 
(dependent variable), considering BA SR, noradrenaline and IL-6 
concentrations as potential independent contributors. Different from the within-
subject correlation, however, multiple linear regression requires independence 
of observations, which was attained by performing tests for each condition and 
time-point (e.g. a model was created with data obtained at 30 minutes of heavy 
exercise condition). Hence data from each participant was used only once in 
each multiple regression model. 
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Due to technical issues with the GE ultrasound device, data of one 
individual had to be acquired using a different system (ProSound SSD5500, 
Aloka, Japan) during the exercise visits, with no data recorded on the control 
day. Due to the completely random nature of the missing data, a mean 
substitution treatment was applied for the missing information (in CON), instead 
of the listwise deletion procedure to ensure full participant datasets were 
incorporated in all analyses. Finally, [Hb] results could not be collected in the MI 
for one participant because of technical limitations, so a similar mean 
substitution data treatment was used. 
  The statistical analysis was performed using statistical software (SPSS 
version 20, IBM, USA), GraphPad Prism (version 5.03, GraphPad Software, 
USA), and SigmaPlot (version 13, Systat Software, UK) with significance level 
at α < 0.05 for all analyses. 
 
5.4. Results 
5.4.1. Limb and systemic haemodynamics 
 Estimated lower limb BF increased during cycling as a function of 
exercise intensity (P < 0.05, Time x Condition interaction), and remained 
elevated at 5 min post-exercise with more pronounced values in HI reflecting 
the augmented metabolic demand of the lower limbs (P < 0.05) (Figure 5-3C). 
Correspondingly, early post-exercise recovery FA mean SR was higher than 
baseline, with substantially greater values post heavy cycling compared to 
moderate intensity (P < 0.05, Time x Condition interaction) (Table 5-2). This BF 
and SR response occurred mostly through a rise in blood velocity to the lower 
limbs (P < 0.05), with arterial vasodilation playing a smaller role. 
 During exercise, BA vasodilation occurred and the mean blood velocity 
was increased (P < 0.05) (Table 5-2), with a resultant rise in BA BF during 
exercise and into early recovery (P < 0.05, Time x Condition interaction) (Figure 
5-3D). The higher BF to upper limbs during heavy compared to moderate 
exercise was mostly driven by changes in blood velocity, as no differences in 
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BA diameter were observed between exercise intensities. Similar to velocity 
changes, mean BA SR was augmented during cycling as a function of exercise 
intensity (P < 0.05), and was still elevated above baseline by 5 min of post 
heavy exercise recovery (P < 0.05), returning to resting values by 20 min. 
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Figure 5-3. Systemic and limb haemodynamics at rest control, and during moderate, and heavy 
intensity exercise and subsequent recovery. Grey symbols are estimated leg blood flow. Data 
are mean±SEM for 9 participants. N = 7 for cardiac output. * significant different from baseline 
within condition (P < 0.05); 
†
 significant different from control visit (P < 0.05); 
‡
 significant 
different from moderate exercise (P < 0.05). 
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Table 5-2. Arterial and blood profile during rest control, moderate, and heavy intensity exercise visits 
 
Experimental conditions 
 
Baseline 
 
Rest or exercise 
 
Recovery 
 Time (min) 0   20 40   65 80 100 120 150 180 240 
BA diameter (cm) 
      Control 0.39±0.01 
 
0.39±0.02 0.39±0.02 
 
0.39±0.01 0.39±0.01 0.39±0.02 0.39±0.01 0.39±0.01 0.39±0.01 0.39±0.01 
     Moderate exercise 0.39±0.01 
 
0.41±0.01*
†
 0.41±0.01*
†
 
 
0.40±0.01 0.39±0.01 0.39±0.01 0.39±0.01 0.39±0.01 0.39±0.01 0.39±0.01 
     Heavy exercise 0.38±0.02 
 
0.41±0.01*
†
 0.42±0.01*
†
 
 
0.41±0.01*
†
 0.40±0.01 0.39±0.01 0.39±0.01 0.39±0.01 0.39±0.02 0.39±0.01 
BA Vmean (cm
.
s
-1
) 
                 Control 9.4±0.9 
 
8.8±0.9 8.8±1.1 
 
9.3±1.0 8.3±1.0 8.7±0.6 8.4±0.8 8.4±0.7 8.3±0.9 8.3±1.1 
     Moderate exercise 10.1±1.2 
 
19.4±2.6*
†#
 20.5±3.4*
†#
 
 
16.0±2.6 10.9±2.0 9.3±1.3 8.7±1.5 8.2±1.6 7.9±1.2 7.9±1.1 
     Heavy exercise 10.4±1.3 
 
30.5±2.8*
†
 32.3±3.3*
†
 
 
23.7±3.6*
†
 12.9±2.5 11.6±2.0 11.5±1.9 9.3±1.6 9.9±1.4 9.0±1.3 
BA mean shear rate (s
-1
) 
                 Control 98±10 
 
92±10 92±13 
 
97±13 88±13 91±8 88±10 88±10 87±11 87±13 
     Moderate exercise 106±15 
 
194±28*
†#
 201±36*
†#
 
 
162±29 112±21 97±21 91±18 88±19 84±15 83±14 
     Heavy exercise 112±18 
 
300±32*
†
 309±34*
†
 
 
236±40*
†
 135±29 122±24 120±22 97±19 106±19 97±17 
FA diameter (cm) 
                 Control 0.90±0.02 
 
- - 
 
0.89±0.02 0.90±0.02 0.89±0.02 0.89±0.02 0.89±0.02 0.89±0.02 0.90±0.02 
     Moderate exercise 0.90±0.02 
 
- - 
 
0.96±0.02*
†
 0.94±0.02
†
 0.92±0.02 0.92±0.02 0.91±0.02 0.91±0.02 0.91±0.02 
     Heavy exercise 0.90±0.02 
 
- - 
 
0.96±0.02*
†
 0.96±0.02
†
 0.92±0.02 0.91±0.02 0.91±0.02 0.90±0.02 0.90±0.02 
FA Vmean (cm
.
s
-1
) 
                 Control 10.0±0.9 
 
- - 
 
9.1±1.1 9.3±0.8 8.5±1.0 9.3±0.9 9.3±1.0 8.9±0.7 8.8±0.7 
     Moderate exercise 8.2±0.5 
 
- - 
 
16.6±1.4*
†#
 9.0±0.7 8.8±0.5 8.2±0.4 9.0±0.7 8.5±0.7 9.0±0.4 
     Heavy exercise 9.0±0.7 
 
- - 
 
29.4±2.0*
†
 12.1±1.0
†
 10.5±0.9 10.4±0.9 9.5±0.7 9.6±0.9 9.4±0.6 
FA mean shear rate (s
-1
) 
                Control 45±5 
 
- - 
 
42±6 42±4 38±5 42±5 42±5 41±4 40±4 
     Moderate exercise 37±2 
 
- - 
 
70±7*
†#
 39±3 36±3
#
 36±2 40±3 38±4 40±1 
     Heavy exercise 40±4   - -   122±8*
†
 52±5 46±5 46±4 42±4 43±4 42±3 
Data are mean±SEM for 9 participants; BA, brachial artery; Vmean, time averaged mean blood flow velocity; FA, femoral artery; * P < 0.05 compared to baseline within 
condition; 
†
 P < 0.05 from control visit at the same time point; 
#
 P < 0.05 from heavy exercise visit at the same time point. 
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  At the start of exercise HR readily increased in relation to exercise 
intensity and remained elevated throughout the exercise bouts (P < 0.05, Time 
x Condition interaction), returning to baseline by the 20th min of recovery after 
both exercise protocols, whereas SV increased during cycling independent of 
exercise intensity (P < 0.05, Time effect) and returned to resting values within 
the first 5 min of recovery (P ≥ 0.05) (Table 5-3). This resulted in an elevated Q̇ 
throughout cycling in accordance with exercise intensity (P < 0.05, Time x 
Condition interaction) (Figure 5-3A). In the first 5 min of recovery after heavy 
exercise, Q̇ remained greater than baseline and in comparison to CON (P < 
0.05), whereas it returned to values similar to rest following the MI protocol (P ≥ 
0.05). Similarly, MAP increased during exercise reaching higher values during 
the HI compared to the MI at 40 min (P < 0.05, Time x Condition interaction) but 
quickly returned to baseline at the end of exercise. The MAP at 5 min of 
recovery, however, was lower during the HI compared to MI reflecting a 
tendency for post-exercise hypotension after prolonged heavy exercise (Figure 
5-3B). 
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Table 5-3. Cardiac parameters and blood pressure during rest control, moderate exercise, heavy exercise and subsequent recovery 
 
Experimental conditions 
 
Baseline 
 
Rest or exercise 
 
Recovery 
 Time (min) 0   20 40   65 80 100 120 150 180 240 
Heart rate (beats
.
min
-1
) 
      Control 59±4 
 
61±4 60±3 
 
61±2 58±3 58±3 59±3 57±3 59±3 60±4 
     Moderate exercise 59±3 
 
118±5*†#   118±6*
†#
 
 
86±7* 63±3 65±3 61±3 58±2 56±2 57±2 
     Heavy exercise 61±3 
 
157±5*†  158±4*
†
 
 
84±3*
†
 73±2
†
 64±3 62±3 60±3 60±4 58±2 
Left ventricular EDV (ml) 
                 Control 135±9 
 
130±8 130±8 
 
129±9 127±8 129±7 131±8 131±8 124±8 128±9 
     Moderate exercise 136±9 
 
145±11 142±9 
 
134±9 131±10 131±8 130±9 134±9 130±8 131±10 
     Heavy exercise 126±10 
 
146±12   143±12 
 
122±8 120±8 120±9 126±10 128±10 124±9 127±10 
Left ventricular ESV (ml) 
                 Control 45±6 
 
46±6 44±5 
 
45±5 45±5 44±5 45±5 46±5 41±5 44±6 
     Moderate exercise 53±8 
 
43±7 41±6* 
 
47±6 47±6 49±6 49±7 50±6
#
 47±6 48±7 
     Heavy exercise 46±7 
 
27±7 27±7 
 
35±2 38±3 39±5 44±7 44±6 45±9 43±6 
Stroke volume (ml) 
                 Control  92±4 
 
86±3  89±4 
 
89±4 87±4 89±3 89±4 88±3 87±3 89±4 
     Moderate exercise 86±3 
 
   107±6*
†
   107±5*
†
 
 
96±5 86±3 84±2 83±3
†
 84±3 84±3 88±4 
     Heavy exercise 89±5 
 
   119±6*
†
   116±5*
†
 
 
79±10 82±3 80±2
†
 82±2
†
 90±5 83±3
†
 89±5 
SBP (mmHg) 
                 Control 130±2 
 
127±2     127±3 
 
127±4 129±4 129±4 128±4 124±4 123±4 126±4 
     Moderate exercise 130±3 
 
160±3*
†#
   156±4*
†#
 
 
134±3 125±2 125±4 127±4 129±3
#
 125±4 129±3 
     Heavy exercise 129±2 
 
173±3*
†
 176±3*
†
 
 
123±5 119±2 121±3 121±2 120±3 119±3 122±3 
DBP (mmHg) 
                 Control 70±2 
 
69±3 69±3 
 
 70±4 71±3 71±3 73±3 71±3 71±3 71±3 
     Moderate exercise 71±1 
 
79±2* 77±2* 
 
 74±3
#
 73±2 72±3 72±3 73±2 70±2 74±2 
     Heavy exercise 68±2   80±2* 80±3*    65±2 71±1 72±2 72±2 70±2 70±2 69±2 
Data are expressed in mean±SEM for 9 participants. N = 5 for cardiac volumes and 7 for stroke volume (data from 2 subjects were obtained by 
photoplethysmography). EDV, end diastolic volume; ESV, end systolic volume; SBP, systolic blood pressure; DBP, diastolic blood pressure; * P < 0.05 
compared to baseline within condition; 
†
 P < 0.05 from control visit at the same time point; 
#
 P < 0.05 from heavy exercise visit at the same time point. 
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5.4.2. Plasma platelet and endothelial derived microvesicles 
 [EMV] was stable throughout the 4 h of CON and did not change in MI 
and HI trials (P ≥ 0.05) (Figure 5-4). However, a significant Time x Condition 
interaction (P < 0.05) was observed for [PMV], which increased with heavy 
exercise. A biphasic PMV response was apparent during HI trial; increasing by 
~2 fold during 30 and 60 min of heavy exercise (P < 0.05) after which a 
decrease occurred, however a second rise above baseline was evident at 60 
min post heavy exercise (P < 0.05). Plasma volume corrections did not 
eliminate any changes in PMVs during and after heavy exercise (P < 0.05, data 
not show). 
 The PMV area under the time-concentration curve was higher during HI 
(154 ± 16 PMV.µl-1.103.h) compared to CON (89 ± 6 PMV.µl-1.103.h) and MI (108 
± 9 PMV.µl-1.103.h) (P < 0.05, Time x Condition interaction). There were no 
differences in the EMV area under the curve among CON (46 ± 3 EMV.µl-
1.103.h), MI (46 ± 1 EMV.µl-1.103.h) and HI (48 ± 3 EMV.µl-1.103.h) (P ≥ 0.05).   
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Figure 5-4. Circulating platelet (PMV - A) and endothelial (EMV - B) microvesicles at rest 
control, and during moderate and heavy exercise, and subsequent recovery. Exercise had no 
impact on [EMV], but heavy intensity cycling increased circulating PMVs during and at 1 h of 
post-exercise recovery. Data are mean±SEM for 9 participants. * Significant different from 
baseline (P < 0.05); † significant different from control visit (P < 0.05); ‡ significant different from 
moderate exercise (P < 0.05). 
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5.4.3. Whole-blood lactate, haemoglobin and haematocrit 
 Hct increased throughout the heavy intensity bout, with increases during 
MI evident at the end of moderate exercise (Table 5-4) (P < 0.05, Time x 
Condition interaction) and 20 min of recovery. Concomitant changes in blood 
Hb concentration were observed at all exercise time points during both cycling 
intensities (P < 0.05, Time x Condition interaction) and returned to baseline 
during recovery. Plasma volume was reduced during both moderate and heavy 
cycling (P < 0.05), and returned to baseline between 20 and 40 min after 
exercise (P ≥ 0.05). 
 As expected heavy intensity exercise (performed above the VT1) elicited 
higher metabolic demands amongst the active muscles as evidenced by 5-6 
fold increases in blood lactate concentrations throughout the exercise session 
(P < 0.05, Time x Condition interaction) (Table 5-4). This response was 
proportional to exercise intensity, with moderate exercise only inducing a small 
change in blood lactate (i.e. from ~1 at baseline to 1.6 mmol.l-1), although this 
was significant at the 30 min exercise time point (P < 0.05). After exercise 
lactate was similar to baseline (P ≥ 0.05), but its concentration was lower 
throughout the first 1.5 h of recovery from moderate exercise compared to 
heavy (P < 0.05). 
 
5.4.4. Plasma noradrenaline and interleukin-6 
 Plasma noradrenaline concentration rose from baseline levels during 
heavy cycling (P < 0.05, Time x Condition interaction), with greater values 
observed throughout the heavy cycling period compared to control, and at 30 
min of exercise compared to moderate cycling (P < 0.05) (Table 5-4). 
Noradrenaline concentration returned to baseline within the first hour of 
recovery after heavy exercise and remained similar to baseline until the end of 
the recovery period (P ≥ 0.05). No changes from baseline were observed during 
CON and MI (P ≥ 0.05). 
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 By the end of 1 h of heavy cycling IL-6 concentration increased 
compared to moderate intensity exercise and resting control (P < 0.05, Time x 
Condition interaction) (Table 5-4) and values remained elevated above baseline 
throughout the recovery period. Interestingly IL-6 concentrations also increased 
from baseline in the CON and MI during the 3rd and 4th h of the protocol (P < 
0.05), so that at the end of the recovery period no differences were observed 
between trials. 
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   Table 5-4. Blood-derived parameters during rest control, moderate exercise, heavy exercise and subsequent recovery   
  
Experimental conditions 
  
Baseline 
 
Rest or exercise 
 
Recovery 
  Time (min)   0   30 60   80 100 120 150 180 240 
Haematocrit (%) 
       Control 
 
42±1  
 
42±1  42±1  
 
42±1  42±1  43±1  43±1  42±1  42±1  
     Moderate exercise  42±1  
 
44±1 44±1* 
 
43±1* 43±1 43±1 43±1 43±1  43±1 
     Heavy exercise 
 
42±1 
 
46±1*
†
 45±1*
†
  
 
44±1
†
  43±1 43±1 43±1 43±1 43±1 
Haemoglobin (g
.
l
-1
) 
                 Control 
 
141±4  
 
142±3 141±4  
 
141±3  140±3    142±3    142±4  140±4  142±4  
     Moderate exercise  144±3  
 
154±3*
†
  154±3* 
 
146±3  146±3  146±3    146±3  148±3  145±3  
     Heavy exercise 
 
142±3  
 
155±4*
†
  154±4*
†
 
 
147±4 141±3  139±4  142±3    142±3    142±3    
PV change (%) 
                 Control 
 
- 
 
-0.4±0.7 -0.1±1.4 
 
0.3±1.4 0.5±1.7 -1.3±1.9 -1.7±1.6 0.7±1.6 -0.9±1.4 
     Moderate exercise  - 
 
-10.2±1.2* -10.7±1.4* 
 
-3.5±1.2 -2.8±2.5 -2.4±2.4 -2.8±2.4 -4.3±2.2 -2.2±2.1 
     Heavy exercise 
 
- 
 
-13.7±1.2* -13.3±1.5* 
 
-5.3±1.7* -0.3±1.9 2.0±2.5 -0.3±1.7 -0.6±1.5 -1.1±1.3 
Lactate (mmol
.
l
-1
) 
                 Control 
 
1.0±0.1 
 
0.9±0.1 0.9±0.1 
 
0.8±0.1 0.8±0.1 0.8±0.1 0.8±0.1 0.8±0.1 0.8±0.1 
     Moderate exercise  1.0±0.1 
 
1.6±0.1*
#†
      1.3±0.1
#†
  
 
0.9±0.1
#
   0.8±0.1
#
   0.8±0.1
#
   0.7±0.1
#
 0.8±0.1 1.1±0.1 
     Heavy exercise 
 
1.0±0.1 
 
6.3±0.7*
†
    5.1±0.9*
†
 
 
 2.2±0.3*
†
  1.4±0.2  1.2±0.1  0.9±0.1  0.9±0.1  1.0±0.1  
Noradrenaline (nmol
.
l
-1
) 
                Control 
 
3.2±0.3  3.2±0.5 3.6±0.4  - - 2.9±0.4 - 2.6±0.3 3.4±0.4 
     Moderate exercise  3.0±0.3 
 
4.4±0.8
#
 4.4±0.5 
 
- - 2.5±0.4 - 3.7±0.6 3.0±0.5 
     Heavy exercise 
 
3.0±0.2 
 
   8.8±1.1*
†
    9.0±1.5*
†
 
 
- - 2.8±0.4 - 3.0±0.5 3.5±0.6 
IL-6 (pg
.
ml
-1
) 
                 Control 
 
0.8±0.1 
 
0.8±0.2 0.7±0.2 
 
- - 1.1±0.3 - 2.0±0.5* 2.5±0.5* 
     Moderate exercise  0.8±0.2 
 
0.7±0.1 0.9±0.1
#
 
 
- - 1.3±0.2 - 1.7±0.2* 1.9±0.5* 
     Heavy exercise 
 
0.6±0.1 
 
0.7±0.1 1.9±0.3*
†
 
 
- - 2.0±0.4* - 2.3±0.3* 1.8±0.1* 
Data are expressed in mean±SEM for 8-9 participants; PV, plasma volume; IL-6, interleukin-6; * P < 0.05 compared to baseline within condition; 
†
 P < 
0.05 from control trial at the same time point; 
#
 P <0.05 from heavy exercise trial at the same time point. 
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5.4.5. Relationship between circulating microvesicles and putative 
agonists 
 Since shear stress, noradrenaline, and IL-6 have been shown to act as 
agonists for PMV release in vitro, within-subject regressions were performed to 
identify whether haemodynamic and biochemical variables could explain the 
changes observed in PMVs with exercise. A modest yet significant relationship 
was found between PMVs, BA SR and noradrenaline concentrations when all 
time-points were investigated (P < 0.05) (Figure 5-5A and B, respectively). 
Further analysis revealed that [PMV] moderately correlated with BA SR (R2 = 
0.43; P < 0.05) (Figure 5-5D) and, to a lesser degree, noradrenaline levels (R2 = 
0.21; P < 0.05) (Figure 5-5E) prior and during exercise. Furthermore, [PMV] 
were also related to Q̇ (R2 = 0.47; P < 0.05), and to estimated leg BF (R2 = 0.56; 
P < 0.05) during exercise. PMVs displayed no significant correlation with IL-6 
under these conditions (P ≥ 0.05). 
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Figure 5-5. Relationship between circulating platelet microvesicle (PMV), brachial artery (BA) 
shear rate, noradrenaline (NA) and interleukin-6 (IL-6) concentrations at rest control, moderate, 
and heavy intensity exercise trials at all time-points (A-C), and only during baseline and 
exercise time-points (D-F). Data are mean±SEM for 9 participants. 
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 Multiple linear regressions were further performed in an attempt to 
discriminate predictors of PMV changes. Using a between-subject model, the 
independent variables were unrelated to PMVs (Pearson Correlation; P ≥ 0.05) 
at all time-points, resulting in no significant multiple linear regression model.         
 
5.5. Discussion 
 This study sought to characterise the time-course of plasma MV 
appearance in the venous circulation during and after prolonged cycling at 
moderate and heavy intensities compared to a resting control condition, and to 
gain insights into relationships between exercise-formed MVs and potential 
haemodynamic and biochemical agonists in vivo. The main findings were that 
the increase in circulating PMVs, but not EMVs, occurs not only after, but also 
during exercise within the heavy intensity domain. Circulating [PMV] did not 
differ from baseline early after exercise, but a second peak was observed at 1 h 
post heavy cycling, suggesting a biphasic response in this MV population. 
Haemodynamic measurements were moderately related to the PMV dynamics 
during exercise, with an additional correlation observed between PMVs and 
plasma noradrenaline. 
 
5.5.1. Time-course of microvesicle appearance with exercise 
 Little attention has been placed upon the kinetics of circulating MV 
appearance with exercise, with earlier efforts limited to the description of PMV 
dynamics during recovery. These studies generally support the concept that 
after exercise platelets introduce MVs into the venous circulation, with peak 
plasma concentrations occurring within 1-2 h of recovery (Sossdorf et al., 2010; 
Chaar et al., 2011; Sossdorf et al., 2011; Maruyama et al., 2012). Our results 
demonstrate for the first time that increases in circulating PMVs are not limited 
to the recovery period but actually occur during exercise, and that exercise 
intensity influences this PMV response.  
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 Relative exercise intensity modulates a variety of physiological 
responses, including increases in blood catecholamine concentrations (Galbo et 
al., 1975; Rosenmeier et al., 2004) and haemodynamic adjustments (Rådegran, 
1997; Saltin et al., 1998; Calbet et al., 2007; Mortensen et al., 2008; Chiesa et 
al., 2015), which have been suggested to activate platelets and induce 
subsequent release of PMVs during exercise at high relative workrates. Another 
hypothesis that may explain the rise in PMVs with heavy exercise may relate to 
purinergic activation of platelets. As described as part of a model of 
haemodynamic control, exercise-induced changes in the intravascular milieu 
including reduced local blood oxygenation, elevated vascular shear stress, and 
increased blood temperature are believed to trigger the release of ATP from 
intra and extravascular sources in order to improve local hyperaemia 
(González-Alonso, 2012). Intravascular ATP can be hydrolysed to ADP and 
further AMP by the ectonucleoside triphosphate diphosphohydrolase, an 
enzyme family reported to display increased activity in platelets of exercising 
rats (Cardoso et al., 2015). ADP has traditionally been used as an agonist in 
platelet function studies (Davis et al., 1990; Coppola et al., 2005), thus it may 
stimulate the generation of new PMVs. In this sense, it has been reported that 
acute exercise increases intravascular ADP concentrations, and this increase in 
circulating ADP induces platelet activation ex vivo (Yegutkin et al., 2007). 
Unfortunately, quantification of circulating nucleotides was not possible in the 
current study, but it seems possible that likely increases in intravascular ADP 
may be involved in the signalling pathways leading to the formation of PMVs 
with exercise. 
 The fact that PMVs increased from baseline and then remained stable 
from 30 to 60 min during exercise probably indicates a rapid MV turnover, which 
ought to be confirmed using tracer techniques. Several processes may account 
for PMV removal as suggested by in vitro experiments. Specifically, evidence 
for endothelial and renal epithelial cell uptake exists (Terrisse et al., 2010; 
Cantaluppi et al., 2012). Infused endothelial progenitor cell-derived MVs were 
localised in renal endothelial and tubular cells of rats during recovery from renal 
injury, suggesting the kidney as a MV extractor organ in these conditions 
(Cantaluppi et al., 2012). Besides the fact that MVs, including PMVs and EMVs, 
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have been identified in the urine of healthy humans (Viñuela-Berni et al., 2015), 
it is still difficult to assess the fate of MVs with exercise from these experiments, 
even more so when one considers that renal BF (and thus MV delivery) is 
reduced during intense exercise (Tidgren et al., 1991). 
 The second rise in [PMV] observed 1 h after the heavy intensity bout is 
intriguing, and is in agreement with other authors who found peak PMV values 
to occur within 1 h (Sossdorf et al., 2010, 2011; Maruyama et al., 2012) or 2 h 
(Chaar et al., 2011; Sossdorf et al., 2011) into the recovery period. Because 
these studies did not investigate circulating [PMV] at earlier recovery time points 
it is likely that they have missed this biphasic response, which was identified 
here due to the greater temporal resolution of our sampling protocol. The 
reason for this pattern is unknown, but implies that secondary mechanisms may 
lead to late platelet vesiculation after exercise since some potential platelet 
agonists investigated in this study, such as vascular SR, and blood 
noradrenaline returned to baseline levels rapidly. A potential cause of the 
secondary PMV peak might be related to platelet recruitment as exercise may 
lead not only to a pro-coagulant state (Davis et al., 1990; Coppola et al., 2005) 
but also an increase in platelet count after exercise sessions (Davis et al., 1990; 
Ikarugi et al., 1999). A reduction in plasma volume could be postulated to 
mediate part of this increase in platelet count through haemoconcentration but it 
should not be the case in the present study since plasma volume at 1 h of 
recovery was similar to baseline. It has also been proposed that new platelets 
may enter the circulation after being released from various platelet pools, 
including the spleen and bone marrow (El-Sayed et al., 2005). Although no 
direct measurement was made in this study, an increase in platelet 
concentration could result in late MV formation by newly recruited platelets and 
may explain the biphasic PMV response observed in this study. 
 In the present experiment no change was observed in [EMV] during and 
after prolonged cycling, implying that the two submaximal exercise stimuli had 
little impact on vesiculation of endothelial cells. Inconsistent results have been 
published regarding EMV kinetics, with researchers reporting increases 
(Sossdorf et al., 2011; Kirk et al., 2013; Lansford et al., 2015), no change 
(Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf et al., 2011; Guiraud et al., 
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2013; Ross et al., 2014), or even decreases (Wahl et al., 2014) after exercise. 
This apparent discrepancy is likely a result of different experimental conditions, 
including exercise mode, intensity and volume; and/or reflects the specific 
marker used to identify the EMV population. Since different proteins can be 
expressed by newly formed EMVs, it is plausible that the measured changes in 
plasma EMVs may depend on the endothelial marker investigated. For 
instance, Lansford et al. (2015) found increased circulating CD62E+ EMVs, but 
not CD42b-/CD31+ EMVs, after cycling at 70% of V̇O2max in men, and Kirk et 
al. (2013), reported plasma CD105+ and CD106+ EMVs to be elevated at 1.5 h 
post supramaximal cycling. Endoglin (CD105) expression is known to increase 
in endothelial cells undergoing angiogenesis (Nassiri et al., 2011), whereas the 
expression of vascular adhesion molecule-1 (CD106) is upregulated in the 
endothelium under inflammatory stimulation. These two latter proteins, 
however, are also weakly expressed by other cells including monocytes and 
macrophages, limiting the conclusion that endothelial cells were the unique 
source of MVs. Considering this, we cannot rule out the hypothesis that EMVs 
expressing other endothelial markers could be elevated in response to exercise. 
 An aspect of importance in the current experiment was the description of 
circulating MV concentrations during CON. So far, studies investigating 
circulating MVs and exercise have assumed there are no temporal changes in 
plasma MV concentrations with natural physiological circadian variations, or due 
to intrinsic experimental aspects (e.g. issues related to successive blood 
drawing), accepting that any deviation from baseline was a consequence of the 
exercise stimulus itself (Mobius-Winkler et al., 2009; Sossdorf et al., 2010; 
Chaar et al., 2011; Sossdorf et al., 2011; Guiraud et al., 2013; Kirk et al., 2013; 
Ross et al., 2014; Wahl et al., 2014; Lansford et al., 2015). The current results 
corroborate this idea by demonstrating that neither PMV nor EMV plasma 
concentrations are altered over 4 h of rest in a quiet thermoneutral laboratory 
environment. These control data support the validity and reproducibility of our 
MV concentration measures and the novel finding that [PMV] increases during 
heavy exercise. 
 
96 
 
5.5.2. Relationship between platelet microvesicles and putative agonists 
 The mechanisms eliciting PMV formation in response to exercise have 
not been studied by others but elevation in vascular shear stress during 
exercise may interact with systemic candidates to induce the observed 
response. It is known that as core temperature increases during exercise, a 
portion of the Q̇ is distributed towards the peripheral circulation (Brengelmann et 
al., 1977), as a consequence a rise in non-exercising limb BF during prolonged 
exercise may occur to facilitate dissipation of heat originating in the working 
muscles (Padilla et al., 2011b; Simmons et al., 2011). Accordingly, arm BF was 
elevated during exercise in the current study, and because this adjustment was 
driven mostly by changes in blood velocity, a concomitant rise in SR also 
occurred as a function of exercise intensity. As anticipated, changes in [PMV] 
during exercise were correlated with vascular SR, which agrees with studies 
where human platelets released MVs when exposed to incremental shear 
forces (Miyazaki et al., 1996; Reininger et al., 2006). A weak relationship was 
also apparent between noradrenaline and [PMV], which may indicate an 
adrenergic influence on PMV production during exercise. As previously 
mentioned, noradrenaline is a platelet agonist and so this association seems 
logical, but the precise biochemical pathways related to MV formation from 
noradrenaline-stimulated platelets are unknown. [PMV], however, did not 
correlate with IL-6 as the time course of appearance of this myokine was 
distinctly different from that of PMVs. These observations suggest that levels of 
IL-6 are not stimulating PMVs under these conditions. Supporting this is the fact 
that the increase in MV production reported by Nomura et al. (2000) occurred 
when incubating platelets with 100 pg.ml-1 of IL-6. These values far exceed the 
IL-6 plasma concentrations observed in this study, and thus it seems likely that 
physiological doses of this cytokine reached during exercise may not suffice to 
stimulate PMV production. 
 Although correlations do not necessarily represent causation, the fact 
that high shear stress stimulates PMV formation in vitro, and that plasma [PMV] 
changed with alterations in SR in vivo in the current experiment, strengthens the 
view that overall vascular shear stress may be one of the mediators of PMV 
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release during exercise. In addition, noradrenaline may play a synergistic role in 
stimulating PMV formation during exercise. 
 
5.5.3. Limitations 
 The current experiment does have some limitations. For instance, lower 
limb cycling was performed whereas blood samples were obtained from an 
antecubital vein. Hence an assumption of this study was that peripheral venous 
samples mirror the MV dynamics of active limbs. Also, BA SR was used here in 
an attempt to characterise the importance of shear stress on MV formation. It is 
important to note that arm SR does not represent the magnitude of systemic 
shear stress generated during lower limb exercise. During cycling most of the Q̇ 
is directed to the lower limbs, inevitably flowing through the descending aorta 
and downstream arteries. Since only small diameter changes are expected to 
occur in large arteries during exercise, Q̇ measurements may seem to more 
reasonably reflect systemic shear stress during lower limb cycling than localised 
SR in the arm. Therefore, multiple linear regressions were also performed 
between PMVs, Q̇, and estimated leg BF, with results indicating similar 
coefficients of determination compared to that observed with BA SR, further 
supporting the hypothesis that shear stress plays a role in the dynamics of PMV 
during exercise. 
 
5.6. Conclusion 
 Heavy exercise increases the concentration of circulating PMVs during 
and at 1 h post exercise, with no impact on EMVs. This phenomenon depends 
on exercise intensity, since moderate cycling did not bring about this 
physiological response. The rise in PMVs during heavy exercise was 
accompanied by changes in vascular shear stress, and plasma noradrenaline 
concentration, and both variables appear to explain part of the MV dynamics 
during exercise. Therefore, this study demonstrates that exercise bouts 
performed in the heavy exercise domain increase the appearance of circulating 
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PMVs in young healthy men, potentially through the interplay of factors such as 
elevations in vascular shear stress and circulating catecholamines.  
  
99 
 
6. Chapter 6 - Study 2: Arteriovenous Microvesicle 
Dynamics with Heat Stress and Exercise  
Engaging a Large or Small Muscle Mass 
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6.1. Abstract 
 The appearance of MVs in the circulation might be a physiologically 
relevant response to exercise in humans but our current understanding of MV 
dynamics is still limited to the venous circulation, and the mechanisms 
underlying MV release with exercise remains largely unknown, yet increases in 
vascular shear stress are thought to be involved. In this study, we investigated 
the PMV and EMV arteriovenous (a-v) responses to increases in exercise-
dependent and independent shear stress in two studies. In the first experiment, 
8 trained men had vascular shear stress manipulated through passive whole-
body heat stress and incremental cycling. In experiment 2, 8 additional males 
were exposed to passive whole-body heat stress whereas one leg remained 
cooled throughout, followed by dynamic single leg knee extensor exercise with 
the heated leg and the contralateral cooled leg. Vascular SRs in the FA were 
determined or estimated and blood samples were obtained from the radial 
artery and the femoral veins at rest and during very heavy exercise (80% PPO) 
in both experiments. In experiment 1, baseline [PMV] was higher in the venous 
than arterial circulation (P < 0.05). Passive heat stress increased vascular SR 
and arterial PMVs (P < 0.05) abolishing the baseline a-v PMV difference (P ≥ 
0.05). Very heavy cycling with heat stress elevated SR by ~30-fold and 
increased the appearance of PMVs in the venous circulation (P < 0.05), 
whereas there was no a-v PMV difference during control cycling (P ≥ 0.05). 
EMVs increased from baseline in the venous circulation but only during heat 
stress cycling (P < 0.05). In experiment 2, no differences between arterial and 
venous samples were observed (P ≥ 0.05) and heat stress whilst one leg 
remained cooled did not affect [PMV] or [EMV] (P ≥ 0.05), despite a ~3-fold 
increase in vascular SR in the heated leg (P < 0.05). Very heavy knee extensor 
exercise further increased active leg SRs by ~12-fold from baseline and 
stimulated the release of PMVs which appeared at all sampling sites (P < 0.05). 
Taken together, these findings reveal that whole-body heat stress increases 
arterial [PMV], and very heavy large or small muscle mass exercise stimulates 
an increase in both arterial and the venous [PMV]. However, local shear stress 
does not appear to be a primary stimulus for localised formation of PMVs, since 
they also increased in the venous circulation of non-active limbs.  
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6.2. Introduction 
 The previous chapter demonstrates that the [PMV] is elevated in the 
circulation during heavy exercise, which may be linked to increases in vascular 
shear stress. Our understanding of the physiological responses underlying 
cellular vesiculation, however, is limited and remains restricted to events 
happening within the venous circulation. In the current study, we took a step 
further to understand the dynamics of circulating MVs in the arterial and venous 
circulation of exercising humans, and the potential relevance of vascular shear 
stress in this process. 
 Strenuous exercise involving a large muscle mass, such as cycling, 
running, or rowing, unarguably imposes very high demands upon physiological 
systems. During exercise, increases in blood velocity augment the laminar 
shear forces between the blood and its surrounding vasculature, causing shear 
stress to rise (Tanaka et al., 2006; Padilla et al., 2011b; Simmons et al., 2011). 
Stimulation of platelets with shear forces has been found to promote PMV 
formation and appearance ex vivo (Miyazaki et al., 1996; Reininger et al., 
2006), and the previous chapter of this thesis reported a relationship between 
plasma [PMV] during exercise and vascular SR in non-exercising limbs. 
Because intravascular shear forces increase dramatically in vessels feeding 
exercising muscles, it is reasonable to consider shear stress as a putative 
stimulus leading to platelet vesiculation during exercise. If that is the case, 
manipulation of shear stress in exercising humans should induce changes in 
circulating [PMV].  
 Large muscle mass exercise, however, also induces systemic changes in 
circulating factors that may act as agonists that induce MV formation. For 
example, under conditions of intense effort, adrenergic activity increases 
alongside relative exercise intensity leading to an exponential rise in circulating 
catecholamines (Galbo et al., 1975; Rosenmeier et al., 2004). Noradrenaline 
(Tschuor et al., 2008), and other factors responsive to exercise, including 
angiotensin II (Burger et al., 2011), and cytokines (Jimenez et al., 2003; Abid 
Hussein et al., 2008) have been identified as agonists that induce PMV and 
EMV release in vitro. Since the concentration of these potential agonists also 
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increases in the circulation during strenuous exercise, mechanistic information 
about the impact of shear stress on MV formation during large muscle mass 
exercise becomes inherently more difficult to isolate. Fortunately, dynamic knee 
extensor exercise can be used to address this shortcoming. This single limb 
exercise model has been used for decades for the investigation of local 
haemodynamic responses, since the exercising limb can be maintained 
relatively stable for ultrasound measurements (Andersen et al., 1985). Exercise 
engaging a small muscle mass may reduce the number of physiological 
confounding factors involved in PMV formation by eliciting relatively smaller 
systemic neuroendocrine responses compared to larger muscle mass exercise 
(Mourtzakis et al., 2004; Rosenmeier et al., 2004), while inducing marked local 
haemodynamic adjustments (Mourtzakis et al., 2004; Mortensen et al., 2005; 
Calbet et al., 2007; Mortensen et al., 2008). 
 Vascular shear stress can also be modulated relatively independent of 
metabolism, albeit to a lesser degree, by manipulating body temperature. 
Passive heat stress imposes a significant stress to the cardiovascular system, 
with skin and limb tissue perfusion increasing as a function of the rise in local 
and core temperature, whereas arterial pressure can be preserved, or declines 
somewhat, simultaneously with marked elevations in Q̇ (Minson et al., 1998; 
Chiesa et al., 2015). As a result, increases in vascular shear stress become 
evident during passive heat stress (Padilla et al., 2011b; Simmons et al., 2011) 
with minor effects on plasma catecholamines when passive heating is 
associated with localised single-limb cooling (Chiesa et al., 2015), although 
muscle nerve adrenergic outflow increases progressively during whole-body 
heat stress with plasma noradrenaline spillover observed at high core 
temperatures (Kim et al., 1979; Pearson et al., 2011; Gagnon et al., 2015). 
These unique features make passive heat stress and dynamic knee extensor 
exercise two pertinent approaches to test whether local increases in vascular 
shear stress with and without exercise stimulate increases in circulating MVs, 
and whether or not these elevations are a systemic or localised phenomenon. 
 Accordingly, the aim of the current study was to investigate the dynamics 
of PMV and EMV appearance with heat stress as well as large and small 
muscle mass exercise across major arterial and venous vessels; and to test 
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whether expected elevations in circulating MVs are closely associated with 
elevations in shear stress induced by passive heat stress and exercise. Two 
experiments were performed in which participants were exposed to whole-body 
passive heat stress, and combined heat stress and very heavy large muscle 
mass exercise, or passive heat stress followed by a single limb knee extensor 
exercise with one leg kept cool throughout the main experiment to modulate 
shear responses. We hypothesised that plasma PMV concentrations would 
increase from baseline during passive heat stress and exercise, and that this 
response would reflect local changes in vascular shear stress. The 
concentration of EMVs would remain similar to baseline with heat stress and 
small muscle mass exercise, while increasing slightly during very heavy cycling 
due to the greater exercise challenge. 
 
6.3. Methods 
6.3.1. Participants 
 Healthy male participants were recruited to partake in one of two 
experiments of this chapter. Eight trained male cyclists were recruited for 
experiment 1 (heat stress and cycling), and 8 healthy physically active males 
took part in experiment 2 (heat stress and knee extensor exercise with single 
leg cooling) (Table 6-1). Study design and aims were explained to each 
participant prior to obtaining informed written consent. 
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Table 6-1. Study 2 participants’ characteristics 
Experiment 1   
Age (years)     26±6 
Height (cm) 
 
 181±6 
Body mass (kg) 
 
   76±9 
BMI (kg
.
m
-2
) 
 
   23±2 
V̇O2max (l
.
min
-1
) 
 
  4.5±0.3 
Heat stress V̇O2max (l
.
min
-1
) 
 
  4.0±0.2 
Cycling PPO (W)   371±33 
Heat stress cycling PPO (W)   321±27 
Experiment 2    
Age (years)     25±4 
Height (m)   176±4 
Body mass (kg)     73±5 
BMI (kg
.
m
-2
)     24±1 
Knee extensor exercise PPO (W)     63±8 
Mean±SD for 8 participants in each experiment; BMI, 
body mass index; V̇O2max, maximal oxygen uptake; 
HRmax, maximum heart rate; PPO, peak power output 
 
6.3.2. Study design 
 This chapter describes the results of two experiments performed in 
collaboration with Dr SJ Trangmar (experiment 1) and Dr ST Chiesa 
(experiment 2), as it allowed acquisition of samples in an experimental setup 
that otherwise would not be possible. Original manuscripts exploring the effects 
of heat stress and exercise on human cardiovascular control within the same 
conditions are either under preparation (cycling and heat stress) or have been 
published elsewhere (Chiesa et al., 2015). The first experiment was performed 
to investigate the effect of passive heat stress and very heavy large muscle 
mass exercise on arteriovenous PMV and EMV dynamics; whereas experiment 
2 enabled us to gain insights into the influence of local haemodynamic factors 
on MV formation during passive heat stress and very heavy small muscle mass 
exercise. 
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6.3.2.1.  Experiment 1 
Trained cyclists attended the laboratory on two occasions: 1) to 
determine their PPO; and 2) for the main experimental visit, both of which 
involved upright cycling on an ergometer (Excalibur, Lode, Netherlands, Figure 
6-1). Condition-specific PPO was obtained during two maximal incremental 
cycling tests during thermoneutral and heat stress conditions, starting at 50% of 
the predicted PPO, with 10% step increments every 2.5 min. Participants cycled 
between 70-90 rpm and the test was terminated when a cadence above 60 rpm 
could no longer be sustained for more than 3 continuous seconds. Gas analysis 
was performed breath-by-breath with a metabolic cart (Quark B2, Cosmed, 
Italy). After 1 h of recovery under heat stressed conditions (outlined in Figure 
6-2), a second incremental test was performed to determine the PPO with an 
elevated core body temperature (i.e. heat stress). 
 
 
Figure 6-1. Upright cycle ergometer used in study 2. 
 
During the main experimental trial participants arrived at the laboratory 
after their usual breakfast and were instrumented (see below). Following 
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baseline measurements, participants were exposed to passive whole-body heat 
stress by circulating hot water through a custom-made water perfused suit 
connected to a water circulator (Julabo F-34, Seelbach, Germany, 50°C) until 
their core temperature increased by approximately 1°C (~53 min). The suit 
covered the entire torso and legs of the participants, and the protocol elicited 
moderate heat stress (+ ~1°C core temperature and ~6°C in skin temperature). 
Then, participants performed incremental exercise under heat exposure (Figure 
6-2), followed by a recovery period during which body temperature was allowed 
to return to baseline levels. After the recovery period a final incremental 
exercise protocol under thermoneutral conditions (control exercise) was 
performed. The incremental exercise protocol consisted of five 2.5 min 
incremental stages at percentages of their specific PPO, and blood samples 
were taken at the end of the fourth incremental stage (80% of PPO). The 
experimental protocol also included an incremental exercise bout after brief 
heat stress exposure leading to skin hyperthermia but normal core temperature; 
however, this segment of the protocol was not used in the assessment of MV 
dynamics due to logistical constraints and is thus not included in this thesis.
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Figure 6-2. Experimental design of the upright cycling trial of study 2. Participants were exposed to whole-body passive heat stress and then incremental bouts of exercise 
according to their condition-specific peak power output (PPO) during heat stress and thermoneutral conditions.  blood samples. 
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6.3.2.2.  Experiment 2 
 In the knee extensor experiment, participants visited the laboratory on two 
separate days: 1) to familiarise themselves with a custom-built single-leg knee 
extensor exercise ergometer and determine their individual dynamic knee-extensor 
exercise PPO; and 2) to perform the main experimental visit used to characterise the 
impact of local heat stress and exercise-induced changes in SR on arteriovenous 
MV dynamics. Exercise was performed on a modified Monark ergometer (Figure 6-3) 
with flywheel resistance controlled by friction. After familiarization with this 
ergometer, individual PPO of the right and left quadriceps femoris muscles was 
determined during an incremental test consisting of 3 min stages at 60 knee 
extensions per minute and 6 W increases at each stage. The test was terminated 
when participants could no longer maintain the cadence above 50 extensions per 
minute for 3 s. 
 
 
Figure 6-3. Modified Monark ergometer used for the dynamic knee extensor exercise protocol in 
study 2. 
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 On the day of their main experimental visit, participants had their usual 
breakfast and arrived at the laboratory in the morning (between 7:00 am and 9:30 
am). After instrumentation (described below) and a period of rest in the supine 
position, baseline measurements were obtained from both legs and participants were 
exposed to passive heat stress for 1 h by wearing a suit (perfused with hot water, 
50°C), which covered their torso and right leg, whereas the left leg was exposed to 
ice packs (KoolPak, Warwickshire, UK) for local limb cooling (Figure 6-4). Passive 
heat stress was followed by an incremental knee extensor exercise protocol 
performed using the cooled leg, while the heated leg remained inactive. After 20 min 
of recovery, the same incremental knee extensor exercise protocol was performed 
with the heated leg whilst the cooled limb remained inactive. Torso and right leg 
heating was continuously applied from the onset of passive heat stress until the end 
of the experimental visit (from time 0 to 104 in Figure 6-4 top), whereas the left leg 
was concomitantly kept cooled throughout the experimental protocols (from time 0 to 
104 min in Figure 6-4 bottom). 
 Arterial and venous blood samples (from the heated and cooled leg) were 
obtained simultaneously at baseline and at the end of each condition (passive heat 
stress, cooled leg exercise, recovery from exercise, and heated leg exercise). Ice 
packs were replaced on the cooled leg every 30 min and participants drank water ad 
libitum to minimise potential confounding effects of dehydration. 
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Figure 6-4. Experimental design of the single limb exercise trial of study 2.   blood samples;   ultrasound measurements. 
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6.3.3. Instrumentation and measurements 
6.3.3.1. Catheter placement and blood sampling 
 Upon arrival, participants in both experiments were instrumented while they 
rested in the supine position in a thermoneutral preparation room. Arterial and 
venous cannulation was performed under local anaesthesia (1% lidocaine) by 
experienced clinicians. In experiment 1, cannulas (Logicath Quad Lumen, 18 gauge, 
MXA234X16X85, Smiths Medical International, UK) were placed into the non-
dominant arm BA, and antegrade into the right common femoral vein using the 
Seldinger technique. For experiment 2, the radial artery of the right wrist was 
cannulated (18 gauge catheter, 16 cm, Multi-Med M2716HE, Edwards Lifesciences, 
USA), and intravenous cannulas were placed bilaterally in the femoral veins in the 
retrograde direction under ultrasound guidance with the tip of the cannulas located 
approximately 1 to 2 cm distal to the inguinal ligament. Blood samples were taken 
simultaneously from all catheters at the experimental time points indicated in Figure 
6-2 and Figure 6-4. Samples were transferred to sodium citrate or EDTA blood 
tubes. Platelet-rich plasma was obtained by one step centrifugation, and citrated 
PPP was obtained by a second centrifugation process as described previously. 
 
6.3.3.2. Circulating microvesicle quantification 
 Plasma MVs were measured by imaging flow cytometry in PPP obtained from 
citrated blood. After thawing, samples were incubated at room temperature with a Fc 
receptor blocking solution for 10 min (BioLegend, USA), followed by incubation with 
anti-human CD41 (PE/Cy5) and CD62E (PE) monoclonal antibodies (BioLegend, 
USA) for 30 min in the dark. After incubation, samples were washed with PBS and 
the pellet obtained after centrifugation was resuspended in buffer solution for 
imaging flow cytometric analysis using an ImageStreamX® Mark II (Amnis 
Corporation, USA) at 60x magnification. Quantification of MV concentrations was 
performed with IDEAS 6.1 software (Amnis Corporation, USA) after single-staining 
matrix compensation. Size gating was performed to exclude non-MV events based 
on exclusion of events with a diameter greater than the 1 µm diameter size 
calibration beads (Polysciences, USA). PMs were identified as CD41+ events with 
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low SSC, whereas CD62E+ events were used to identify EMVs, with positive events 
established by FMO samples. Dilution factor correction was performed to 
compensate for sample dilution during the acquisition analysis steps. 
 
6.3.3.3. Blood and plasma volume changes 
 Participants’ Hct and Hb were obtained using a blood gas and metabolite 
analyser (BL 800 FLEX, Radiometer, Denmark) according to the manufacturer’s 
instructions, and the shift in blood and plasma volume was calculated as described 
in the general method section. 
 
6.3.3.4. Body temperatures 
 In experiment 1, core body temperature was measured in the main 
experimental trial as blood temperature obtained from a thermistor inserted through 
the cannula in the common femoral vein (see Local Haemodynamics section below) 
and connected to a thermocouple meter (TC-2000, Sable Systems, USA). 
Temperature data were synchronised using an analogue-to-digital converter linked to 
a data acquisition board (Powerlab, ADInstruments, Australia) and data were 
analysed using Labchart software (version 8, ADInstruments, UK). For experiment 2, 
intestinal temperature was measured using a wireless telemetry temperature sensor 
(HQInc, Palmetto, US) which was ingested 2 to 3 h prior the main experimental trial. 
 Skin temperatures were obtained using wireless thermistors interfaced with 
data loggers (iButtons, Maxim, USA) which were attached to the skin using adhesive 
tape. During experiment 1, mean skin temperature was calculated as the weighted 
mean temperatures obtained from thermistors placed on the chest, arm, thigh and 
calf according to the equation: Mean Skin Temperature = 0.3 x (chest + arm) + 0.2 
(thigh + calf) (Ramanathan, 1964); whereas skin temperatures in experiment 2 were 
obtained from thigh thermistors placed on the heated and cooled legs.  
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6.3.3.5. Systemic haemodynamics 
 In both studies, MAP was obtained from direct arterial blood pressure 
measurements at the brachial or radial arteries using pressure transducers 
positioned at the level of the heart (Pressure Monitoring Set, Edwards LifeSciences, 
Germany). In experiment 1, HR was obtained with a heart rate monitor (Polar 
Electro, Finland) and the Fick principle was used to estimate Q̇ based on systemic 
V̇O2 and estimations of systemic O2 extractions, as detailed in the general method 
section. For experiment 2, HR was calculated by the pulsatile pressure rate from the 
intra-arterial transducer, and SV was obtained using the Modelflow method in the 
radial pressure tracing with BeatScope package (FMS, Netherlands). Transducers 
were connected to a data amplifier (BPAmp, ADInstruments, UK) and a data 
acquisition system (PowerLab, AdInstruments, UK). Synchronised data analysis was 
performed with Labchart software (AdInstruments, UK). 
 
6.3.3.6. Local haemodynamics 
 Arterial diameters and mean blood velocities within the FA were obtained by 
ultrasonography (Vivid 7, GE Logic, UK) using a linear array transducer for resting 
measurements of experiment 1 and all measurements of experiment 2. Vascular SR 
was calculated as 4 x time-averaged mean blood velocity / vessel diameter; and BF 
was the product of time-averaged mean blood velocity x π x vessel radius2 x 60, as 
detailed before. The thermodilution technique was employed in experiment 1 to 
measure leg BF during exercise. To do so, ice cold saline was introduced into the 
common femoral vein through a quad lumen catheter using a Harvard pump 
(Harvard Apparatus, USA; ~20 s and infusion rate of 120-160 ml.min-1). Changes in 
blood temperature were obtained using a thermistor (T204a, PhysiTemp, USA) 
positioned 10 cm beyond the catheter tip, after saline infusion. Leg BF values were 
calculated using a heat balance equation as described previously (Andersen & 
Saltin, 1985). Because BF values obtained by ultrasonography and thermodilution 
techniques are highly correlated (r = 0.996) (Rådegran, 1997), the FA vascular SR 
could be calculated using estimations of blood velocities from thermodilution BF, 
assuming relatively unchanged FA diameters as observed here and in previous 
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studies (Rådegran, 1997). Thus, SRs could be estimated during the cycling bouts in 
experiment 1.  
 Due to logistical constraints, haemodynamic measurements from resting legs 
were not recorded during the knee extensor exercise, and from the cooled leg during 
cooled leg recovery in experiment 2. Hence, vascular SRs in the resting leg during 
knee extensor exercise were estimated from BF changes, assuming that resting leg 
BF increased 75% during contralateral leg knee extensor exercise (Keller et al., 
2003). For presentation purposes, SR values in the cooled leg during recovery were 
assumed to be equal to those from the same leg during passive heat stress.  
 
6.3.4. Statistical analysis 
 All descriptive data are presented as mean ± SEM, unless otherwise stated. 
In experiment 1, a one-way repeated measures ANOVA was used to compare 
differences in the dependent haemodynamic variables, and Condition (5 levels – 
baseline, passive heat stress, heat stress exercise, recovery, and thermoneutral 
control exercise, respectively). The dependent blood-derived variables, including 
MVs, were compared with a two-way repeated measures ANOVA, considering 
Condition (5 levels – from baseline to control exercise, as indicated above) and 
Sampling Site (2 levels – arterial and venous samples) as independent variables. 
 In experiment 2, change in the dependent variable vascular SR was 
compared with a two-way repeated measures ANOVA with Condition (5 levels – 
baseline, passive heat stress, cooled leg exercise, recovery, and heated leg 
exercise, respectively) and Leg (2 levels – heated leg and cooled leg) as 
independent variables; whereas Condition (5 levels – as above) and Sampling Site 
(3 levels – arterial, cooled leg venous, and heated leg venous samples) served as 
independent variables when examining changes in MVs and blood-derived variables. 
 Follow-up tests were carried out whenever significant F-ratios were observed 
across Condition, Sampling site, Leg, and when significant interactions between 
Condition x Sampling Site (experiment 1 and 2) or Condition x Leg (experiment 2) 
were observed. The Dunnett’s test for multiple comparisons employed to identify 
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differences from baseline, and Bonferroni corrections performed a posteriori between 
conditions. Arteriovenous MV differences were compared to an expected nought 
value with one sample T-tests. Statistical analysis was performed using statistical 
software (SPSS version 20, IBM, USA) with Dunnett’s post hoc analyses calculated 
using GraphPad Prism (version 5.03, GraphPad Software, USA). The significance 
level (α) for all tests were set at α < 0.05. 
 Due to technical and logistical limitations, blood samples and haemodynamic 
measurements could not be obtained from all participants (detailed sample sizes are 
displayed in the results). With regards to MVs, samples could only be obtained from 
7 participants in experiment 1 and 5 participants in experiment 2. Baseline 
ultrasonography recordings could be obtained from 4 participants in experiment 1, 
with thermodilution measurements from 6 participants. Due to the completely 
random nature of the missing data, a mean substitution treatment was applied to 
estimate baseline values from ultrasound measurements, instead of the listwise 
deletion procedure to ensure the use of full participant datasets for analyses. During 
experiment 2 ultrasonography recordings from 7 individuals could be obtained, for a 
total of 4 participants with matching MV and local haemodynamic data sets for the 
within participant correlation analysis. For statistical comparisons, however, all MVs 
(n = 5) and local haemodynamics (n = 7) data were used. 
 
6.4. Results  
6.4.1. Experiment 1 - Responses to whole-body heat stress and very heavy 
cycling 
6.4.1.1. Temperature and haemodynamic responses 
 Passive heat stress increased mean skin temperature by ~6°C (from 32.7 ± 
0.4 to 38.7 ± 0.2°C), and core body temperature by ~1°C, with a further ~1.4°C 
increase in core temperature during cycling (P < 0.05) (Table 6-2) while skin 
temperature remained at ~38°C. Thermoneutral recovery decreased core body and 
skin temperatures, although core remained elevated above baseline (P < 0.05) and 
further increased during control exercise; whereas skin temperature remained at 32 ± 
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0.5°C. Blood [Hb] and Hct increased with passive heat stress, reflecting a reduction 
in participants’ blood and plasma volume of ~4-8%, with further reductions observed 
during exercise (Table 6-2). Passive heat stress increased leg BF and SR (P < 0.05) 
(Table 6-2; Figure 6-5). During both heat stressed and control exercise, leg BF and 
SR increased some 30-35 fold from baseline, accompanying increases in Q̇ and 
MAP (P < 0.05). 
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Table 6-2. Core temperature, haemodynamics, and haematological responses to passive heat stress and  very heavy  cycling 
 
Baseline 
 
Passive heat 
stress 
 
Heat stress 
exercise 
 
Recovery 
 
Control exercise 
Core temperature (°C)   36.5±0.1      37.6±0.1*        39.0±0.1*  37.0±0.1*       38.8±0.1* 
Q̇ (l
.
min
-1
)     5.5±0.4        9.3±0.7*        26.1±2.6*    6.1±0.3*       25.4±1.3* 
Two-leg blood flow (l
.
min
-1
)     0.6±0.1        2.3±0.2*        17.1±1.3*    1.5±0.4       19.2±1.0* 
MAP (mmHg)    103±6         95±3         124±7*   102±4        153±7* 
Haemoglobin (g
.
l
-1
)          
Arterial    144±3       149±3*         157±3*   139±3*        152±3* 
Venous    145±3       151±3*         161±3*   140±3*        153±3* 
Haematocrit (%)          
Arterial      44±1         46±1*           48±1*     43±1*          47±1* 
Venous      44±1         46±1*           49±1*     43±1*          47±1* 
Blood volume shift (%)          
Arterial -         -4±1            -9±1       4±1           -6±1 
Venous -         -4±1          -10±1       3±1           -5±1 
Plasma volume shift (%)          
Arterial -         -6±1          -16±1       7±1         -10±2 
Venous -         -8±1          -18±1       6±1         -10±1 
Mean±SEM for 6-7 participants. N = 4 for cardiac output. Q̇, cardiac output; MAP, mean arterial pressure; * P < 0.05 compared to 
baseline. 
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Figure 6-5. Calculated vascular shear rate (SR) in the femoral artery during baseline, passive heat 
stress and very heavy cycling conditions. Passive heat stress increased estimated femoral artery SR, 
which was further augmented during either heat stress exercise or thermoneutral control exercise. * 
Significant difference from baseline (P < 0.05).  
 
6.4.1.2. Circulating microvesicles 
 Baseline concentrations of PMVs were higher in venous than arterial samples 
(P < 0.05, Condition x Sampling Site interaction) (Figure 6-6A). Passive heat stress 
increased the concentration of circulating arterial PMVs (P < 0.05), abolishing the a-v 
PMV difference (P ≥ 0.05), but heat stress exercise induced substantial increases in 
venous PMVs, re-establishing the a-v PMV differences (P < 0.05) (Figure 6-6B). 
Arterial [PMV] remained elevated during the recovery from heat stress exercise and 
during control exercise (P < 0.05), with no difference between arterial and venous 
samples (P ≥ 0.05), and venous PMVs increased at the end of the control exercise 
(P < 0.05). 
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Figure 6-6. Effect of passive heat stress and very heavy cycling with and without heat stress on 
arterial and venous platelet microvesicle (PMV) concentrations (A), and arteriovenous PMV difference 
(a-vPMV) (B). Venous PMVs were higher compared to those in arterial plasma, but heat stress 
eliminated this difference at rest, increasing the arteriovenous difference. Exercise further stimulated 
PMV formation causing intravenous [PMV] to be higher than that in arterial plasma with heat stress 
exercise. Mean ± SEM for 7 participants. * Significant difference from baseline (P < 0.05); 
†
 significant 
difference compared to arterial samples at the same time-point (P < 0.05); 
#
 significant difference from 
zero (P < 0.05). 
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 As depicted in Figure 6-7A, baseline [EMV] were similar between arterial and 
venous samples (P ≥ 0.05), and passive heat stress per se did not affect [EMV] (P ≥ 
0.05), yet strenuous exercise combined with heat stress increased EMVs in the 
venous circulation compared to baseline (P < 0.05). Correction for plasma volume 
shift, however, abolished this increase [EMV] (P ≥ 0.05). Arteriovenous EMV 
difference remained similar to nought throughout the study period. Venous [EMV] 
returned to resting levels during thermoneutral recovery, and remained similar to 
baseline during very heavy control exercise (P ≥ 0.05). 
 
 
Figure 6-7. Effect of passive heat stress and very heavy cycling on arterial and venous endothelial 
microvesicle (EMV) concentrations (A), and arteriovenous EMV difference (a-vEMV) (B). Arterial 
EMVs were unaffected by passive heating and control exercise, but venous EMVs increased with 
cycling under heat stress, returning to baseline in during thermoneutral recovery. Mean ± SEM for 7 
participants. * Significant difference from baseline (P < 0.05).  
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6.4.2. Experiment 2 – Responses to whole-body heat stress and very heavy 
single leg knee extensor exercise with and without local heat stress 
6.4.2.1. Temperature, local and systemic haemodynamic responses 
 One hour of passive heat stress with localised leg cooling increased core 
temperature by about 0.5°C (P < 0.05) (Table 6-3), which remained elevated 
compared to baseline throughout the experimental trial. During passive heat stress, 
heated leg mean skin temperature increased from 28.6 ± 0.9 to 38.3 ± 1°C, whereas 
it decreased in the cooled leg to 17.5 ± 1.7°C (P < 0.05) and remained below 
baseline during cooled leg exercise (23.8 ± 0.6°C, P < 0.05). Skin temperature of the 
heated leg was ~8°C above baseline during heated leg exercise (P < 0.05). 
Increases in the concentration of Hb and Hct were evident at the end of cooled leg 
exercise, and remained elevated until the end of the trial (P < 0.05, Condition effect) 
(Table 6-3), reflecting a decrease in blood and plasma volume throughout the 
experimental protocol. Thermal manipulations effectively produced distinct local 
haemodynamic adjustments, with BFs (Table 6-3) and heated leg SRs (Figure 6-8) 
being higher than baseline during passive heat stress in the heated leg only (P < 
0.05, Condition x Leg interaction) as a result of unchanged FA diameters (P ≥ 0.05 
vs baseline and between legs) but increases in FA blood velocity (from 6.7 ± 0.5 at 
baseline to 21 ± 2 cm.s-1; P < 0.05). Exercise with either the cooled or the heated leg 
elevated their respective BFs and vascular SRs (P < 0.05). Passive heat stress 
decreased MAP (P < 0.05) (Table 6-3), whereas exercise with either leg elevated Q̇ 
and MAP (P < 0.05). 
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Table 6-3. Core temperature, haemodynamics, and haematological data during passive heat stress and very heavy single leg knee extensor exercise 
 
Baseline 
 
Passive heat 
stress 
 
Cooled leg 
Exercise   
Recovery 
cooled leg 
exercise    Heated leg exercise 
Core temperature (°C)  37.2±0.1      37.7±0.1*       37.8±0.1*     37.9±0.1*          38.0±0.1* 
Q̇ (l
.
min
-1
)    6.8±1.6        8.9±1.6*       13.5±2.2*       7.7±1.4          14.2±2.0* 
Leg blood flow (l
.
min
-1
)          
Heated leg    0.3±0.02        0.9±0.08*
†
              -       0.7±0.8*            3.7±0.10* 
Cooled leg    0.3±0.02        0.3±0.02         3.1±0.15*             -                 - 
MAP (mmHg)   107±10  
 
       91±7* 
 
      141±12* 
 
      92±16* 
 
         120±4* 
Haemoglobin (g
.
l
-1
)          
Arterial   145±4       150±6         158±4*       155±4*          159±4* 
Venous (heated leg)   144±4       149±6         160±4*       154±4*          156±4* 
Venous (cooled leg)   144±4       152±5         163±4*       154±4*          158±3* 
Haematocrit (%)          
Arterial     44±1        47±3           48±1*         51±3*            52±3* 
Venous (heated leg)     44±1        46±2           48±1*         49±3*            49±2* 
Venous (cooled leg)     44±1        47±2           50±1*         47±1*            51±3* 
Blood volume shift (%)          
Arterial        -        -3±2            -8±1          -7±1             -9±1 
Venous (heated leg)        -        -3±2          -10±2          -6±2             -8±2 
Venous (cooled leg)        -        -5±2          -11±4          -6±2             -9±2 
Plasma volume shift (%)          
Arterial        -       -8±5          -15±2        -17±5           -22±5 
Venous (heated leg)        -       -6±3          -16±3        -14±5           -16±4 
Venous (cooled leg)        -       -9±3          -20±3        -11±3           -20±5 
Data are mean±SEM for 5-7 participants. Q̇, cardiac output; MAP, mean arterial pressure; * P < 0.05 compared to baseline; 
†
 P < 0.05 compared to the 
cooled leg in the same condition. 
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Figure 6-8. Femoral artery mean shear rate (SR) in the cooled and heated leg during passive 
heat stress and dynamic single leg knee extensor exercise. Grey bars are estimated SRs. 
Owing to changes in blood velocity, vascular SR increased in the heated leg during passive 
heat stress while cooling the contralateral limb with ice packs blunted these rises and 
diminished SR increases during exercise. Data are mean ± SEM for 7 participants. * Significant 
difference from baseline (P < 0.05); 
†
 significant difference compared to the cooled leg. 
 
6.4.2.2. Circulating microvesicles 
 Participants’ [PMV] was similar in the arterial and venous samples at rest 
and did not change during passive heat stress with localised one-limb cooling 
(P ≥ 0.5) (Figure 6-9). However, exercise with the cooled leg increased the 
concentration of circulating PMVs in the arterial circulation and in both the 
cooled and heated leg venous circulations (P < 0.05, Condition effect; without 
Condition x Sampling Site interaction). PMVs remained elevated from baseline 
during recovery and heated leg exercise (P < 0.05). Further analysis indicated 
that no increase took place in circulating [PMV] from recovery to heated leg 
exercise (P ≥ 0.05). 
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Figure 6-9. Effect of passive heat stress and dynamic single leg knee extensor exercise on 
arterial (A), heated leg venous (B), and cooled leg venous (C) plasma platelet microvesicles 
(PMVs). Heat stress did not influence plasma [PMV] at any sampling site, but PMVs increased 
systemically during cooled leg knee extensor exercise and remained elevated during recovery 
and heated leg exercise. Data are mean ± SEM for 5 participants. * Significant difference from 
baseline (P < 0.05). 
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 Circulating [EMV] was similar in the arterial, cooled and heated leg 
venous samples throughout the experimental protocol (P ≥ 0.05) (Figure 6-10). 
Neither passive heat stress nor dynamic knee extensor exercise with the cooled 
or heated leg affected the concentrations of circulating EMVs at any site of 
measurement (P ≥ 0.05). 
 
 
Figure 6-10. Effect of passive heat stress and dynamic single leg knee-extensor exercise on 
arterial (A), heated leg venous (B), and cooled leg venous (C) plasma endothelial microvesicles 
(EMV) concentrations. Neither heat stress nor single leg knee extensor exercise affected the 
[EMV]. Data are mean ± SEM for 5 participants.  
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6.4.3. Relationship between circulating microvesicles and shear rate 
 Within participant regressions revealed that arterial and venous [PMV] 
moderately correlated with estimations of vascular SR in the FA through 
haemodynamic manipulations with passive heat stress and exercise in 
experiment 1 (R2 = 0.30, P < 0.05) (Figure 6-11A). In experiment 2, when 
arterial and venous concentrations of PMVs from the heated and cooled legs 
were plotted against their respective leg vascular SRs a weak, though still 
significant, correlation was found (R2 = 0.11, P < 0.05) (Figure 6-11B). 
 
 
Figure 6-11. Relationship between arterial and venous platelet microvesicle (PMV) 
concentrations and femoral artery shear rate. Vascular shear rate was estimated during passive 
heat stress and cycling exercise (A), or calculated during passive heat stress with simultaneous 
cooling of one leg and during single limb knee extensor (KE) exercise.  
 
6.5. Discussion 
 Current evidence suggests that large muscle mass exercise induces MV 
appearance in the venous circulation, but their arterial dynamics and the 
importance of local regulatory mechanisms on MV release were unknown prior 
to the current study. Here, we investigated the a-v PMV and EMV dynamics 
127 
 
during large and small muscular mass exercise to further explore the potential 
relevance of systemic and local vascular shear stress in MV formation. We 
demonstrated that the increase in PMVs with exercise was not limited to the 
venous circulation, and that even short duration small muscle mass exercise 
induces an increase in plasma [PMV]. Moreover, it appeared that the formation 
of PMVs in healthy humans was not under direct control of local shear stress. 
 
6.5.1. Arteriovenous microvesicle dynamics during heat stress and 
exercise with small and large muscle mass 
 The present study investigated MV arterial and venous concentrations 
and a-v differences across the leg with heat stress and exercise. Notably, 
participants in the upright cycling trial (i.e. first experiment of study 2) displayed 
higher concentrations of PMVs in the venous circulation of the legs compared to 
arterial samples at baseline, suggesting PMV release across the resting leg 
microcirculation. Whole-body passive heat stress increased arterial [PMV] and 
also tended to elevate venous concentrations in these individuals. This 
response abolished the a-v PMV difference observed at baseline with no 
influence of corrections for plasma volume changes, indicating an increase in 
MV release from platelets. It has been reported that in vivo moderate passive 
heat stress (+1.3°C in core temperature) may increase pro-coagulant activity in 
the blood (Meyer et al., 2013), and increased concentrations of pro-coagulant 
annexin-V+ MVs have been reported in the circulation of baboons experiencing 
heatstroke induced by severe heat stress (rectal temperature ~44°C) 
(Bouchama et al., 2008). However, ex vivo heat-induced platelet 
hyperaggregability (an index of activation) has been reported only when platelet 
incubation temperatures reach as high as 43°C (Gader et al., 1990), suggesting 
that elevated temperature per se is not the mechanism inducing the increase in 
[PMV] during moderate passive heat stress seen in this thesis. Speculatively, 
the elevation in arterial [PMV] with passive heat stress observed in experiment 
1 of this chapter may relate to purinergic activation of platelets, as an increase 
in plasma ATP concentration has been observed in the intra-arterial 
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compartment of healthy individuals exposed to moderate passive heat stress 
(Pearson et al., 2011; Kalsi & González-Alonso, 2012). 
 The present study is the first to characterise the a-v MV dynamics across 
working limbs, and demonstrates that very heavy exercise influences the [PMV] 
in arterial and venous circulations. Short duration cycling elevated [PMV] in the 
venous circulation of the lower limbs, which is in accordance with results 
obtained in systemic venous samples after very heavy (Chaar et al., 2011; 
Maruyama et al., 2012) and moderate exercise (Sossdorf et al., 2010, 2011). 
The arterial concentration of PMVs, however, remained above baseline after 
passive heat stress but without further evident rise during exercise (only 6% 
increase from passive heat stress to heated leg exercise, and 12% increase 
from thermoneutral recovery to control exercise). An a-v PMV difference 
became evident again during heat stress, resulting to greater amount of PMVs 
leaving the leg circulation. In contrast to large muscle mass, unilateral exercise 
involving a small muscle mass (i.e. knee extensor protocol) caused a similar 
increase in arterial and venous PMVs, without significant a-v differences. This 
rise in PMVs was apparent at all vascular sampling sites by the end of cooled 
leg exercise and remained elevated above baseline throughout the 
experimental protocol, indicating that exercise may alter MV dynamics by 
causing a sustained increase in PMVs during post-exercise recovery, which 
agrees with past investigations where blood concentrations of MVs were 
elevated after exercise (Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf et 
al., 2011). Hence, these results demonstrate that short duration, very heavy 
exercise is a physiological stimulus inducing PMV formation even when a small 
muscle mass is involved, and indicates an increased release of PMVs into the 
venous circulation of exercising limbs during large muscle mass exercise. 
 Results concerning the appearance of PMVs in veins draining non-active 
limbs (i.e. veins in the antecubital region) during heavy cycling in the previous 
chapter are in agreement with the findings of the knee extensor experiment in 
this study, in which concomitant elevations in PMVs were observed in the 
venous circulation of both the active and non-active legs, and in arterial 
samples. These results point to a systemic effect of exercise on [PMV]. 
However, data from the large muscle mass exercise experiment in the current 
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chapter suggest that venous release of PMVs may occur in exercising limbs 
during heat stress incremental cycling, which seems contradictory. It is difficult 
to determine why a greater increase in venous compared to arterial [PMV] was 
observed during large muscle mass exercise during heat stress, but one 
potential explanation relate to the different venous sampling sites used in the 
experiments of chapter. In the heat stress and cycling experiment (experiment 
1), catheterisation of the common femoral vein was performed in the 
anterograde direction, meaning that blood samples were obtained at level of the 
external iliac vein; whereas blood samples were obtained from the femoral vein 
during the knee extensor experiment (experiment 2) due to retrograde 
cannulation. The femoral vein receives blood from various muscular tributary 
vessels, whereas the external iliac vein receives blood from the femoral vein 
and from subcutaneous collecting vessels (e.g. great saphenous vein) (Black, 
2014). Although evidence of specific PMV release at the level of the cutaneous 
circulation is lacking, it may be speculated that during combined heat stress and 
exercise the skin circulation may contribute to the activation of platelets, 
resulting in subsequent PMV release, which would explain the divergent 
findings observed in the current study. Further experiments, however, are 
necessary to shed some light upon this topic. 
The fact that plasma volume corrections did not abolish the increases in 
[PMV] substantiates these changes as not mere artefacts caused by 
haemoconcentration. Instead, this raises at least three possibilities during large 
muscle mass exercise: an increase in PMV release, a decrease PMV uptake, or 
a combination of both. Increased PMV release is logical since mechanical 
forces (Miyazaki et al., 1996; Reininger et al., 2006) and biochemical agonists 
(Nomura et al., 2000; Tschuor et al., 2008) that stimulate production of PMVs 
are known to increase during intense exercise. Evidence supporting MV uptake 
also exists and derives from combined in vitro and in vivo experiments (Terrisse 
et al., 2010; Cantaluppi et al., 2012; Dasgupta et al., 2012). PMV appears to 
undergo rapid clearance (Rand et al., 2006) and might be internalised by 
endothelial cells in the pulmonary and systemic circulation (Terrisse et al., 2010; 
Dasgupta et al., 2012), but a reduction in PMV uptake seems less likely based 
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on the tendency for a greater difference between venous and arterial [PMV] 
during large muscle mass exercise.   
 The present findings also demonstrate that thermal stress coupled with 
large muscle mass very heavy exercise results in increases venous [EMV]. 
Conflicting results exist regarding changes in blood [EMV] in response to acute 
thermoneutral exercise, with increases (Sossdorf et al., 2011; Kirk et al., 2013; 
Lansford et al., 2015), no changes (Mobius-Winkler et al., 2009; Chaar et al., 
2011; Lansford et al., 2015), and even decreases (Wahl et al., 2014) in venous 
[EMV] reported in the literature during recovery. Interestingly, plasma volume 
corrections abolished the observed EMV increase in the current experiment, 
providing some insight about potential confounding factors related to this 
exercise response. As exercise starts, enhanced hydrostatic pressure drives 
protein-free filtrate into the extravascular compartment, which in conjunction 
with increasing sweating rates leads to a reduction in plasma volume (Dill & 
Costill, 1974). Hence, the eventual increase in plasma [EMV] does not 
necessarily represent endothelial activation and EMV shedding, but most likely 
reflects the effects of haemoconcentration. Nevertheless, surrounding cells may 
ultimately respond to the increase in concentration of intravascular EMVs and 
may respond accordingly. 
 
6.5.2. Mechanistic insights 
 The formation and release of MVs from different cells is influenced by a 
myriad of agonists (see Table 2-1 in the Review of Literature chapter). Several 
platelet stimulating agents have been identified that induce PMV formation, 
including thrombin (Brill et al., 2005), noradrenaline (Tschuor et al., 2008), and 
interleukin-6 (Nomura et al., 2000), but it remains unknown whether these in 
vitro agonists are also involved in MV formation with exercise. Vascular shear 
stress seems to be a potential agonist since it increases markedly with exercise 
(Tanaka et al., 2006; Tinken et al., 2009; Credeur et al., 2010) and platelet 
stimulation with shear forces promotes PMV formation ex vivo (Miyazaki et al., 
1996; Reininger et al., 2006). Since platelets are in suspension in the 
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circulation, increases in frictional forces between the blood and the vascular 
wall through rises in blood velocity also increase the shear stress on the surface 
of rolling platelets in contact with the endothelial layer. Regarding EMVs, 
however, increases in shear stress may limit endothelial vesiculation, whereas 
low shear forces appear to induce endothelial apoptosis and EMV release in 
vitro (Vion et al., 2013b) and possibly in vivo (Jenkins et al., 2013). In this 
sense, we speculated that manipulations of vascular shear stress could lead to 
PMV formation in humans, whereas any change in [EMV] would be linked to 
shear-independent mechanisms. 
 The haemodynamic implications of passive heat stress are diverse, with 
the eventual elevation in blood velocity in large arteries (Minson et al., 1998; 
Chiesa et al., 2015) leading to increases in the frictional forces between the 
blood and the surrounding vasculature (Tinken et al., 2009; Padilla et al., 
2011b). In agreement with previous work, SR (a surrogate marker of shear 
stress) increased within the vasculature feeding heat stressed and exercising 
legs in both experiments of this study, whereas local cooling of the contralateral 
leg abolished this response. These thermal and exercise manipulations of SR 
provided insights on the impact of shear stress in local and systemic MV 
responses. Passive heat stress (+ ~0.5°C in core temperature in experiment 2) 
did not affect arteriovenous [PMV], although it elevated vascular SR in the 
heated leg to similar levels as those experienced during moderate whole-body 
heat stress in experiment 1. Increases in vascular SR in the cooled leg during 
exercise coincided with the observed increases in PMVs at all vascular sites 
including the contralateral resting leg, resulting in a weak association between 
[PMV] and vascular SR. This provides evidence against the original hypothesis 
of this study that local haemodynamic adjustments would influence the 
formation of PMVs. Nevertheless, it seems possible that a minimal level of 
vascular shear stress might be required to promote PMV formation in vivo. For 
example, SR in the heated leg was similar between both studies during passive 
heat stress (i.e. 3.4-fold vs 3.3-fold increase from baseline in experiment 1 and 
2, respectively), but the overall mean vascular shear stress was inevitably lower 
in experiment 2 where no changes SR occurred in the cooled leg. It remains 
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speculative, however, whether such a systemic shear stress threshold for PMV 
formation really exists.  
 
6.5.3. Limitations 
 Some limitations exist in the present study. By investigating each 
condition in a non-randomized order, we cannot exclude a possible repeated 
exercise effect influenced the concentration of circulating MVs in both studies. 
Also, factors other than haemodynamic adjustments might be involved in the 
MV response to exercise. Sympathetic activity, for example, increases even 
during mild heat stress (Gagnon et al., 2015), and noradrenaline has been 
shown to stimulate PMV production (Tschuor et al., 2008). Evidence for 
intravascular noradrenaline spillover with mild heat stress is equivocal (Chiesa 
et al., 2015; Gagnon et al., 2015), but it seems to occur consistently with further 
rises in body temperature (Kim et al., 1979; Meyer et al., 2013; Gagnon et al., 
2015). It is difficult, though, to make conclusions about adrenergic activation of 
platelets in the present experiments since blood catecholamine concentrations 
were not determined. 
 
6.6. Conclusion 
 The a-v PMV and EMV dynamics in response to heat stress and exercise 
were investigated in the current study. We demonstrated that whole-body 
passive heat stress may increase arterial [PMV], while abolishing an a-v 
difference that resulted in a release of venous PMVs in these participants at 
rest. Large muscle mass exercise under heat stress restores this difference 
between arterial and venous samples by markedly increasing the appearance of 
PMVs into the venous circulation. Small muscle mass exercise also increases 
the concentration of PMVs, but with no differences between arterial and venous 
circulations, whereas blood [EMV] increase only under strenuous conditions, 
such as very heavy heat stress exercise involving large muscle mass, probably 
as a consequence of exercise-induced haemoconcentration. Finally, and 
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contradicting our initial hypothesis, local adjustments in vascular shear stress 
do not seem to be the major mechanism leading to local PMV formation with 
exercise, since the concentrations of these MVs were elevated even in the 
circulation of resting limbs where the shear stress was low. These results 
provide evidence for a systemic release of PMVs and raise the possibility of 
additional mechanisms controlling their dynamics during exercise. 
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7. Chapter 7 - Study 3: Impact of Circulating 
Microvesicles Produced during Exercise upon 
Endothelial Cells: In Vitro Insights 
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7.1. Abstract 
 The influence of a variety of exercise stimuli on circulating MVs have 
been described in this thesis, but the role played by those MVs formed during 
exercise remains unknown. Since exercise training brings about beneficial 
adaptations to the vascular endothelium, we tested the hypothesis that MVs 
formed during exercise would stimulate endothelial cell proliferation and 
angiogenesis. Circulating MVs were obtained from healthy donors (n = 6, 24 ± 1 
years, 179 ± 4 cm, 83 ± 6 kg, mean ± SD) at rest and during heavy exercise 
and subsequently incubated in HUVEC culture to assess their effect on 
endothelial proliferation, migration, scratch wound-healing, and in vitro 
angiogenesis. Circulating MVs were isolated by centrifugation; those obtained 
at rest (rMVs) and during exercise (exMVs) were resuspended in culture 
medium for experiments. MV-free plasma supernatant was used as an internal 
control. Treatment with exMVs increased HUVEC proliferation and migration in 
comparison to rMV and supernatant treatments (P < 0.05). rMVs increased 
endothelial migration compared to rest supernatant treatment (P < 0.05), but 
induced similar cell proliferation when compared to exercise supernatant (P ≥ 
0.05). The exMV treatment enhanced the scratch wound closure rate by about 4 
fold compared to the negative control, and had the greatest effect compared to 
the other treatments (P < 0.05). Similarly, the number of tubule-like structures 
and branching points was greater with exMV treatment (P < 0.05), although the 
number of branching points did not differ from rMV condition (P ≥ 0.05). These 
findings demonstrate that MVs produced during exercise present a pro-
angiogenic potential in cultured endothelial cells, which is linked to the 
proliferative and chemotactic effects of exMVs. Together, these results provide 
the first evidence of a novel mechanism through which exercise may mediate 
vascular responses.  
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7.2. Introduction 
 Since their discovery, the biological roles played by MVs have been 
increasingly investigated by the scientific community. A wide variety of functions 
have now been attributed to specific MV populations, including influencing 
haemostasis, inflammation, and intercellular communication (Curtis et al., 2009; 
Sossdorf et al., 2011; Tushuizen et al., 2011), beyond serving as potential 
biomarkers that reflect the physiological state of their parent cells (Jimenez et 
al., 2003). The isolation of MVs from single cell populations to uncover their 
function (e.g. EMVs or PMVs) is generally performed by stimulation of cell 
cultures or ex vivo platelets with specific agonists. Human fluids, such as blood, 
contain a mixture of MV populations (Sossdorf et al., 2011; Headland et al., 
2014) and the isolation of a heterogeneous MV pool has frequently been 
performed through centrifugation protocols (Boulanger et al., 2001; Vanwijk et 
al., 2002), which allow researchers to study the impact of complex MV 
preparations in experimental models. 
 The vascular endothelium is a dynamic tissue that acts as a sensor and 
responds to its surrounding milieu, orchestrating a variety of functions within the 
cardiovascular system that vary from modulating vascular tone, to the regulation 
of extravascular traffic of cells and molecules (Michiels, 2003). The 
maintenance of adequate endothelial function is an essential step in the 
prevention and treatment of numerous cardiovascular diseases, with endothelial 
dysfunction linked to several pathological conditions and preceding poor 
cardiovascular outcomes (Williams et al., 1996; Gokce et al., 2003; Inaba et al., 
2010).  
 Endothelial cells are known to interact with circulating MVs through a 
variety of mechanisms that may depend on the MV source, which, in turn vary 
in composition based on the stimulus of formation (Boulanger et al., 2001; 
Vanwijk et al., 2002; Curtis et al., 2009). As a consequence, seemingly 
contradictory endothelial responses may arise from MV-endothelial interactions. 
For example, isolated PMVs were reported to protect endothelial cells from 
apoptosis, and have been linked to angiogenesis (Kim et al., 2004; Brill et al., 
2005); whereas EMVs obtained from cell cultures may promote paracrine pro-
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inflammatory actions in recipient endothelial cells (Curtis et al., 2009), and 
depress NO production in vitro while impairing acetylcholine dependent dilation 
in situ (Brodsky et al., 2004). Moreover, plasma containing circulating MVs from 
myocardial infarction (Boulanger et al., 2001), and pre-eclamptic patients 
(Vanwijk et al., 2002) have been shown to depress vascular reactivity in situ, 
with no detrimental effects observed when MVs were obtained from apparently 
healthy donors. Although the effects of MVs upon endothelial cells have been 
explored using MVs isolated from single cell sources or obtained from patients, 
little is known about the biological function of circulating MVs produced during 
physiological challenges like exercise. 
 Exercise training has long been recognised as an efficient intervention to 
ameliorate the risks or even prevent cardiovascular diseases, but the protective 
effects of exercise against cardiovascular events are only partially explained by 
the related changes in traditional risk factors (Mora et al., 2007), leading to the 
theory that non-traditional or undiscovered “exercise factors” may impart some 
of the observed benefits (Joyner & Green, 2009). Exercise may stimulate 
angiogenesis in the skeletal (Jensen et al., 2004; Gavin et al., 2015) and 
cardiac muscle (Iemitsu et al., 2006), and is known to bring about increases in 
vascular eNOS expression (Sessa et al., 1994; Laughlin et al., 2001) and 
subsequent improvement of endothelial function through acute increases in 
vascular shear stress (Tinken et al., 2009; Credeur et al., 2010; Tinken et al., 
2010; Birk et al., 2012). It also acts through indirect processes that may 
enhance NO bioavailability, such as improved anti-oxidant defences and 
through changes in a variety of circulating factors (Rush et al., 2003; Padilla et 
al., 2011b). Acute changes in circulatory agents have been suggested as 
complementary mechanisms to vascular shear stress that promote endothelial 
adaptations (Padilla et al., 2011a), but we still have only a partial understanding 
of the mechanisms by which exercise training stimulates protective vascular 
responses. Because circulating PMVs have been shown to increase in 
response to exercise in previous chapters of this thesis, and this MV population 
has been reported to stimulate endothelial repair and morphogenesis (Kim et 
al., 2004; Brill et al., 2005), it seems plausible that circulating MVs produced 
during exercise may be involved in endothelial adaptation. 
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 Therefore, the aims of this study were to test whether physiological 
concentrations of MVs obtained during heavy exercise would stimulate 
endothelial cell responses related to exercise adaptation. We hypothesised that 
both resting and exercise-derived MVs would enhance endothelial cell 
proliferation and in vitro angiogenesis over MV-free plasma. 
 
7.3. Methods 
7.3.1. Experimental design 
 To investigate the impact of exercise-derived MVs on endothelial cells, 
HUVECs were incubated with circulating MVs obtained at rest (rMV) and during 
exercise (exMV) to test their capacity to stimulate cellular migration, 
proliferation, wound-healing, and in vitro angiogenesis. Unless otherwise stated, 
experimental media for proliferation, and wound-healing assays were serum-
free growth medium made up in M199 (wound-healing medium) or phenol red-
free M199 (proliferation assay medium); whereas migration and tubule 
formation assays were performed in M199 with 1% penicillin-streptomycin and 
0.1% HEPES. Experiments were performed by supplementing the experimental 
media with MVs, VEGF, or FBS as detailed in the general method section. 
VEGF or FBS supplemented experimental media were used as positive 
controls. The supernatant of MV pellets (MV-free plasma) were also used as 
additional internal controls. 
 
7.3.2. Microvesicle acquisition and storage 
 Plasma samples for rMV and exMV isolation were obtained from male 
participants (Table 7-1, n = 6) who underwent 1 h of heavy exercise on a semi-
recumbent ergometer as described in chapter 5 of this thesis. Citrated venous 
blood samples were obtained without stasis from a cannula positioned in a vein 
of the antecubital region at rest, and between 30 and 60 min of exercise. PPP 
139 
 
was obtained after the two-step centrifugation protocol and aliquots were stored 
at -80°C until required for experiments.  
 
Table 7-1. Microvesicle donors' characteristics 
Age (years) 
 
24±3 
 
Height (cm) 
 
179±11 
 
Body mass (kg) 
 
83±14 
 
BMI (kg
.
m
-2
) 
 
26±2 
 
V̇O2max (l
.
min
-1
) 
 
3.3±0.7 
 
Exercise intensity (%PPO) 
 
63±5 
 
Mean±SD for 6 donors; BMI, body mass index; V̇O2max, 
maximal oxygen uptake; PPO, peak power output 
 
7.3.3. Microvesicle supplemented medium 
 On the day of the experiments, PPP vials were thawed at room 
temperature and aliquots transferred to new microcentrifuge tubes. Samples 
were diluted with the same volume of PBS and tubes were centrifuged for 1 h at 
17,500 g at 4°C to pellet MVs. After centrifugation, all but 60 µl of supernatant 
was removed and the MV pellet was resuspended in respective experimental 
medium to the original concentration for the migration and wound-healing 
assays or to double the original MV concentration for the proliferation or tubule 
formation assays, but the suspension was further diluted to the original 
concentration in subsequent steps of those respective assays. 
 The plasma supernatant obtained after centrifugation was also used to 
make separate aliquots of MV-free experimental medium, to quantify responses 
to stimuli within the plasma independent of MVs that could confound observed 
MV effects. Accordingly, results from a pilot study, in which imaging flow 
cytometric analysis was performed (using the PMV marker CD41), confirmed 
that negligible concentrations of MVs were observed in these supernatant 
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samples (i.e. 9 ± 2% compared to the resuspended MV pellet; n = 4). Hence, 
the MV-free supernatant medium was used as an internal control in the current 
experiments. 
 
7.3.4. Culture of human umbilical vein endothelial cells 
 Stored HUVECs were quickly removed from liquid nitrogen and thawed 
in warmed distilled water. Cells were seeded in culture flasks, slowly diluted in 
growth medium, and incubated at 37°C in 5% CO2. A complete medium change 
was performed 24 h after seeding (Freshney, 2010b) with subsequent half 
medium changes every 48-72 h. Passaging or experiments were performed 
when monolayers became 60-80% confluent. To do so, each flask was washed 
with PBS, and HUVECs were detached from the coated wells by the application 
of trypsin. The enzyme was inactivated by FBS supplemented medium and cells 
were centrifuged for 6 min at 300 g. If experiments were not performed, 
passaging was completed by seeding the cell pellet into 3 new culture flasks 
with growth medium. Experiments were performed in FBS-free experimental 
medium unless stated otherwise, with cells between passage 3 – 6. 
 
7.3.5. Proliferation assay 
 Proliferation of HUVECs was quantified by the MTT assay in pre-coated 
0.5% gelatin 96-well plates in MTT experimental medium. The cell pellet was 
resuspended in MTT medium (FBS-free growth medium) and each well was 
loaded with 50 µl of the cell suspension (2,000 cells) with the same volume of 
conditioned experimental medium, with 20% FBS supplemented medium 
serving as positive control. After 48 h of incubation each well was subsequently 
incubated with the MTT solution for further 4 h. All but 30 µl was removed and 
DMSO was applied to each well before absorbance analyses using a microplate 
reader (ELx808, BioTek Instruments, USA). The average of quadruplicate wells 
was calculated and expressed as a percentage of the negative control 
condition. 
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7.3.6. Migration assay 
 Migration of HUVECs towards MV containing wells was measured with a 
modified 48 wells Boyden chamber (AP48, Neuro Probe, USA). Briefly, 
migration experimental medium (1% penicillin-streptomycin, 0.1% heparin 
M199) was loaded into wells in the lower chamber to the point of forming a 
slight meniscus, and a gelatin pre-coated polycarbonate filter was positioned 
over loaded wells. Wells loaded with 10% FBS experimental medium were used 
as positive control. The upper chamber was then loaded with 50 µl of a 
suspension of pre-starved cells (25,000 cells in 1% penicillin-streptomycin, 
0.1% heparin M199), and incubated to allow cells to migrate. After 
disassembling the chamber, cells adherent to the migrated side of the filter were 
fixed with methanol and stained with Giemsa stain. Three random images of 
each well were obtained with an Axioskop 2 microscope (Zeiss, Germany) at 
20x magnification, and the number of migrated cells were counted with ImageJ 
software (version 1.48, National Institutes of Health, USA). Because cells did 
not migrate in the FBS-free conditions, the average of triplicate wells was 
expressed as a percentage of 10% FBS controls. 
  
7.3.7. Scratch wound-healing assay 
 The scratch wound-healing assay was performed to investigate the 
impact of human MVs on HUVECs undergoing wound repair. Cells were 
cultivated in 96-well plates pre-coated with gelatin. On the experimental day, a 
scratch was made on serum starved cell monolayers using a pipette tip, and 
cells were incubated with experimental medium. Experimental medium 
supplemented with 20% FBS served as positive control. Images were obtained 
at baseline and after incubation using an inverted microscope (Axiovert 200M, 
Zeiss, Germany) at 10x magnification. The ImageJ software (version 1.48, 
National Institutes of Health, USA) was used to determine the cell free area, 
from where wound closure was calculated. The average of quadruplicate wells 
for each condition was then expressed as a percentage of the wound closure 
observed in the negative control condition. 
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7.3.8. Tubule formation assay 
 The angiogenic potential of MVs was assessed by a tubule formation 
assay. Briefly, 96-well plates were coated with a basement membrane protein 
gel (Geltrex®, Thermo Fisher Scientific, UK) and incubated at 37°C to allow the 
gel to solidify. Starved cells were suspended in M199 (1% penicillin-
streptomycin, 0.1% heparin) and 50 µl (10,000 cells) per well were incubated 
with the same volume of experimental medium. The plate was returned to the 
incubation chamber for 24 h and imaged at 5x magnification (AxioVert 
microscope, Zeiss, Germany). The number of tubule-like structures and 
branching points were determined using ImageJ software (version 1.48, 
National Institutes of Health, USA), and the average of triplicate wells was 
expressed as a percentage of tubules and branches formed in the negative 
control condition. 
 
7.3.9. Statistical analysis 
 Results are expressed as mean ± SEM unless stated otherwise. 
Changes in dependent variables (i.e. proliferation, migration, closure of scratch 
wound, formation of tubule-like structures and branching points) were compared 
using a repeated measures ANOVA, with Condition (4 levels – rest supernatant, 
exercise supernatant, rMVs, and exMVs) as the independent variable. 
Differences between conditions were identified using the least significant 
difference correction when a significant F-ratio was observed. The statistical 
analysis was performed with SPSS software (version 20, IBM, USA), with α < 
0.05. 
 
7.4. Results 
7.4.1. Proliferation 
 HUVECs proliferated almost 50% quicker than the negative control 
condition when treated with rMVs, and cell proliferation almost doubled from 
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control with exMVs (Figure 7-1). The exMV treatment increased HUVEC 
proliferation in comparison to the rMV and both the resting and exercise 
supernatants (P < 0.05). rMVs also increase HUVEC proliferation in comparison 
to resting supernatant, but it was similar to the exercise supernatant condition 
(P ≥ 0.05). No differences in cell proliferation were observed between resting 
and exercise supernatants (P ≥ 0.05). 
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Figure 7-1. Proliferation of human umbilical vein endothelial cells incubated with rest or 
exercise microvesicles, or microvesicle-free supernatant. Experimental medium supplemented 
with 20% foetal bovine serum (FBS) served as positive control. Top: representative images of 
negative control (A), positive control (B), rest (C) and exercise (D) microvesicle-free 
supernatant, as well as rest (E) and exercise (F) microvesicles. Bottom: Treatments with 
exercise microvesicles stimulated cells to proliferate at a higher rate when compared to other 
experimental conditions. Data are expressed in mean±SEM relative to negative control. n = 5; * 
significant different from rest supernatant (P < 0.05); ‡ significant different from exercise 
supernatant (P < 0.05); # significant different from rest microvesicles (P < 0.05).  
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7.4.2. Migration 
 Both MV and supernatant conditions stimulated HUVEC migration as 
depicted in Figure 7-2. The MV treatments, however, produced a greater 
stimulus for endothelial cell migration when compared with their respective 
supernatants (P < 0.05). A greater number of cells migrated towards wells 
loaded with exMVs in comparison to rMVs (P < 0.05), but no difference was 
observed between the two MV-free supernatant conditions. 
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Figure 7-2. Migration of human umbilical vein endothelial cells towards experimental medium 
supplemented with rest or exercise microvesicles, or microvesicle-free supernatant. Top: 
representative images of negative control (A), positive control (B), rest (C) and exercise (D) 
microvesicle-free supernatant, as well as rest (E) and exercise (F) microvesicles. Bottom: 
Increased migration was observed towards wells loaded with exercise microvesicles in 
comparison to the other experimental conditions Dara are expressed in mean±SEM relative to 
positive control since no migration occurred towards negative control wells; n = 5; * significant 
different from rest supernatant (P < 0.05); ‡ significant different from exercise supernatant (P < 
0.05); # significant different from rest microvesicles (P < 0.05). 
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7.4.3. Scratch wound-healing 
 The effects of supernatant and MV treatments were evident in the 
scratch wound-healing assay (Figure 7-3). HUVECs treated with supernatants 
displayed an almost 2-fold increase in the rate of repair compared to negative 
control wells, but no difference was observed between resting and exercise 
supernatants (P ≥ 0.05). Both MV conditions enhanced the closure rate 
compared to the supernatant conditions, with rMVs stimulating wound healing to 
a similar extent to that observed in the FBS positive control wells (i.e. nearly 3 
fold quicker than the negative control), and this process was augmented in the 
presence of exMVs (P < 0.05). 
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Figure 7-3. Scratch wound-healing capacity of human umbilical vein endothelial cells incubated 
with rest or exercise microvesicles, or microvesicle-free supernatant. Experimental medium 
supplemented with 20% foetal bovine serum (FBS) served as positive control. Top:  
representative images of negative control (A), positive control (B), rest (C) and exercise (D) 
microvesicle-free supernatant, as well as rest (E) and exercise (F) microvesicles. Bottom: 
Endothelial cells treated with exercise microvesicles displayed enhanced repair in comparison 
to the other experimental treatments, as measured by wound closure. Dara are expressed in 
mean±SEM; n = 5; * significant different from rest supernatant (P < 0.05); ‡ significant different 
from exercise supernatant (P < 0.05); # significant different from rest microvesicles (P < 0.05). 
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7.4.4. Tubule formation 
 HUVECs formed tubule-like structures when seeded on basement 
membrane matrix (Figure 7-4). Treatment with exMVs induced greater 
formation of tubule-like structures in comparison to all other conditions (P < 
0.05) (Figure 7-4A), with no differences observed amongst rMVs and 
supernatant treatments (P ≥ 0.05). The number of branching points was also 
increased in endothelial cells treated with exMVs compared to those incubated 
with MV-free supernatant (P < 0.05) (Figure 7-4B), although exMVs treatment 
did not increase the number of branching points in comparison to rMVs (P ≥ 
0.5). 
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Figure 7-4. In vitro angiogenic parameters of human umbilical vein endothelial cells treated with rest or exercise microvesicles, or microvesicle-free supernatant. Vascular 
endothelial growth factor (VEGF) was used as a positive control. Top: representative images of negative control (A), positive control (B), rest (C) and exercise (D) 
microvesicle-free supernatant, as well as rest (E) and exercise (F) microvesicles. Bottom: exercise microvesicles increased the formation of tubule-like structures (A) in 
comparison to rest microvesicles and microvesicle-free supernatants; as well as the number of branching points (B) in comparison supernatant treatments. Dara are 
expressed in mean ± SEM; n = 5; * significant different from rest supernatant (P < 0.05); 
‡
 significant different from exercise supernatant (P < 0.05); 
#
 significant different 
from rest microvesicles (P < 0.05). 
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7.5. Discussion 
 Intravascular MVs have been shown to display either stimulatory (Kim et al., 
2004; Brill et al., 2005), or inhibitory (Boulanger et al., 2001; Vanwijk et al., 2002; 
Brodsky et al., 2004; Curtis et al., 2009) effects on the vascular endothelium, 
depending on the MV cell source as well as their mechanism of formation, and heavy 
exercise was shown to increase [PMV] in plasma of healthy humans in this thesis, 
but the biological role of these submicron vesicles produced during exercise was 
unknown. Here, we took the first step in understanding the effects produced by MVs 
formed during exercise upon the vascular system, demonstrating that exMVs display 
a stimulatory effect in cultured endothelial cells by supporting repair and 
angiogenesis. 
 Part of the cardiovascular benefits of exercise training are mediated through 
endothelial adaptations in response to repetitive increases in vascular shear stress 
(Tinken et al., 2009; Credeur et al., 2010; Tinken et al., 2010; Birk et al., 2012), 
although complementary mechanisms involving the release of circulating mediators 
have also been hypothesised (Padilla et al., 2011a). In agreement with the latter 
hypothesis, our experiments suggest that circulating MVs from healthy humans may 
be involved in the endothelial adaptive responses to exercise, since physiological 
concentrations of exMVs stimulated cultured endothelial cells to a greater extent 
than rMVs, and because the observed effects were generally blunted in treatments 
involving MV-free supernatant. 
 Cell division and migration are fundamental aspects of cellular function, and 
are required during development of complex organisms. In adults, endothelial cells 
are kept in a quiescent state but retain their proliferative capabilities and may re-
enter the gap 1 phase and resume the cell cycle if required (Cooper & Hausman, 
2009; Freshney, 2010a). Under favourable environmental conditions and upon 
growth factor stimulation endothelial cells can proliferate, and migrate toward 
chemotactic agents (Jaffe et al., 1973b; Kim et al., 2004; Kitamura et al., 2008; 
Battinelli et al., 2011). Endothelial chemotaxis and angiogenesis are part of an 
integrated system involving the sequential recruitment of specific signalling cascades 
that include the phosphoinositide 3 kinase, and mitogen activated protein kinase 
pathways, which act downstream of VEGF receptor activation and are critical for 
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endothelial cell extension and migration (Lamalice et al., 2007). The findings of the 
present study indicate that MVs produced during exercise induce enhanced 
proliferative and migratory behaviour in endothelial cells compared with MVs 
produced during basal conditions. Findings from isolated proliferation and migration 
assays are supported by results of the scratch wound-healing assay, which 
represents a more complex process that depends on cell migratory and proliferative 
capacities. The fact that rMVs did not stimulate HUVEC proliferation to a greater 
extent than MV-free plasma suggests that resting plasma of healthy humans 
contains enough nutrients to support endothelial maintenance, with circulating MVs 
playing a minor role in this process. 
 Endurance training has been reported to induce angiogenesis in active 
tissues in animal (Iemitsu et al., 2006) and human models (Jensen et al., 2004; 
Gavin et al., 2015). Angiogenesis is the complex integrated phenomenon of new 
capillary formation, stimulated by several stimuli including hypoxia (Deveci et al., 
2002) and local vascular shear stress (Galie et al., 2014), with VEGF believed to be 
the major, albeit not single, growth factor implicated in the formation of the new 
capillary network (Jensen et al., 2004; Iemitsu et al., 2006; Gavin et al., 2015). Since 
it has been demonstrated that dynamic high intensity training enhances 
capillarization in human skeletal muscles (Jensen et al., 2004), and because acute 
bouts of heavy intensity exercise elevate the concentrations of circulating PMVs in 
humans, we hypothesised that MVs produced during exercise would act on the 
vascular endothelium and stimulate angiogenesis. To test this hypothesis, we treated 
human endothelial cells seeded onto basement membrane matrix proteins with 
circulating MVs obtained from humans at rest and during heavy exercise. Exercise 
MVs increased the number of endothelial tubule-like structures in comparison to 
rMVs and their respective MV-free supernatants, suggesting that MVs produced 
during exercise may enhance the angiogenic activity of the endothelium during 
exercise. Because PMVs have been found to increase during exercise it seems 
plausible that this MV population would be involved with the angiogenic response. In 
agreement, MVs obtained from thrombin-stimulated platelets have been shown to 
display pro-angiogenic potential in vitro (Kim et al., 2004; Brill et al., 2005), and in 
vivo (Brill et al., 2005), which may indicate that the PMV could be the MV population 
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responsible for bringing about the observed angiogenic effects in the present 
experiments. 
 By staining the proliferation-related protein Ki-67, Jensen et al. (2004) 
demonstrated that the increased skeletal muscle angiogenesis observed after 
training is in fact associated with migration and proliferation of endothelial cells 
forming new capillaries, and the results of the current study indicate that pro-
angiogenic effects of MVs released during exercise may be supported by their 
stimulatory effects that induce endothelial migration and proliferation. It is worth 
noting that exercise increased the concentration of PMVs in the intravascular space 
and this might seem counterproductive since MV stimulation on the apical side of 
endothelial cells may stimulate migration into the vessel luminal space. However, 
under specific chemoattractant stimulation platelets may undergo transmigration 
through an activated endothelium (Kraemer et al., 2010) and potentially deliver MVs 
beneath the basal surface of endothelial cells. Moreover, PMVs have been reported 
to adhere preferentially to the subendothelial extracellular matrix in comparison to 
endothelial cells and to serve as a binding site for platelets on the vessel wall 
(Merten et al., 1999). The precise interplay between circulating MVs, endothelial 
migration stimulation, and angiogenesis is still far from understood, but one could 
speculate that PMVs might bind to points where the extracellular matrix is exposed 
and support vessel repair and angiogenesis. However, it is difficult to evaluate the 
relevance of this hypothesis during exercise without evidence of vascular damage. 
 The mechanisms responsible for exMVs induced morphogenic and mitogenic 
effects were not a focus of this study, yet a number of candidate mechanisms exist. 
One potential pathway through which MVs bring about their effects may be VEGF-
related (Brill et al., 2005; Benameur et al., 2010). VEGF binds with high affinity to 
fms-like tyrosine kinase 1 and fetal liver kinase 1, with subsequent angiogenic and 
proliferative responses associated with the activation of several downstream 
effectors and second messengers, including protein kinase B and cyclic guanosine 
monophosphate related-pathways (Morbidelli et al., 1996; Ziche et al., 1997; 
Kitamura et al., 2008). eNOS activation also seems to be required to mediate the 
proliferative and angiogenic effects of VEGF (Morbidelli et al., 1996; Ziche et al., 
1997; Fukumura et al., 2001). Human MVs have been shown to carry active forms of 
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eNOS (Horn et al., 2013), and the in vitro pro-angiogenic effects of PMVs may be 
inhibited by VEGF receptor blockade (Brill et al., 2005), suggesting a potential 
mechanism through which MVs increase endothelial motility, mitogenesis, and 
morphogenesis. It is worth also noting that depletion of lipids from PMVs also 
abolishes their angiogenic effects (Kim et al., 2004), suggesting biologically active 
lipids as further mediators of MV functions. 
 
7.5.1. Limitations  
The results of the current study suggest a positive role for MVs, but also exhibit 
some limitations. Even though efforts were made to isolate circulating MVs, one 
cannot rule out that other agents might be mediating the observed effects. This, 
however, is still an intrinsic issue of this research field and the current study used an 
accepted approach applied by others to investigate the impact of circulating MVs in 
the vascular endothelium (Boulanger et al., 2001; Vanwijk et al., 2002). Moreover, 
the results with MV-free plasma provide further support that our findings arose from 
MV stimulation and not additional soluble molecules. One should also take into 
account that current methods for MV isolation do not enable the separation specific 
MV populations from human plasma without ex vivo agonist stimulation, and even 
though it seems logical that PMVs were the primary mediators of our findings, we 
cannot reject the hypothesis that other MV populations induced the observed 
responses. Furthermore, due to the dynamic nature involved in MV formation it 
remains unknown whether the influence of exMVs on endothelial cells resulted 
simply from their greater concentration in this condition, or due to distinct intrinsic 
characteristics of MVs produced during exercise (e.g. different cargo). Finally, it is 
essential to keep in mind that observations taken from static cell culture experiments 
are not necessarily transferable to other cell lines, and within complex whole 
organism models. Nevertheless, our results serve as a first step in this exciting new 
field of study in exercise sciences. 
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7.6. Conclusion 
 In conclusion, plasma MVs produced during exercise displayed a regenerative 
and pro-angiogenic potential in cultured endothelial cells when compared to 
circulating MVs from resting humans, which were supported by the stimulatory 
effects of exMVs on endothelial proliferation and migration, since these two 
processes are essential for angiogenesis and wound repair. Together, this set of 
data offers the first evidence of the biological role of exercise-derived MVs upon cells 
of the human vasculature, and provides evidence of a novel mechanism that may 
help us to uncover how exercise mediates vascular adaptations. 
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8. Chapter 8 - General Discussion and Conclusions 
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8.1. Introduction 
 The major aims of this thesis were to investigate the circulating PMV and 
EMV dynamics, the stimuli governing their formation during exercise, and to further 
explore the potential impact of circulating MVs upon endothelial cells in vitro. The 
human experiments described here explored the effect of large and small muscle 
mass exercise on arterial and venous concentrations of MVs and their appearance 
kinetics with exercise, focusing primarily on exercise-induced haemodynamic 
adjustments as the latent mechanism inducing PMV formation; whilst in vitro assays 
were used to examine proliferative, chemotactic and angiogenic potential of 
circulating MVs formed during exercise on human endothelial cells. More specifically, 
chapter 5 examined the time-course of appearance of venous PMV and EMV during 
two intensities of prolonged submaximal exercise and recovery, in order to explore 
the time-course of MV appearance in the circulation and further examine the 
potential relationships between vascular shear stress and additional biochemical 
agonists as mediators of intravascular MV release. Chapter 6 covered the a-v PMV 
and EMV responses to small and large muscle mass exercise, and the influence of 
vascular shear stress manipulations on local and systemic MV formation was 
explored with the aid of local thermal manipulations and single limb exercise. Finally, 
in chapter 7 the biological relevance of MVs was examined in cell culture to gain 
insights into the potential agonist effects of exercise-derived MVs on endothelial cell 
proliferation, migration, wound-healing, and angiogenesis. 
 The following chapter will centre on the interpretation of the main findings of 
this thesis from an integrative physiology perspective and in comparison to the 
literature, followed by a discussion of intrinsic methodological aspects of the studies. 
Finally, perspectives for future research in the area will be presented. 
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8.2. Main findings 
8.2.1. Microvesicle dynamics 
8.2.1.1. Platelet microvesicles during exercise 
 Our understanding of exercise as a physiological stress capable of stimulating 
MV blebbing, is very recent as most of the literature in this area has been published 
within the last decade. This means that several aspects related to MV dynamics in 
response to exercise and their physiological relevance are largely unexplored. 
Increases in plasma PMVs have been described in samples taken from the venous 
circulation far from exercising limbs (e.g. antecubital vein blood samples during leg 
cycling) during recovery from a variety of exercise protocols ranging from prolonged 
submaximal (Sossdorf et al., 2010, 2011) to short duration very heavy or severe 
dynamic exercise (Chaar et al., 2011; Maruyama et al., 2012), but no study to date 
has explored the dynamics of PMVs during exercise. In chapter 5, we showed for the 
first time that [PMV] increase during exercise, and chapter 6 demonstrated that this 
elevated appearance of circulating PMVs occurs in both the arterial and venous 
circulations. During large muscle mass exercise, however, the a-v PMV difference 
was different from zero. This suggests a release of MVs by platelets that appear in 
the venous circulation, because the rise in [PMV] occurred in both the arterial and 
venous samples but it tended to be greater in the venous circulation draining 
exercising limbs. The mechanisms linked to this increased PMV release in the 
venous circulation are unknown, but it is possible that local factors stimulate the 
activation of calcium dependent (Fox et al., 1991; Chang et al., 1993; Dachary-
Prigent et al., 1995) and independent (Cauwenberghs et al., 2006) pathways that 
lead to PMV formation when platelets are travelling through the microcirculation of 
active limbs during large muscle mass exercise. 
 In chapter 5, we demonstrated that PMV formation depends on the exercise 
stimulus, as PMVs were unaltered with moderate exercise (~35% PPO), but 
increased during heavy cycling (~60% of PPO). Previous studies investigating 
plasma PMVs applied exercise protocols varying from 45% to 100% of PPO, and 
consistently reported elevations in [PMV] after exercise (Sossdorf et al., 2010; Chaar 
et al., 2011; Sossdorf et al., 2011; Maruyama et al., 2012). Understanding the effects 
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of exercise intensity was not the focus of chapter 6, but its results also provide some 
support for the suggestion that exercise intensity is a modulator of the PMV 
responses, since very heavy (80% PPO) large and small muscle mass exercise 
triggered an increase in PMVs. Another interesting observation from this thesis is 
that the increases in PMVs were similar amongst the 3 human experiments (Figure 
8-1), despite the rather distinct exercise stimuli (e.g. from moderate to very heavy 
and short to prolonged duration exercise performed with either small or large muscle 
mass). This does not preclude exercise intensity as a factor involved in the 
stimulation of PMV formation, but rather indicates that there might be a threshold for 
platelet stimulation after which a plateau in [PMV] occur. After this theoretical point, 
additional mechanisms increasing MV clearance or preventing their release probably 
limits further appearance of PMVs in the circulation. Although it ought to be 
confirmed in future studies, this hypothetical “capping effect” in [PMV] may be a 
protective response to avoid the establishment of an excessive pro-coagulant 
environment induced by uncontrolled formation of MVs (Sossdorf et al., 2010, 2011) 
which could dysregulate the body’s haemostatic control. 
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Figure 8-1. Baseline fold increase in arterial vascular shear rate (top) and venous plasma platelet 
microvesicle (PMV) concentrations (bottom) measured at the level of non-exercising limbs (study 1), 
and of exercising limbs (study 2) in the three human experiments of this thesis. During heavy and very 
heavy exercise, PMVs increased approximately 2 fold in the circulation of non-exercising and 
exercising limbs, whereas rather distinct SRs were observed in arteries feeding non-exercising and 
exercising limbs. Data are mean±SEM for 5 – 9 participants. Short very heavy cycling SRs are 
estimations, as described in chapter 6. 
 
8.2.1.2. Platelet microvesicles during post-exercise recovery 
 Previous studies focused on the MV response shortly after exercise and 
during 2 h of recovery. Data in the literature allow us to speculate that the rise in 
circulating PMVs with large muscle mass exercise probably reaches its peak within 1 
h of recovery (Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf et al., 2011; 
Maruyama et al., 2012). Our enhanced temporal resolution results from chapter 5 
confirmed that platelets continue to release MVs in the early recovery period, which 
may persist for up to 1 h after heavy exercise. Indirect evidence for such post-
exercise MV kinetics is also found in chapter 6, where circulating PMVs tended to be 
higher than baseline during the recovery from the first bout of very heavy exercise. 
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This MVs release might be supported by platelet activation during exercise, which 
may remain active during recovery when recruitment of new platelets may also occur 
(Davis et al., 1990; Ikarugi et al., 1999). From a practical perspective, these results 
demonstrate that the exposure of the human vasculature to augmented 
concentrations of PMVs is not limited to the exercise period, enabling these MVs to 
induce their intravascular effects for around 1 h after cessation of heavy exercise. 
 
8.2.1.3. Endothelial microvesicles 
 Endothelial cells have been shown to produce MVs under several 
physiological conditions. Cultured endothelial cells release MVs following activation 
and apoptotic stimulation (Jimenez et al., 2003), and augmented [EMV] have been 
linked to a wide spectrum of pre-clinical and clinical conditions ranging from obesity 
to coronary artery disease, and are thought to reflect vascular damage in these 
populations (Bernal-Mizrachi et al., 2003; Esposito et al., 2006; Horn et al., 2013). 
 The appearance of circulating EMV with exercise has been investigated 
recently. The original work by Mobius-Winkler et al. (2009) described no changes in 
plasma EMVs with 4 h of moderate intensity cycling, with more recent work reporting 
conflicting results with either an increase (Sossdorf et al., 2011; Kirk et al., 2013; 
Lansford et al., 2015), no change (Sossdorf et al., 2010; Chaar et al., 2011; Sossdorf 
et al., 2011; Guiraud et al., 2013; Ross et al., 2014), and even reductions in 
circulating [EMV] (Wahl et al., 2014) observed after exercise. It is currently difficult to 
determine which factors lead to these divergent findings in the literature, but the 
results of this thesis consistently demonstrate a lack of change in plasma [EMV] 
across a range of exercise intensities, exercise modalities and durations. The only 
condition in the present thesis in which [EMV] increased was a combination of heat 
stress and very heavy exercise, and remarkably these increases in concentration 
were completely explained by reductions in plasma volume. Changes in plasma 
volume during exercise have been overlooked by other researchers. For example, 
Sossdorf et al. (2011) reported a slight rise in participants’ Hct accompanied by an 
increase in venous [EMV] in one of their experimental groups. It is possible that the 
~25% elevation in EMVs in Sossdorf et al. (2011) work might have been partially 
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explained by reductions in plasma volume although it is difficult to estimate blood 
volume changes without Hb information. Nevertheless, it is likely that the 
modifications in [EMV] with exercise may at least in part be a consequence of simple 
haemoconcentration, and do not exclusively represent activation of the vascular 
endothelium with subsequent MV release.  
 
8.2.2. Insights into platelet microvesicle formation in humans 
 The stimulation of ex vivo platelets with mechanical and biochemical factors 
have allowed scientists to identify a number of agonists that induce PMV formation 
and their respective downstream related pathways (Fox et al., 1991; Dachary-Prigent 
et al., 1995; Cauwenberghs et al., 2006; Reininger et al., 2006). These in vitro 
findings are extremely relevant from a mechanistic view point, but it is also important 
to appreciate that ex vivo results are not always transferable to in vivo situations, 
where a myriad of factors interact to maintain homeostasis. Hence, it is necessary to 
stress that a reductionist approach cannot explain the multifaceted processes 
involved in physiological responses since the activation of several complementary, 
often redundant, mechanisms can ensure an appropriate outcome (Joyner, 2013). In 
this thesis, therefore, we attempt to gain insight into a few potential mechanisms 
involved in MV formation during exercise with a particular emphasis on vascular 
shear forces, since they can activate vesiculation of platelets ex vivo (Miyazaki et al., 
1996; Reininger et al., 2006) and they increase progressively throughout the 
vascular tree until arteriolar beds (Papaioannou et al., 2006).  
 Accordingly, a novel aspect of this thesis was the investigation of potential 
stimuli related to the production of PMVs in exercising humans. Past studies have 
described the MV response after exercise protocols, but no effort has been made to 
understand the mechanisms explaining such responses. In vivo results from the 
three experiments of the thesis demonstrated that [PMV] display a weak to moderate 
correlation with vascular SR. Data from chapter 6, however, imply that vascular 
shear stress is not a key regulator of the localised production of PMVs, as their 
concentration increased simultaneously in the venous circulation of exercising and 
non-exercising limbs where SRs differed considerably. In addition, changes in [PMV] 
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during passive heating and/or exercise were relatively small in comparison to the 
marked differences in estimated leg vascular SRs induced by the different protocols 
(Figure 8-2). These results, however, do not rule out vascular shear stress as an in 
vivo agonist since platelets might be rapidly stimulated to produce MVs through local 
shear forces and then these platelets may quickly travel and release MVs 
systemically, even if they were activated in the exercising limb. Nevertheless, it 
seems that alternative systemic regulators are also involved in PMV formation during 
exercise. Noradrenaline, for example, is a platelet agonist that induces MV release in 
vitro (Tschuor et al., 2008), and a positive correlation between circulating PMV and 
noradrenaline levels was reported in chapter 5. Additional intravascular platelet 
agonists present in the systemic circulation (that unfortunately could not be 
determined), such as thrombin (Brill et al., 2005) and nucleotides (Yegutkin et al., 
2007), might also be involved with PMV formation, although the ability of the latter to 
promote PMV release still has to be confirmed. 
 
 
Figure 8-2. Plasma platelet microvesicle (PMV) and estimated or calculated common femoral artery 
shear rate (SR) fold change from baseline during passive heating, small and large muscle mass 
exercise in the three human experiments. Femoral artery SRs were predicted from blood flow 
estimations during experiment 1 (semi-recumbent cycling), and estimated from thermodilution blood 
flow measurements in experiment 2 (upright cycling), assuming baseline arterial diameters as a 
reference; vascular SRs were calculated directly from ultrasound measurements in experiment 3 
(knee extensor exercise trial). 
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Hence, this thesis provides initial evidence for the understanding of 
mechanical and biochemical agents related to PMV formation during exercise. 
Although increased vascular shear stress might be involved to a degree with PMV 
formation, there is certainly not one single factor driving the systemic changes in 
[PMV] during exercise. Future experiments ought to expand these findings by using 
isolated shear stress manipulations with select agonists, and/or platelet vesiculation 
stimulation/blockade with exercise responsive biochemical agonists in vivo. 
 
8.2.3. Circulating microvesicles and endothelial cell interactions 
 The physiological function of a variety of specific subpopulations of MVs has 
been intensively studied, which has changed our view of MVs from simple cell dust 
or by-products to biologically active cell biomarkers (Hargett & Bauer, 2013). Several 
studies have pointed to circulating MVs as putative regulators of vascular function in 
situ (Boulanger et al., 2001; Vanwijk et al., 2002), inducing a variety of stimulatory 
and inhibitory effects in cultured endothelial cells depending on the MV source and 
stimulus of formation (Brodsky et al., 2004; Kim et al., 2004; Brill et al., 2005; Curtis 
et al., 2009). This well-known MV – endothelial interaction led us to hypothesise that 
MVs circulating in the vasculature during exercise could be part of the intricate 
mechanisms through which exercise stimulates its beneficial vascular effects such 
as enhanced endothelial function and the formation of new capillaries. 
 As a follow up of chapters 5 and 6, where increased plasma concentrations of 
PMVs were consistently observed in healthy men performing short very heavy and 
prolonged heavy intensity exercise, in chapter 7 we provided the first evidence that 
physiological concentrations of circulating MVs are likely to be involved with 
endothelial responses to exercise, since cells treated with exMVs displayed 
enhanced proliferation and migratory capacities, which support a pro-angiogenic 
influence. The use of a MV-free internal control validated these findings by 
demonstrating that plasma obtained during exercise but depleted of MVs did not 
produce the same stimulatory effects. Intrinsic features related to circulating MV 
isolation obviously limit our capacity to clearly identify the contribution of specific MV 
subpopulations in the experimental assays. The [PMV], however, was greater in 
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exMV compared to rMV treatments, and Kim et al. (2004) demonstrated that PMVs 
promote a dose-dependent stimulation of endothelial proliferation and angiogenesis. 
This MV population has also been identified as an intravascular source of VEGF 
(Brill et al., 2005), which suggests PMVs as a potential factor inducing angiogenic 
effects in cell culture observed in this thesis. Taken together, results from previous 
studies investigating the impact of MVs outside the context of exercise in addition to 
the present findings of this thesis suggest that exercise-derived MVs might be a 
novel candidate mechanism for vascular adaptation with exercise training. Whether 
these in vitro responses will transfer to the in vivo situation, however, remains to be 
determined in future experiments. 
 
8.3. Significance of findings 
 Altogether, the human and cell culture experiments of this thesis represent an 
integrative approach that enhances our understanding of the complex interplay 
between acute haemodynamic changes and circulating factors that eventually may 
lead to enhanced endothelial adaptations with exercise training (Padilla et al., 
2011a). Based on the experimental chapters of this thesis and existing literature, a 
theoretical integration of blood MV responses to exercise and their physiological 
outcomes can be proposed. 
 In this hypothetical model, elevations in PMVs may be part of an integrative 
response to exercise that complement the effects of shear stress in inducing 
endothelial adaptations (Figure 8-3). As exercise intensity increases, both vascular 
shear stress and blood noradrenaline concentrations become elevated. These and 
additional factors, such as intravascular ADP, likely act together to activate platelets 
(Miyazaki et al., 1996; Reininger et al., 2006; Yegutkin et al., 2007; Tschuor et al., 
2008), culminating in MV production after an agonistic threshold level is attained. 
The increased concentrations of MVs may play a role in the complex thrombotic-
fibrinolytic control with exercise (Sossdorf et al., 2010, 2011) whilst also being taken 
up by endothelial cells (Terrisse et al., 2010; Dasgupta et al., 2012), which in turn 
may stimulate endothelial repair and angiogenesis through direct MV – endothelial 
interactions. Although still speculative, increased blood noradrenaline concentrations 
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may negatively affect endothelial cells (Kaplon et al., 2011), and it might be possible 
that the increase in PMVs with exercise is a compensatory response to the 
increased blood catecholamine levels necessary for haemodynamic regulation within 
these conditions. A lack of change in plasma concentrations intuitively leads to the 
idea of no MV formation, but it is also possible that both the MV release and its 
uptake might be increased during moderate exercise. If that were the case, the 
intracellular concentration of MVs could be increased in endothelial cells, which may 
stimulate the vascular responses even if the net concentrations of MVs in the 
circulation remain unaltered. Whether or not the concentration of circulating MVs 
during moderate exercise actually reflects a matched increase in their formation and 
uptake ought to be determined. Overall, this hypothetical construct provides an 
integrative view of the physiological processes involved with exercise-induced MV 
formation and their potential impacts related to vascular adaptations. Future 
experiments will be required to confirm the validity and relevance of this hypothetical 
model. 
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Figure 8-3. Theoretical model depicting stimuli for exercise-induced PMV formation and the potential 
biological relevance of circulating MVs in vascular function. As heavy or very heavy exercise 
progresses, vascular shear stress increases alongside blood catecholamine levels and several 
endothelial agonists. Vascular shear stress is likely to be the major stimulus for vascular adaptations 
(Tinken et al., 2010; Birk et al., 2012); whereas evidence suggests that elevations in blood 
noradrenaline concentrations have a depressor effect on endothelial function (Kaplon et al., 2011). 
The interplay between these two factors potentially promotes PMV release during exercise, which 
may interact positively with endothelial cells as a compensatory mechanism to increased circulating 
catecholamines and add to shear stress stimulation and the contribution of chronic amelioration in 
cardiovascular risk factors. Circulating [PMV] does not increase during light exercise, which may 
reflect a lack of formation or alternatively a matching between increased MV shedding and clearance. 
 
8.4. Methodological considerations 
 Although in vitro assays are performed under very strictly controlled 
experimental conditions, variations amongst individuals markedly increase variability 
and data dispersion with in vivo experiments. Likewise, the sample size in human 
experiments within this thesis (n = 9 for chapter 5, and n = 7 and 5 for MV results of 
chapter 6) may be considered small, which intrinsically increases the chances of 
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type II statistical error. Attaining so called “appropriate” levels of statistical power is a 
common issue in human and exercise physiology, with invasiveness and the 
difficulties of some procedures frequently limiting sample sizes, not to mention 
logistical and economic constraints. This was the case within the invasive 
experiments of chapter 6 where arteriovenous samples were obtained, whereas the 
time-consuming nature of experiments in chapter 5 restricted the number of 
volunteers willing to partake in prolonged experimental sessions (i.e. > 5 h involved 
in each main trial). To overcome potential issues related to sample size certain 
procedures were used, including a many-to-one comparison (Dunnett’s test) instead 
of a general all possible pairwise-comparisons post hoc, to increase statistical 
power. However, the main dependent variables (i.e. MVs) frequently displayed 
changes in magnitude of ~100% or more during exercise, with effect sizes for PMVs 
varying from 1.4 to 1.5 during heavy exercise in chapter 5 and from 1 to 1.6 in 
chapter 6, which are far from trivial. Thus, even though larger sample sizes would be 
beneficial from a statistical point of view, it is more reasonable to consider that the 
results of this thesis fall within the standards of human physiology experiments of 
this nature. 
 In this thesis circulating MVs were determined using a state-of-art imaging 
flow cytometer (ImageStreamX® Mark II, Amnis Corporation, USA), rather than a 
traditional cytometer. Imaging flow cytometry is a relatively new technique that allows 
not only the acquisition of positive events, but the identification and image analysis of 
each individual event. According to the “iceberg hypothesis”, only a small portion of 
MVs fall within the detection limits of traditional laser flow cytometers (Harrison & 
Gardiner, 2012). The 60x objective magnification in our imaging flow cytometer 
provided us with enhanced resolution for size discrimination compared to standard 
cytometers (Harrison & Gardiner, 2012; Headland et al., 2014), which in all likelihood 
allowed us to perform MV quantification with a much improved limit of detection 
compared to past studies. Hence, due to the improved resolution and meticulous 
titration of antibodies to optimize MV analyses, findings resulting from this thesis 
should be considered a step forward in our understanding of MV dynamics with 
exercise, even though their absolute values might not compare directly to previous 
research in the field using traditional flow cytometric techniques.  
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 Finally, an important characteristic of circulating MVs relates to their 
phenotype in response to specific agonists. PMVs can be identified by a variety of 
surface antigens that are believed to be expressed independent of the platelet 
agonist. Endothelial cells, however, are known to secrete MVs with distinct markers 
depending on their intracellular state (Jimenez et al., 2003). It is important, then, to 
draw attention to our CD62E+ events, which are thought to reflect EMVs released by 
activated endothelial cells; however, we cannot rule out the presence of other EMV 
populations arising from other endothelial stimuli, such as those released by 
apoptotic endothelia.  
 
8.5. Future perspective 
 The present thesis explored a number of interactions between exercise, 
intravascular MVs, and the vascular endothelium. Although the present findings 
expand our current knowledge, they certainly do not cover all aspects of this 
relatively new research field. Hence, directions for future investigations will be 
presented below. 
 Results from this thesis demonstrate the importance of exercise intensity in 
PMV formation. However, the precise intensity at which significant elevations in MV 
appearance occurs was not determined. Since circulating MVs formed during 
exercise were initially seen as novel postulants of positive endothelial responses in 
this thesis, the identification of a minimal workrate necessary to bring about 
increases in blood MVs could be of practical significance for future training related 
research in the applied setting. This could be accomplished using maximal 
incremental test protocols with blood sampling performed at each exercise step. 
Although, this could have been completed in chapter 6 of this thesis, logistical 
restrictions limited the number of blood samples available for MV quantification, and 
this topic will have to be address in future experiments.      
 The acute influence of circulating MVs formed during exercise on the 
proliferation and morphogenesis of cultured endothelial cells were also explored in 
this thesis, but their importance in vivo and relevance in relation to long term 
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vascular adaptations with exercise remain to be determined in experiments where 
exercise-derived MVs are applied in in vivo models, and in which blockade of the 
increase in circulating MVs during exercise is performed. Blunting the release of 
PMVs during acute exercise might be possible in experiments using high doses of 
platelet antagonists, such as acetylsalicylic acid, and could provide further 
mechanistic insight about PMV formation during exercise and their subsequent 
effects on endothelial cells. Longitudinal experiments with chronic inhibition of MV 
formation might be difficult to perform in humans, but the investigation of long term 
vascular responses to exercise amongst Scott syndrome patients (a rare congenital 
bleeding disorder due to defects in platelet plasma membrane remodelling and MV 
release) may provide the first insight into the importance of acute changes in MVs on 
chronic endothelial adaptations. This would have clinical relevance amongst Scott 
syndrome and other patient populations and may ultimately lead to the development 
of training strategies to optimise the prevention of vascular dysfunction. 
 Moreover, future research involving the in vitro blockade of intracellular 
pathways would help identify mechanisms through which exercise-derived MVs 
promote their positive effects on endothelial cells. This could expand our knowledge 
about vascular physiology and might help identify novel targets for the promotion of 
vascular health. 
 
8.6. Hypotheses 
8.6.1. Study 1 
1) Plasma [PMV] increase during and after exercise, according to relative 
exercise intensity (accepted) 
2) PMVs return to baseline values in the late recovery period (accepted)  
Changes in [PMV] during exercise correlate with:  
3) Vascular SR (accepted) 
4) Plasma noradrenaline concentrations (accepted) 
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5) Plasma IL-6 concentrations (rejected) 
6) Plasma [EMV] remain stable with submaximal exercise (accepted) 
 
8.6.2. Study 2 
1) Circulating [PMV] increase during passive whole-body heat stress and 
exercise (accepted) 
2) Localised shear stress manipulations coincide with local changes in venous 
PMVs during single limb heat stress and exercise (rejected) 
3) [EMV] remain stable during passive heat stress but increase with very heavy 
large muscle mass exercise (accepted)  
 
8.6.3. Study 3 
Compared to other conditions, circulating MVs obtained during exercise 
stimulate greater endothelial cell:  
1) Proliferation (accepted) 
2) Migration (accepted) 
3) Healing from a scratch-wound (accepted) 
4) In vitro angiogenesis (accepted) 
 
8.7. Summary of findings 
 Throughout prolonged leg cycling and recovery [EMV] measured at a vein 
from the antecubital region remained unaltered, whereas PMVs increased and 
plateaued within 30 min of heavy, but not moderate, exercise. Changes in [PMV] 
during exercise were correlated with increases in peripheral vascular SR and plasma 
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noradrenaline concentrations. Elevated levels of PMVs were also observed 1 h after 
heavy cycling and returned to baseline in late recovery, demonstrating an early post-
exercise effect on PMV dynamics. 
Moderate, but not mild, passive heat stress augmented arterial [PMV], which 
remained elevated during short duration very heavy exercise. Venous concentration 
of PMVs tended to be elevated with moderate passive heat stress, and markedly 
increased during both large and small muscle mass exercise, leading to a tendency 
of PMV release in the venous circulation of active limbs during large muscle mass 
exercise. The concentration of EMVs, on the other hand, increased only in the 
venous circulation and during large muscle mass exercise under heat stress 
conditions, most likely reflecting haemoconcentration. Isolated manipulations of 
vascular SR revealed little association between local PMV production and vascular 
shear stress, indicating a systemic effect of exercise on PMV formation. 
 Lastly, circulating MVs isolated from humans during heavy intensity exercise 
enhance the proliferative and migratory capacity of cultured human endothelial cells 
compared to those isolated from resting humans. Moreover, parameters related to in 
vitro angiogenesis were also increased under these conditions, with minor effects of 
MV-free plasma controls.  
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PRE-PARTICIPATION HEALTH CHECK QUESTIONNAIRE 
Health and safety within this investigation is of paramount importance. For this reason we 
need to be aware of your current health status before you begin any testing procedures. The 
questions below are designed to identify whether you are able to participate now or should 
obtain medical advice before undertaking this investigation, Whilst every care will be given to 
the best of the investigators ability, an individual must know his/her limitations. 
 
Subject name………………………………………………………………………………… 
Date of birth…...…………………………………………………………………..………….  
Emergency contact name and number:……………………………………………….... 
 
Please answer the following questions:       
                  YES           
NO 
Has your doctor ever diagnosed a heart condition or recommend  
only medically supervised exercise? 
Do you suffer from chest pains, heart palpitations or  
tightness of the chest? 
Do you have known high blood pressure? If yes, please give details  
(i.e. medication) 
Do you have low blood pressure or often feel faint or have dizzy  
spells? 
Do you have known hypercholesteremia? 
Have you ever had any bone or joint problems, which could be  
aggravated by physical activity? 
Do you suffer from diabetes? If yes, are you insulin dependent? 
Do you suffer from any lung/chest problem,  
i.e. Asthma, bronchitis, emphysema? 
Do you suffer from epilepsy? If yes, when was the last incident? 
Are you taking any medication? 
Have you had any injuries in the past?  
e.g. back problems or muscle, tendon or ligament strains, etc… 
 Are you currently enrolled in any other studies? 
 I have already participated in a recent blood donation program 
 Are you a smoker? 
 Do you exercise on a regular basis (at least 60 min a week)?      
Do you have known anaemia?  
 
 Describe your exercise routines (mode, frequency, intensity/speed, race times): 
If you feel at all unwell because of a temporary illness such as a cold or fever please inform 
the investigator. Please note if your health status changes so that you would subsequently 
answer YES to any of the above questions, please notify the investigator immediately. 
 
I have read and fully understand this questionnaire. I confirm that to the best of my 
knowledge, the answers are correct and accurate. I know of no reasons why I should 
not participate in physical activity and this investigation and I understand I will be 
taking part at my own risk. 
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Appendix IV – List of Cell Culture Supplies 
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Phosphate buffered saline (CAT# P4417-100TAB), medium 199 (M199 - 
Hyclone; CAT# SH30024.01), modified medium 199 (phenol red, l-glutamine, and 
sodium hydrogen carbonate-free; CAT# M3769), dimethyl sulfoxide (DMSO; CAT# 
472301), trypsin-EDTA (CAT# 59418C-100ml), sodium citrate, thiazol blue 
tetrazolium bromide (MTT; CAT# M5655), gelatine solution (2%; CAT# G1393-
100ML) were from Sigma-Aldrich (USA). Heparin sodium (CAT# 411210010), l-
glutamine (CAT# AC119951000), and azur eosin methylene-blue (Giemsa stain 
solution; CAT# AC295591000) were from Acros Organics (by Fisher Scientific, UK). 
Sodium hydrogen carbonate (CAT# S/4200/60), HEPES (CAT# BP299-100), and 
VEGF (CAT# RP-75746) were from Fisher Scientific (UK). Trypan blue (CAT# 
SV30084.01), and penicillin-streptomycin (CAT# SV30010) solutions were from 
Thermo Fisher Scientific (UK). Foetal bovine serum (FBS – CAT# 10270-106), and 
Geltrex® (CAT# A1413202) were from Life Technologies (UK). Fc receptor blocking 
solution (Human Trustain FcX; CAT# 422302), PE anti-human CD62E 
(CAT#322606) and PE/Cy5 anti-human CD41 antibodies (CAT#303708) were from 
BioLegend (USA). Endothelial cell growth supplement (CAT# 4110-5004) was from 
Bio-Rad (UK). Pipette tips for the scratch wound-healing were from Fisherbrand, UK 
(1-200 µl, CAT# 10283882); and combitips used for coating plates for angiogenesis 
assay were from Eppendorf (0.5 ml, CAT# 12674587, Eppendorf, Germany). 
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EXERCISE INTENSITY MODULATES THE APPEARANCE OF CIRCULATING 
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CELLS 
Eurico Nestor Wilhelm, José González-Alonso, Christopher Parris, Mark 
Rakobowchuk 
Manuscript accept for publication at the American Journal of Physiology – 
Heart and Circulatory Physiology. 
DOI: 10.1152/ajpheart.00516.2016 (in Press). 
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CIRCULATING MICROVESICLE DYNAMICS WITH EXERCISE AND THEIR 
IMPACT ON HUMAN VASCULAR CELL FUNCTION 
EURICO NESTOR WILHELM, JOSÉ GONZÁLEZ-ALONSO, MARK 
RAKOBOWCHUK 
Oral presentation at ECSS 2016, Vienna, Austria 
Introduction: Microvesicle release into the bloodstream may be a signalling 
mechanism controlling the function of vascular cells, but the impact typical 
endurance exercise sessions on circulating concentrations, and the role played by 
these blood constituents on surrounding endothelial cells remains unknown. Here, 
we tested the hypothesis that exercise intensity would affect the time-course of 
platelet-derived (PMV) and endothelial-derived (EMV) microvesicle appearance in 
the circulation through changes in vascular shear stress and biochemical agonists; 
and that microvesicles obtained during exercise would enhance angiogenic and 
reparative potential of endothelial cells. Materials and methods: Nine young health 
men (25± 4 years, 1.79±0.09 m, 80.5±12.0 kg) had venous blood samples taken to 
measure plasma microvesicle, interleukin-6 (IL-6) and noradrenaline (NA) 
concentrations prior, during, and throughout the recovery period after 1 h of 
moderate (MI) (36±5% of VO2max) or heavy (HI) (62±4% VO2max) intensity semi-
recumbent cycling and during a time matched control trial. Local haemodynamics 
were determined by ultrasonography. In vitro experiments were performed by 
incubating resting and exercise-derived microvesicles in cell culture to examine their 
effects on morphogenesis, proliferation and migratory capacity of human umbilical 
vein endothelial cells. Results: Circulating PMVs only increased from baseline with 
HI exercise (from 21.2±3.4.103 PMV.μl-1 to 55.8±24.8.103 and 48.0±16.6.103 PMV.μl-1 
at 30 and 60 min, respectively; P<0.05), returning to baseline early in post-exercise 
recovery (P>0.05), whereas EMVs were unchanged (P>0.05). Vascular shear rate at 
the brachial artery (non-exercising limb) increased more during HI (3.1±1.5 fold) 
compared to MI (1.9±0.4 fold) exercise (P<0.05), and changes in PMV 
concentrations were related to limb shear rate (r2=0.43, P<0.05), but not to IL-6 or 
NA (P<0.05). Incubation of microvesicles obtained during exercise with endothelial 
cells enhanced their proliferation, migration, healing of scratch wound (all P<0.05), 
and angiogenesis compared to microvesicles obtained at rest and microvesicle free 
plasma control. Discussion: These results demonstrate that circulating PMVs 
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increase during heavy exercise and that shear stress is a potential candidate 
mechanism triggering this PMV response. The increased microvesicle pool seemed 
to have agonist effects on human endothelial cells by stimulating angiogenesis and 
repair, and may be considered a novel mechanism through which exercise mediates 
vascular healing and adaptation. 
 
